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Microtubules are a major constituent of the cytoskeleton in all eukaryotic cells. They 
are essential for cell morphogenesis and motility. Specifically in the dividing cells, 
microtubules form the spindle which segregates chromosomes. Microtubule plus 
ends constantly switch between phases of growth and shrinkage which is necessary 
for microtubule reorganization and thus their function. Importantly, microtubule 
dynamics are highly regulated by microtubule-associated proteins (MAPs).  
EB1 and Mini spindles (Msps) are unique amongst MAPs because they bind 
and track growing microtubule plus ends autonomously. Although essential for cell 
division and thus highly expressed in dividing cells, EB1 and Msps are also abundant 
in differentiated cells. However, to identify post-mitotic roles of proteins essential for 
cell division, particularly in context of a multicellular organism, is a challenge 
requiring new tools which I aimed to develop in my project.  
Since EB1 acts by recruiting MAPs to the microtubule plus ends, I 
generated short peptides which bind to Drosophila EB1 to block interactions with 
these MAPs. I showed that an EB1-MAP interaction was disturbed in Drosophila S2 
cultured cells and expressing these peptides in developing Drosophila reduced fly 
viability. Further screening and analysis of peptides interacting with fly EB1 and its 
human homologues uncovered sequence determinants promoting strong binding and 
specificity. To uncover Msps function, I generated a msps temperature sensitive 
mutant and found that Msps is essential for neuromuscular function in developing 
Drosophila. 
This study showed that the regulation of microtubule dynamics has crucial 
functions at the whole organism level. These new tools allow the roles of 
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1.1. The microtubules cytoskeleton 
Microtubules were observed in 1950s owing to first electron microscopy images 
which revealed long structures inside the cells called at the time canaliculi, 
endoplasmic reticulum or filamentous elements (Wells, 2005). They were first not 
given much attention and omitted by many researchers up until 1963 when, 
independently by Slautterback as well as Ledbetter and Porter, they were named 
“microtubules” and described as cylindrical cellular structures composed of globular 
subunits (Bryan, 1974; Wells, 2005). The first observations of microtubules in the 
interphase and the mitotic cells were confirmed by other research groups and the 
great importance of these structures was soon recognised.  
Microtubules are an essential element of a eukaryotic cell cytoskeleton, 
required for many cellular processes. They are central to chromosome segregation in 
mitotic and meiotic cell division, cell motility and polarity, organisation of an 
intracellular structure as well as cytoplasmic movement of organelles and proteins. 
Architecture of microtubule network undergoes dynamic changes and depends on an 
activity which is performed by microtubules.  
1.1.1. Structure of microtubules 
Tubulins make a large protein family, so far α-, β-, γ-, δ-, ε-, ζ and η-tubulin have 
been identified, of which α- and β-tubulin are most studied since they are the 
building blocks of microtubules (McKean et al, 2001; Teixido-Travesa et al, 2012). 
Amino acid sequence analysis reveals that similarity within α-tubulins or β-tubulins 
from different species is very high (Tuszynski et al, 2006). Microtubules are 
filamentous, hollow tube-like structures built of tubulin subunits (Figure 1.1). The 
subunits are heterodimers of α- and β-tubulin monomers, each of 55 kDa. Folding of 
the α- and β-tubulin is highly regulated, multistep process leading to formation of a 
very stable αβ-tubulin subunit (Lewis et al, 1997). First assisted by cytosolic 
chaperonin c-cpn, the folding is then facilitated by interaction with cofactors, A in 
case of α-tubulin and cofactor B facilitating β-tubulin folding (Lewis et al, 1997). 
The αβ-tubulin heterodimers polymerise by making interactions between their ends 
in a head to tail manner forming a longitudinal structure called “protofilament” 













Figure 1.1 Structure of a microtubule 
Microtubules are filamentous, hollow tubes built of αβ-tubulin 
heterodimers. These heterodimers polymerise by making interactions 
between α and β tubulin, giving microtubules polarity. The αβ-tubulin 
subunits repeat in a microtubule every 8 nm forming protofilaments 
which associate side by side and are staggered, making microtubule to 
adopt a helical structure. The helix spans three tubulin monomers with 
each turn which gives rise to a discontinuity in α-α-tubulin or β-β-tubulin 
contacts from the neighbouring protofilaments, called a “seam”. The 
more dynamic end where β tubulin is exposed is called a “plus” end and 







each of the heterodimers makes sideways contacts with the subunits from adjacent 
protofilaments (Tuszynski et al, 2006). The side by side association of protofilaments 
forms a cylindrical structure, 24 nm in diameter, a microtubule (Figure 1.1). 
However, protofilaments are staggered by ~0.9 nm, thus making microtubule to 
adopt a helical structure (Mandelkow et al, 1986). The helix spans three tubulin 
monomers with each turn, which is called a 3-start helix (Erickson & Stoffler, 1996). 
While the lateral contacts of the protofilaments arise between either α-α-tubulin or β-
β-tubulin, due to the 3-start helix a discontinuity arises along the microtubule, called 
a “seam”, which results in a lateral contact being made between α- and β-tubulin 
(Figure 1.1) (Erickson & Stoffler, 1996).   
Microtubules are generally assembled from 13 protofilaments in the in vivo 
conditions but there are exceptions such as an 11 or 15-protofilament microtubules in 
neurones of a nematode (Lodish et al, 2007). In vitro, microtubules have also been 
shown to vary in a number of protofilaments with 14-protofilament microtubules 
being the most common (Chrétien et al, 1992; Desai & Mitchison, 1997). Atop of the 
basic singlet structure, microtubules can form doublet and triplet structures by 
joining two and three microtubules laterally. While doublet microtubules are present 
in cilia and flagella, triplet microtubules are characteristic of centrioles and basal 
bodies (Esparza et al, 2013; Lodish et al, 2007; Piasecki & Silflow, 2009). There are 
13 protofilaments in one of the microtubules and 10 protofilaments in the adjacent 
microtubule of these compound microtubules (Lodish et al, 2007).  
1.1.2. Dynamics of microtubules 
Due to the α- to β-tubulin binding of the heterodimers forming a microtubule, 
microtubules have a polarity. Hence, the plus end of the polymer is where the β-
tubulin is exposed and the minus end exposes α-tubulin. In the mitotic and meiotic 
spindle, the minus ends of microtubules are anchored in the centrosome and the plus 
ends are mainly associated with the spindle mid-zone. Microtubules are less dynamic 
at the minus ends than at the plus ends. Polymerisation of microtubules at the minus  
ends is very slow and it is observed in vitro while in cells and in vivo the minus end 
is usually stabilised by a cap or it depolymerises (Jiang & Akhmanova, 2011). 
Contrarily, microtubules can both grow and shrink at the plus ends. 
4
The kinetics of microtubule plus and microtubule minus ends differ from 
each other. When concentration of tubulin dimer is above the critical level, a 
microtubule end polymerises, while below the critical concentration levels, a 
microtubule end depolymerises. Since microtubule plus end has a lower critical 
concentration of tubulin addition than the minus end, microtubules can undergo 
treadmilling in the minus to the plus-end direction (Waterman-Storer & Salmon, 
1997).  Treadmilling is possible when the free tubulin concentration is above the 
critical concentration for the microtubule plus end and below the critical 
concentration for the minus end. However, rate of treadmilling in vivo is significantly 
higher than in vitro (Waterman-Storer & Salmon, 1997). While treadmilling is an 
intrinsic microtubule property, its rate varies and depends not only on free tubulin 
concentration but also microtubule interactions with microtubule associated proteins 
(MAPs) regulating microtubule dynamics (Panda et al, 1999). Treadmilling could 
have a role in cell motility and trafficking. 
Microtubules can also persist for a long time in a state when they neither 
grow nor shrink, so called “pause” state. This pause state must require stabilising 
agents but not much is known about microtubule caps, apart from a ring complex 
discussed later. Also, it is often unclear whether microtubules indeed suspend their 
activities at the plus ends when in pause state or if the subunit turnover is too subtle 
to be detected (Jiang & Akhmanova, 2011). 
The term “dynamic instability” refers to the dynamic behaviour of a 
microtubule end where the polymer undergoes phases of growth and shrinkage. 
Dynamic instability happens at both ends of microtubules but it is more robust at the 
plus end (Panda et al, 1999). The growing microtubule can start rapidly 
depolymerising (catastrophe) followed by a return to the growing mode (rescue) 
(Figure 1.2.) (Gardner et al, 2013). Only the β-tubulin at the plus end with a molecule 
of GTP bound to its exchangeable site (E-site) can add another αβ-tubulin 
heterodimer, a process attributed to an irreversible GTP- to GDP hydrolysis (Desai & 
Mitchison, 1997; Heald & Nogales, 2002).  
During GTP hydrolysis the energy is stored in the microtubule lattice as a 
mechanical strain (Desai & Mitchison, 1997). Loss of this GTP tubulin cap exposes 





Figure 1.2 Dynamics of microtubule polymers 
Microtubules polymerise by adding αβ-tubulin dimers to the plus 
ends. While both α and β-tubulin have bound GTP molecule only the 
β-tubulin can add another αβ-tubulin heterodimer to the plus end, a 
process attributed to an irreversible GTP- to GDP hydrolysis. Loss of 
GTP tubulin cap from the microtubule plus ends exposes the GDP 
tubulin and causes microtubule protofilaments to peel backwards 
from a microtubule filament causing its rapid depolymerisation, 
called catastrophe. Contrarily, microtubule rescue is the event when 
microtubules starts polymerising again, a process associated with 









protofilaments to peel backwards from a microtubule filament causing its 
depolymerisation (Figure 1.2) (Desai & Mitchison, 1997; Heald & Nogales, 2002). 
Faivre-Moskalenko et al. (2002) demonstrated that catastrophes are essential for 
positioning of microtubule organising centres (MTOCs) by investigating positioning 
of artificial MTOCs in microchambers containing already developed microtubule 
array. MTOCs started moving in the microchambers only after addition of a 
catastrophe promoting factor (Faivre-Moskalenko & Dogterom, 2002). Interestingly, 
microtubules undergo an aging process which is indicated by increased catastrophe 
rates in the long microtubules. Microtubules are required to accumulate several 
events before they undergo catastrophe (Gardner et al, 2013).  
Microtubule rescue is the event when microtubule shortening ceases and the 
microtubule starts polymerising again, a process associated with gaining back the 
GTP cap by the microtubule (Figure 1.2) (Gardner et al, 2013).  While it was shown 
that rescue events are not dependent on tubulin concentration, a study by Dimitrov et 
al. (2008) demonstrated that the rescue events may be attributed to features 
embedded in microtubule lattice (Gardner et al, 2013). Dimitrov et al. (2008) used a 
conformation-specific antibody, hMB11, recognising polymerised tubulin bound to a 
non-hydrolyzable analogue of GTP but not to a GTP-bound tubulin. The hMB11 
antibody, in addition to microtubule end, decorated microtubules along their lattice 
giving a randomly distributed dot staining both in vitro and in vivo. These 
unhydrolysed GTP-tubulin islands become exposed upon microtubule 
depolymerisation and they can act as GTP cap and trigger microtubule rescue 
(Dimitrov et al, 2008). Interestingly, in neuronal cells hMB11 staining on 
microtubules is more abundant in axons than dendrites (Nakata et al, 2011). 
Therefore, the GTP tubulin incorporation into the microtubule lattice can be 
regulated and a cell-dependent event improving microtubule stability in cells such as 
neurons. 
1.1.3. Nucleation of microtubules 
Contrarily to the in vitro conditions, where microtubule nucleation can occur without 
aid of any nucleating factors, in in vivo conditions a nucleator is required (Teixido-
Travesa et al, 2012). Microtubule nucleation and organisation is largely regulated by 
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MTOCs which are sites of proteins essential for performing these processes. The key 
player at the MTOCs is γ-tubulin which forms a platform for microtubule nucleation. 
14 molecules of γ-tubulin assemble into a ~2.2 MDa ring structure (γ-TuRC) along 
with other proteins, γ-tubulin complex protein 2 (GCP2), GCP3, GCP4, GCP5 and 
GCP6 (Kollman et al, 2011). γ-tubulin small complexes (γ-TuSCs) are subunits of γ-
TuRCs and they are composed of two γ-tubulin molecules associated with GCP2 and 
GCP3 (Kollman et al, 2011). Although a model is proposed where γ-TuRC serves as 
a template for microtubule nucleation, neither the exact structure of the ring nor the 
number of each of the subunits composing the complex are yet clear (Kollman et al, 
2011). 
While the presence of γ-tubulin in the centrosomal regions has a major role 
in microtubule nucleation, the γ-tubulin pool in the cytoplasm constitutes ~80% of 
the total, suggesting that it has a function at other sites (Moudjou et al, 1996). 
However, the nucleating activity of γ-TuRCs has been restricted to mitotic spindle, 
centrosome or spindle pole body (Choi et al, 2010; Kollman et al, 2011).  γ-TuRCs, 
apart from their microtubule nucleating activity, have also been shown to stabilise 
microtubule minus ends by capping them (Anders & Sawin, 2011; Teixido-Travesa 
et al, 2012).  
A conformational change of GCP3, induced by direct binding of attachment 
factor proteins anchoring γ-TuRCs to the MTOCs, was proposed to convert γ-TuRC 
to an active form and trigger microtubule nucleation (Kollman et al, 2010). Other 
mechanisms modulating γ-TuRC include its post-translational modifications, 
alternating γ-TuRC composition or regulation by targeting γ-TuRCs to specific 
cellular sites (Teixido-Travesa et al, 2012). However, the mechanisms which 
promote microtubule nucleation from γ-TuRCs still remain elusive. 
1.2.The EB family of microtubule plus end-binding proteins 
1.2.1. EB1 is an essential protein  
End binding 1 (EB1) protein was found in a screen for interactors of Adenomatous 
polyposis coli (APC) which is a tumor suppressor. The name EB1 is attributed to the 
protein binding to the C-terminus of APC (Su et al, 1995). EB1 belongs to an 
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evolutionarily conserved group of EB proteins which track microtubule plus ends 
and regulate their dynamics (Su et al, 1995; Tirnauer & Bierer, 2000). EB proteins 
bind autonomously to the growing microtubules, exclusively to their plus ends 
(Bieling et al, 2008; Woods et al, 2013). Importantly, EB proteins are central to 
regulation of microtubule plus end dynamics by recruiting MAPs to the microtubule 
plus ends (Kumar & Wittmann, 2012; Woods et al, 2013). Being key players in 
regulation of microtubule dynamics, EB proteins have an essential role in processes 
such as establishment of cell polarity, spindle positioning and chromosome stability 
(Tirnauer & Bierer, 2000; Tirnauer et al, 2002).  
Throughout the cell cycle, EB proteins associate preferentially with 
microtubule plus ends and centrosomes (Berrueta et al, 1998; Bu & Su, 2001; 
Mimori-Kiyosue et al, 2000). RNAi of Drosophila melanogaster EB1 (DmEB1) 
increases the number of nondynamic microtubules but it does not affect the overall 
microtubule organisation in interphase cells (Rogers, 2002).  In mitosis, depletion of 
DmEB1 by RNAi affects spindle pole focusing, positioning and results in reduction 
in astral microtubules (Rogers, 2002). Defective spindle elongation and chromosome 
segregation was observed in Drosophila embryos injected with anti-EB1antibodies 
(Rogers, 2002). DmEB1 was shown to be essential for Drosophila development and 
viability. Neuromuscular defects and uncoordinated movement of hypomorphic 
DmEB1 escaper mutants was observed (Elliott et al, 2005).  
1.2.2. Conservation  
While only one EB1 homologue is present in yeast, BIM1 in Saccharomyces 
cerevisiae (S. cerevisiae) and Mal3 in Schizosaccharomyces pombe (S. pombe), more 
than one EB protein has been identified in metazoa (Bu, 2003; Tirnauer & Bierer, 
2000). Three genes have been identified in human, EB1, RP1 and EBF3, encoding 
EB1 family proteins EB1, EB2 and EB3, respectively (Su & Qi, 2001). These 
proteins share amino acid identity of 57-66% and have a conserved domain structure 
(Schroder et al, 2011). Whereas there is only one EB1 protein expressed from the 
EB1 gene, there are two EB2 proteins translated from different initiation codons from 
RP1 and two EB3 proteins translated from differently spliced mRNA from EBF3 (Su 
& Qi, 2001).  
9
EB1 is expressed ubiquitously in different lines of human cultured cells. 
Also, DmEB1 is expressed ubiquitously in different tissues and at various 
developmental stages (Bu, 2003; Elliott et al, 2005). However, EB proteins have 
different expression patterns in some cell types. Straube et al. (2007) showed that 
EB3 level in undifferentiated cells is low and it significantly increases when cells 
start differentiating (Straube & Merdes, 2007). Contrarily, EB2 expression is 
switched off upon cell differentiation and EB1 level remained the same (Straube & 
Merdes, 2007). EB3 was also expressed preferentially in brain and it has an essential 
role, together with EB1, in maintaining the integrity of axonal initial segment 
(Leterrier et al, 2011; Nakagawa et al, 2000). EB proteins may have diverged in 
animals to regulate different aspects of microtubule dynamics in differentiated cells.  
However, even though it has been 18 years since the discovery of the first 
members of this crucial protein family, many questions remain unanswered. 
Particularly interesting is the occurrence of the three EB homologues and different 
isoforms in mammals: are they functionally redundant or do they have distinct roles? 
While EB1 has been most extensively studied, not much attention has been given to 
EB2 and EB3. Also, studies of EBs particularly focused on dissecting the proteins at 
the cellular level, while the protein function in context of a whole organism has been 
neglected. The only study in higher organisms has been performed by Elliott et al. 
(2005) demonstrating that DmEB1 has an essential neuromuscular role in 
development of Drosophila. However, what is the protein’s role in a developed 
organism? How is the protein function influenced, if at all, by the interaction with its 
numerous partners in a context of a multicellular organism? Finally, what are the 
sequence determinants which promote binding to EBs and do they differ between the 
family members? Answering these questions requires new tools which will allow 
targeting of specific interactions inside a developed organism.  
1.2.3. Structure 
EBs are small, globular proteins of ~30-kDa composed of two conserved domains, a 
~130-residue N-terminal calponin homology (CH) domain and ~80-residue C-
terminal dimerisation domain (Figure 1.3.). The CH and dimerisation domains are 
separated by an unstructured linker of ~70 residues (Askham et al, 2002; Bjelić et al, 
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Figure 1.3 Schematic representation of EB1 domain organisation 
EB1 proteins are small proteins of ~30kDa highly homologous accross 
the species. Three distinct domains make up EB1 proteins; calponin 
homology (CH) domain in the N-terminus followed by ~70 amino acid 
unstructured linker region and ~80 amino acid dimerisation domain. The 
dimerisation domain is composed of ~30 amino acid coiled coil and ~50 
amino acid EB homology (EBH) domian. CH domain, present in many 
actin and tubulin-binding proteins, has microtubule-binding role in EB1 
(Zimniak et al. 2009). Role of the unstructured linker region is unknown. 
The following coiled coil and EBH regions are both involved in 
formation of EB1 dimers. EBH domain recognizes SxIP motif carried by 
multiple microtubule plus end binding proteins. Conserved EEY/F motif 
at the very end of C-terminus which is specifically recognised by CAP-
Gly domains of microtubule plus-end binding proteins.  











2012; Slep & Vale, 2007). While the roles of the two conserved domains have been 
studied, the role of the linker is not known (Komarova et al, 2009).  
1.2.3.1. The N-terminus of EB1 is a microtubule interaction region 
The crystal structure of the N-terminal CH domain, responsible for interaction with 
microtubules, has been solved, showing a highly conserved fold (Hayashi, 2003; 
Komarova et al, 2009). The CH domains of human and budding yeast EB proteins 
are almost identical. They are formed by α-helices folded into a globule. The central 
hydrophobic helix, α3, is wrapped around by the remaining helices (Figure 1.4.) 
(Slep & Vale, 2007). The α6 helix contains many surface-exposed and highly 
conserved amino acid residues as well as conserved hydrophobic residues creating a 
groove (Figure 1.4). Hence, amino acids located in α6 helix may have an important 
role in protein-protein interactions. However, the microtubule plus end tracking 
activity of EB1 is attributed to residues located on one hemisphere of CH domain 
which is formed by α1 and a loop between α3 and α4 (Slep & Vale, 2007). De Groot 
et al. (2009) showed that mutation of Lys59 and Lys60 on CH domain completely 
abolished microtubule plus end tracking by EB1 (Figure 1.4). 
The amino acid sequence of human EB2 in the CH domain, nearby a 
conserved region essential for microtubule binding, is different from the 
corresponding sequences on EB1 and EB3. However, differences between EB1 and 
EB3 are less obvious (Komarova et al, 2009). The amino acid differences of CH 
domains between the three proteins can imply their different behaviour. In terms of 
microtubule plus end accumulation and catastrophe suppression both of EB1 and 
EB3 is more effective than EB2 (Komarova et al, 2009).  
1.2.3.2. The C-terminus of EB1 is a partner-binding region 
The C-terminal region of EB1 contains a coiled coil region, EB homology (EBH) 
domain and a disordered C-terminal tail (Bjelić et al, 2012).  
The coiled coil region is a universal protein oligomerisation motif 
responsible for dimerisation of EB proteins (Akhmanova & Steinmetz, 2008; 
Honnappa et al, 2005). Although EB1 dimerisation is required for robust microtubule 





















Figure 1.4 Structure of Calponin Homology domain of human EB1. 
The EB1 CH domain is formed by α helices that pack around hydrophobic α3 
helix. The tubulin-binding site is located within loops α1 and α3- α4. The α3- α4 
loop encompasses helix 310 where are located lysines 59 and 60 which are 
essential for microtubule plus end tracking by CH of EB1. Highly conserved  
and surface exposed residues in loop α6 may have important role in protein-
protein interactions. A conserved hydrophobic groove is created by F107, W110 
and F114 and conserved electrostatic residues include Q102, D103, E106, Q109 
and K113 (Slep et al. 2007). The protein model was generated in PyMOL. 
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weakly track growing microtubule plus ends in vivo (Skube et al, 2010).  
Homodimerisation was shown to be important for a partner binding by EB1 since 
residues from each of the EB1 molecules forming a homodimer contribute to 
contacts with microtubule-actin crosslinking factor (MACF) and abrogating EB1 
homodimerisation compromised the partner binding (Slep, 2005). While all three, 
EB1, EB2 and EB3, form homodimers, only EB1 and EB3 can also form 
heterodimers (De Groot et al, 2009). Formation of heterodimers may be used to 
recognise diverse proteins for complex regulation of microtubules by EB proteins. 
Considering that the protein dimerisation is essential for its microtubule anti-
catastrophe properties, regulation of EBs dimerisation is another interesting, yet 
unexplored, aspect of regulation of microtubule dynamics (De Groot et al, 2009; 
Komarova et al, 2009).  
The EBH domain partially overlaps with the coiled coil region (Figure 
1.3) (Akhmanova & Steinmetz, 2008). This ~50 amino acid domain is formed of an 
antiparallel four-helix bundle (Slep & Vale, 2007). A patch on the EBH domain 
surface is decorated by highly conserved residues forming a hydrophobic cavity. 
This hydrophobic cavity is a docking site used by a large group of SxIP (Ser-any 
amino acid-Ile-Pro) motif-containing proteins which regulate microtubule plus end 
dynamics (Akhmanova & Steinmetz, 2008; Slep & Vale, 2007).  
The C-terminal tail of EBs contains EEY/F (Glu-Glu-Tyr/Phe) sequence 
motif which is also present at the C-terminus of CLIP-170 and α-tubulin (Mishima et 
al, 2007). EEY/F is a conserved recognition sequence for CAP-Gly (cytoskeleton-
associated protein-glycine-rich) microtubule plus-end binding proteins (Honnappa et 
al, 2006). The acidic-aromatic tail of EB1 comprising the EEY/F sequence 
recognises GKNDG (Gly-Lys-Asn-Asp-Gly) motif located in the hydrophobic cavity 
of the globular CAP-Gly domain (Akhmanova & Steinmetz, 2008). 
1.2.4. EB1 binds to microtubules and regulates their dynamics 
1.2.4.1. EB1 associates with microtubule polymers 
While EB1 and EB3 in CHO-K1 cultured cells display the same, comet-like 
localisation (~2 µm at the microtubule plus ends dispersing in the minus end 
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direction), the localisation pattern of EB2 is different. Immunostaining of EB2 shows 
subtle microtubule plus end association and even distribution along the microtubule 
lattice (Komarova et al, 2009). A study by Komarova et al. (2009) showed that 
binding and tracking of microtubule plus ends by EB1, EB2 or EB3 is independent of 
each other and that the proteins compete for microtubule plus end binding. Depletion 
of EB1 from CHO-K1 cultured cells redistributed EB2 to the plus ends, without 
affecting EB3 localisation. Similar redistribution of EB2 happened when both EB1 
and EB3 were depleted. Depletion of either EB2 or EB3 had no effect on distribution 
of the remaining EBs (Komarova et al, 2009).  
While EB1 binding to microtubule plus ends was demonstrated by several 
research groups, the binding mechanism has been tackled only recently and is not yet 
clear. The first question that was addressed was whether EB1 copolymerised with 
tubulin or whether it bound to the already polymerised tubulin at the microtubule 
plus ends. Bieling et al. (2007) showed that Mal3 does not bind to unpolymerised 
tubulin but it must recognise some features present on a microtubule polymer.  
1.2.4.2. EB1 recognises different tubulin conformations 
Different suggestions have been made as to what are the determinants on a growing 
microtubule recognised by EB1. One of the hypotheses was that EB1 recognised the 
GTP cap which was unlikely because the GTP-bound β-tubulin comprises a 
maximum of two heterodimers at the end of a protofilament while the EB1 binding 
region is much larger (Maurer et al, 2012). Also, if it was the nucleotide binding state 
of β-tubulin dictating EB1 affinity for a microtubule, one could observe a uniform 
EB1 binding along the microtubule lattice which is not the case. Instead, EB1 
immunostaining appears comet-shaped at the microtubule plus ends where the signal 
is the strongest at the plus end and disperses in the minus-end direction. Kueh et al. 
(2009) reviewed increasing evidence that “structural plasticity”, defined as a change 
in structural state, of a microtubule drives the polymer dynamics rather than purely 
its chemical state. If EB1 is attracted to microtubules by particular tubulin 
conformations, this can explain why EB1 binding to the microtubule lattice is 
different from EB1 binding to the microtubule plus end region where tubulin is also 
GDP-bound.  
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A study by Maurer et al. (2011) further supports the idea that EB1 
recognises different tubulin conformations. They demonstrated that Mal3 and EB1 
have particularly strong affinity to the polymerised tubulin transitioning from GTP- 
to GDP-bound state, so in an intermediate conformation(s). Polymerising 
microtubules in presence of GTPγS, a slowly hydrolysable GTP homolog, resulted in 
robust Mal3 or EB1 accumulation along the microtubule lattice (Maurer et al, 2011). 
Hence, tubulin slowly changing its conformation during GTP hydrolysis may have a 
reflection in the comet-like immunostaining of EB1. The tubulin conformation 
favoured by EB1 remains at the microtubule plus end for ~8 seconds, a period of 
time when microtubule is decorated with Mal3 and EB1 (Bieling et al, 2007; Dixit et 
al, 2009). Also, it was shown that EB1 and Mal3 association with microtubules is 
very dynamic. Mal3 dwell time on a microtubule is ~0.28 second (or ~0.8 second for 
mammalian EB1) (Bieling et al, 2007; Dixit et al, 2009).  
1.2.4.3. EB1 promotes conformational change of tubulin 
However, does the tubulin conformation favoured by EB1 serve only as a platform 
for EB1 binding or does the EB1 binding to a microtubule affect tubulin 
conformation? Maurer et al. (2011) demonstrated that the lifetime of the 
conformational state at which Mal3 could bind to microtubule decreased along with 
an increase in Mal3 concentration. Hence, Mal3 can work as a catalyst of tubulin 
transition state (Maurer et al, 2011). Interestingly, addition of Mal3 in vitro increases 
catastrophe frequency and microtubule growth rate (Bieling et al, 2007; Komarova et 
al, 2009; Maurer et al, 2011; Vitre et al, 2008). It is possible that Mal3 dose-
dependent conformational change on the microtubule reduces the Mal3 binding 
region hence increasing the risk of a catastrophe. Also the conformational change of 
tubulin facilitated by EB1 may accelerate closing of the microtubule tube and 
increase the polymerisation rate (Kumar & Wittmann, 2012). Indeed, addition of 
EB1 to microtubules polymerised in presence of DMSO and GMPCPP, known to 
induce unclosed microtubules, significantly increased the proportion of closed 
microtubules (Vitre et al, 2008). However, regulation of microtubule dynamics by 
EB1 in in vivo conditions is more complex and it may depend on EB1 interaction 
with the proteins recruited by EB1 to the microtubule plus ends.  
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1.2.4.4. The precise localisation of EB1 on microtubules is established 
Maurer et al. (2012) showed that CH domains of EBs bind regularly between 
protofilaments (B-lattice) except for the seam of GTPγS-polymerised microtubules 
(A-lattice) (Maurer et al, 2012). Binding of a Mal3 CH domain fragment between the 
neighbouring protofilaments forming the B-lattice forms stabilising 
interprotofilament bridges. The Mal3 CH stabilisation effect on microtubule plus 
ends was predicted by the observation that Mal3 CH immunostaining started 
decaying from the microtubule plus ends several seconds prior to catastrophe 
(Maurer et al, 2012). Therefore, EB1 forms a protective structural cap at the 
microtubule plus ends.  
Maurer et al. (2011) demonstrated that Mal3 CH domain was regularly 
distributed on a microtubule every 8 nm allowing prediction of 12 molecules of Mal3 
CH domain for every 13 tubulin dimmers (Figure 1.5). This is in agreement with the 
measurements of Mal3-GFP fluorescence measured on microtubules at saturating 
concentrations and comparing fluorescence intensity to that of a GFP-labelled 
kinesin-1 which is known to bind one tubulin dimer (Maurer et al, 2011; Maurer et 
al, 2012). They also showed that the Mal3 CH domain binding occurs at the corner of 
four different αβ-tubulin heterodimers where two adjacent α-tubulins and two 
adjacent β-tubulins meet (Figure 1.5). This finding is consistent with EB1 not 
binding along the seam because such a tubulin arrangement does not exist at the 
seam (Maurer et al, 2012). Mal3 CH makes a contact with the β-tubulin helix whose 
structural rearrangement is triggered by GTP hydrolysis. Mutating a conserved 
amino acid residue, Q89, in Mal3 CH domain which contacts the β-tubulin helix 
affects microtubule binding behaviour (Iimori et al, 2012; Maurer et al, 2012). 
Hence, EB1 may sense β-tubulin conformation characteristic of a certain microtubule 
region.  
1.2.5. EB1 functions in mitosis to regulate spindle dynamics  
DmEB1 depletion by RNAi from Drosophila S2 cells resulted in aberrant 
chromosome segregation and a range of mutant spindle phenotypes, such as shorter 



























Figure 1.5 Model of EB1 binding site on a microtubule. 
CH domain of EB1 binds between tubulin dimers of microtubule B-
lattice; an arrangement where α tubulins of the neighbouring 
protofilaments lie next to each other. Such arrangement is not 
present at the seam (A-lattice). The binding occurs regularly at 8nm 
distance between α-tubulins towards the plus end and β-tubulins 
towards the minus end. 
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poles (Rogers, 2002). DmEB1 is required for microtubule plus end tracking by a 
minus end-directed motor protein Ncd, a product of non-claret disjunctional, which 
is a motor protein essential for spindle pole focusing (Goshima et al, 2005). Ncd 
cross-links the neighbouring kinetochore fibers (k-fibers) and helps in their focusing. 
Ncd was also shown to slide the neighbouring microtubules against each other 
(Oladipo et al, 2007). Such sliding along the spindle facilitates transport of 
microtubules, which do not originate from the centrosome, towards the centrosome. 
Although Ncd can transport microtubules towards the centrosomes, this is a 
dominant function of dynein, another minus end-directed motor protein, and Ncd’s 
role is primarly in focusing k-fibers (Goshima et al, 2005). The DmEB1-dependent 
localisation of Ncd to the plus ends of nucleating centrosomal microtubules was 
proposed to have a role in spindle pole focusing as well as in capturing chromosomes 
by the centrosomal microtubules by Ncd which captures k-fibers and connects them 
to the spindle (Goshima et al, 2005).  
EB1 is involved in modulating chromosomal attachments in mitosis. Mal3 
deleted cells show mitotic delay where the time between initiation of SPB separation 
and anaphase onset significantly increases (Asakawa et al, 2005). Asakawa et al. 
(2005) demonstrated that in mitotic cells a spindle checkpoint protein, Bub1, which 
monitors bipolar chromosome attachment, in the absence of Mal3 protein localises to 
the kinetochores. Such Bub1 localisation is specific to incorrect chromosome 
attachment.  
EB1 also participates in control of spindle length (Rogers, 2002; Zimniak et 
al, 2009). Zimniak et al. (2009) demonstrated that in bim1 deletion mutants the 
elongation rate of mitotic spindle was reduced and the spindle was subsequently 
shorter. The spindle elongation and disassembly of spindle mid-zone is positively 
regulated by phosphorylation of Bim1 (Zimniak et al, 2009). In a Bim1 
unphosphorylatable mutant long spindles were generated and spindle mid-zone 
disassembly was prevented. During spindle disassembly in the phosphorylation-
deficient Bim1, a significant amount of Bim1 occupied the spindle mid-zone. 
Contrarily, in the wild-type cells the Bim1 zone in the mid-spindle gradually 
decreased and only small punctae of the protein were observed (Zimniak et al, 2009). 
EB1 depletion from Drosophila S2 or human HeLa cells results in astral 
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microtubules not being formed which may also contribute to the decrease of spindle 
length since the pulling forces exerted by cortical proteins on astral microtubules 
contribute to spindle elongation (Rogers, 2002).  
Therefore, EB1 is involved in regulating various aspects of spindle 
organisation and dynamics.  
1.2.6. EB1 is central to the microtubule plus end binding by MAPs 
Although extensively studied, precise mechanisms of modulating microtubule 
dynamics by EB1 remain unclear. The effects that EB1 exerts on microtubules 
depend on EB1 interaction with other microtubule modulators. Although various 
microtubule plus end binding proteins can regulate microtubule dynamics, EB1 
emerged as a central component of the plus end interaction network. EB1 can 
autonomously bind to the growing microtubules and recruit various proteins to the 
plus ends (Jiang et al, 2012). Contrarily, numerous plus end MAPs require EB1 to 
efficiently accumulate and track growing microtubule plus ends. The C-terminus of 
EB1 is involved in two distinct binding mechanisms required for EB1-mediated 
recruitment of MAPs to microtubules. The EB1 C-terminus is an interaction site for 
proteins containing Cap-Gly domain or/and SxIP motif (Honnappa et al, 2009).  
1.2.6.1. EB1 interacts with CAP-Gly motif-containing proteins 
Conserved from yeast to human, CAP-Gly is a protein domain rich in glycine and 
hydrophobic residues. The CAP-Gly domain was crystallised revealing a globular 
fold, composed of a short α-helix at the C-terminus, followed by three β-sheets 
formed by three, three and two antiparallel β-strands at the N-terminus (Li et al, 
2002). An in silico search for similar structures showed that CAP-Gly domain 
architecture is unique (Li et al, 2002).  
An amino acid segment GKNDG located in a hydrophobic cavity between 
β3 and β4 strand is the longest conserved motif in Cap-Gly and it is essential to 
target the acidic-aromatic tail of EB1 comprising the EEY/F sequence (Akhmanova 
& Steinmetz, 2008; Li et al, 2002; Weisbrich et al, 2007). Proteins containing CAP-
Gly include MAPs such as cytoplasmic linker proteins (CLIPs) and the largest 
Dynactin subunit, p150glued (Schroer, 2004; Weisbrich et al, 2007). Although CAP-
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Gly domains are generally known as tubulin-binding modules, these domains of 
CLIP-170, CLIP115 and p150glued are also involved in interaction with EB1 (Ligon et 
al, 2003; Weisbrich et al, 2007). p150glued, similarly to CLIP-170, uses CAP-Gly 
domain to localise to microtubule plus ends (Steinmetz & Akhmanova, 2008). The 
significance of CAP-Gly interaction with EEY/F is prominent since CLIP-170 
tracking and binding specifically to the microtubule plus ends requires EB1 (Bieling 
et al, 2008; Dixit et al, 2009; Komarova et al, 2005).  
1.2.6.2. EB1 interacts with SxIP motif-containing proteins 
Proteins recruited by EB1 to the microtubule plus ends are structurally and 
functionally heterogeneous (Kumar & Wittmann, 2012). However, the majority of 
these MAPs are recruited to the microtubule plus ends using SxIP which interacts 
with EBH domain of EB1 (Figure 1.6) (Kumar et al, 2012). Interestingly, some of 
these proteins contain multiple SxIP motifs which act in concert to enhance 
microtubule plus end binding and tracking (Honnappa et al, 2009; Kumar & 
Wittmann, 2012). The most conserved amino acid residues of SxIP are 
isoleucine/leucine and proline which are involved in a hydrophobic interaction with 
EB1. Honnappa et al. (2009) investigated an interaction at atomic level between SxIP 
of MACF and C-terminus, amino acids 191-268, of EB1 (EB1c). Ser5477 of MACF 
SxIP forms a network of hydrogen bond interactions with conserved residues 
Arg222, Glu225, Gln229 and Tyr247 of EB1 (Figure 1.7) (Honnappa et al, 2009). 
The nonpolar Ile5479 and Pro5480 of MACF SxIP are deeply buried in the 
hydrophobic cavity on EB1c which is shaped by amino acid residues Phe216, 
Arg222, Glu225, Leu241 and Tyr247 located between two C-terminal helices in 
EB1 (Figure 1.7) (Honnappa et al, 2009; Kumar et al, 2012; Kumar & Wittmann, 
2012). Since mutation of either isoleucine or proline of SxIP to polar amino acids 
abolished interaction with EB1 by all the SxIP proteins tested so far, these residues 
are essential for EB1 binding (Kumar et al, 2012; Kumar & Wittmann, 2012; van der 
Vaart et al, 2011).  
Although essential, SxIP alone is not enough to mediate interaction with 
EB1. SxIP is located within a sequence region particularly rich in arginine and serine 
residues. The positive charge within the SxIP region provided by arginines and 
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Figure 1.6 Fragments of proteins known to use SxIP motif for binding to 
EB1. 
Alignment of 21 sequence fragments from 12 proteins whose interaction with 





MACF1  GLNKPSKIPTMSKKTT 
APC    TSARPSQIPTPVNNNT 
STIM1  QASRNTRIPHLAGKKA 
KIF2C  RRSVNSKIPAPKESLR 
KI18B  KRQRQSFLPCLRRGSL 







CK5P2  REAKKSRLPILIKPSR 
Sentin VTTGATGIPKPSGLRP  
Kebab  QGTPATKIPSQRNPKE 
Kebab  LSKSHTCIPSSEPQPI 
IPL1   QRNPNSKIPSPVREKL 





Figure 1.7 Atomic-level interaction network of MACF-EB1 complex. 
Nonpolar Ile5479 and Pro5480 of MACF SxIP are buried in hydrophobic 
cavity on EB1 and are essential for SxIP proteins’ binding to EB1. The 
hydrophobic cavity on EB1 is formed by residues Phe216, Arg222, 
Glu225 and Tyr247 which are located between C-terminal helices of EB1. 
Conserved residues on EB1, Arg222, Glu225, Gln229 and Tyr247, form a 
network of hygrogen bond interactions with Ser5477 of MACF SxIP.  
The residues constituting SxIP motif in MACF are coloured in orange, the 
residues outside SxIP are in yellow and EB1 is coloured gray. Dashed 
yellow lines denote hydrogen bonds. The figure is adapted from 
Honnappa et al, 2009. 
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negative charge near the EB1 C-terminus are likely to contribute to the binding 
(Kumar et al, 2012). Additionally, EB1 interaction with SxIP proteins is negatively 
regulated by phosphorylation (Honnappa et al, 2009; Kumar et al, 2012).  
Even though EB1 recruits many MAPs by SxIP, a novel Drosophila protein, 
Sentin, is a dominant partner of DmEB1 for promoting microtubule dynamics (Li et 
al, 2011). Sentin may be a functional homologue of mammalian SLAIN2 (Li et al, 
2012a). Li et al. (2011) replaced the C-terminal fragment of DmEB1, which is 
responsible for binding to all of the known protein partners, with Sentin. They 
observed that the wild-type phenotype was restored after expression of the DmEB1-
Sentin fusion in double RNAi DmEB1-Sentin cells. However, other MAPs 
interacting with EB1 may have more specific functions than Sentin, such as 
facilitating microtubule plus end association via EB1 with different organelles and 
structures inside the cells (Kumar & Wittmann, 2012). Also, different SxIP-
containing proteins may be required to modulate specific processes inside the cells 
involving microtubule plus ends. An example is CLASP, whose microtubule plus 
end localisation is spatially regulated in fibroblasts (Lansbergen et al, 2006). CLASP 
also localises to the cell cortex, Golgi, kinetochores and spindle mid-zone 
(Lansbergen et al, 2006; Patel et al, 2012). 
Therefore, the interaction of EB1 with MAPs containing SxIP is a very 
interesting mechanism required for regulation of microtubule dynamics, yet new and 
unexplored.   
1.3. The Dis1/TOG family of proteins 
The Dis1/TOG family of proteins has homologues across the species, from yeast to 
mammals. A Dis1/TOG family member, XMAP215 (Xenopus microtubule assembly 
protein), was first identified from egg extracts as a 215-kDa protein which promoted 
microtubule elongation ~10-fold (Brouhard et al, 2008; Gard & Kirschner, 1987). 
The Drosophila Mini spindles (Msps) protein of 227-kDa was identified as a factor 
responsible for keeping spindle integrity in cytological screen for mitotic mutants. A 
msps mutation results in formation of small additional spindles, defocused spindle 
poles and chromosome misalignment (Cullen et al, 1999). In meiotic spindles, Msps 
is responsible for maintaining bipolarity of acentrosomal spindles (Cullen & Ohkura, 
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2001). In interphase cells, Msps has an antipausing activity on microtubules (Brittle 
& Ohkura, 2005). Depletion of Msps from Drosophila S2 cells results in 
microtubules not extending towards the cell periphery and causes microtubule 
bundling (Brittle & Ohkura, 2005). Localisation of Msps is dynamic in dividing cells 
thus suggesting that Msps-microtubule association is cell cycle regulated. Msps 
localises to centrosomes in all mitotic stages, it spreads along the spindle in 
metaphase and anaphase and in telophase lower level of Msps immunostaining is 
observed at the spindle mid-body (Cullen et al, 1999). In interphase cells, Msps 
localises along the microtubules and Msps immunostaining is particularly strong at 
the microtubule plus ends (Brittle & Ohkura, 2005). 
Interestingly, apart from being abundant in the dividing cells, Msps is highly 
expressed in brain, suggesting that the protein has also a role in nonproliferating cells 
(Charrasse et al, 1998; Cullen et al, 1999; Gard & Kirschner, 1987).  
1.3.1. Structure 
The characteristic feature of Msps and its homologues is the presence of multiple 
tumor overexpressed gene (TOG) domains at their N-termini (Figure 1.8 A) (Ayaz et 
al, 2012; Ohkura et al, 2001). Human ch-TOG, plant MOR1, XMAP215 and Msps 
have five TOG domains, Zyg-9 of nematode has three TOG domains and yeast Stu2, 
Alp14 and Dis1 have two TOG domains (Widlund et al, 2011).  The higher 
eukaryote Msps homologues are likely to be monomeric while the yeast homologues 
form homodimers (Al-Bassam et al, 2007). Dimerisation of Stu2 is essential in vivo 
since the dimerisation mutants had growth defects. Also, the microtubule affinity of 
Stu2 is strongly reduced in the mutants lacking the dimerisation domain (Al-Bassam, 
2006). The TOG domains are αβ-tubulin-binding modules (Ayaz et al, 2012). In 
higher eukaryotes and nematode, the TOG domains are followed by a variable region 
and a conserved C-terminal region (Al-Bassam et al, 2007). In yeast, TOG domains 
are followed by a basic linker and a coiled coil region which is used for the protein 
homodimerisation (Figure 1.8 A) (Al-Bassam, 2006).  
The C-terminus of Msps is known to be an interaction region with D-TACC 
(Drosophila transforming acidic coiled-coil-containing) which is required for Msps 
localisation to spindle poles (Cullen & Ohkura, 2001; Lee et al, 2001). It was shown 
25























Figure 1.8 Schematic representation of XMAP215 domain 
organisation and sequence conservation within TOG domains. 
(A) Members of the higher order XMAP215 family are monomers. They 
contain five arrayed TOG domains in the N-terminal region and a 
conserved C-terminal region. TOG domains are classified into three 
groups based on sequence homology; TOG1 and TOG2 are group A, 
TOG2 and TOG4 are group B and TOG5 is group C. Each TOG domain is 
~200 amino acids long and is composed of usually six HEAT repeats, 
which are involved in protein-protein interactions. (B) Sequence 
alignment of the first intra-HEAT loop fragments of different TOG 
domains from D. melanogaster (Msps) and S. cerevisiae (Stu2). The 
prominent position of surface-exposed tryptophan is crucial for 
microtubule binding (red box) and highly conserved accross the TOG 




Msps TOG1   16 CVHKLWKARVDGYE 29 
Msps TOG2  287 LEEKKWTLRKESLE 300 
Msps TOG3  601 LVDSNWKNRLAAVE 614 
Msps TOG4  869 MSDKDWKTRNEGLT 882 
Msps TOG5 1199 MFHDDFRYHLKVIE 1212 
Stu2 TOG1   18 LTYKLWKARLEAYK 31 




in a cell culture that a 502 amino acid long C-terminal fragment of XMAP215 
localises strongly to centrosomes in mitosis and interphase (Popov et al, 2001). An 
N-terminal 1584 amino acid fragment of XMAP215 showed microtubule association 
which was further confirmed by another study, where the microtubule lattice binding 
domain was mapped to amino acids 1150 and 1325, a region between TOG4 and 
TOG5 (Widlund et al, 2011). In Stu2, the microtubule lattice binding region is 
localised after the TOG repeats, in the ~100 amino acid long linker (Wang & 
Huffaker, 1997).  
TOG domains consist of ~200 amino acids and each of the domains is 
composed of, usually six, HEAT repeats (Figure 1.9 A) (Al-Bassam et al, 2007). 
HEAT repeats, present in a variety of proteins, are ~40 amino acid residues long and 
occur in block of 3 to 22 tandem repeats (Groves et al, 1999; Kobe et al, 1999). 
Considering the functional diversity of proteins containing HEAT repeats it was 
proposed that HEATs are involved in protein-protein interactions (Kobe et al, 1999; 
Ohkura et al, 2001). Although the sequence similarity between individual HEAT 
motifs is low, the motifs have a common architecture forming α-helical antiparallel 
structures that stack side by side and form elongated domains (Figure 1.9 A) (Kobe 
et al, 1999). The highest degree of conservation between HEAT repeats of a TOG 
domain was mapped to amino acid residues in intra-HEAT loops (Figure 1.8 B) (Al-
Bassam et al, 2007; Slep, 2009). Apart from being conserved between the TOG 
domains of the same protein, these residues are also conserved across the Dis1/TOG 
family (Al-Bassam et al, 2007).  A tryptophan residue present on a loop of the first 
HEAT repeat of TOGs, except TOG5 (phenylalanine), is a prime determinant of 
TOG domain interaction with tubulin (Slep, 2009). A highly conserved salt bridge, 
which is located directly below Trp292, forces this tryptophan residue to be exposed 
at the protein surface (Figure 1.9 B) (Slep & Vale, 2007). Single mutation of either 
Trp21 on TOG1 or Trp292 on TOG2 of Msps to glutamic acid reduced binding to 
αβ-tubulin and the double mutation inhibited the binding (Slep & Vale, 2007). 
Therefore the tryptophan on TOGs is critical for αβ-tubulin-binding. Similarly, 
mutating conserved Lys151 in first TOG domain (TOG1) of Stu2 in a loop of fourth 
HEAT repeat inhibited tubulin binding (Al-Bassam et al, 2007). Hence the conserved 
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Figure 1.9 TOG2 domain structure of Drosophila Msps. 
(A) TOG domains are structures made of usually six HEAT repeats stack side by 
side and form elongated domains. Each HEAT repeat is formed of two helices 
connected by intra-HEAT loops (on face A)  which contain highly conserved and 
surface exposed residues. Contrarily, inter-HEAT loops connecting individual 
HEAT repeats (on face B) do not have a high degree of conservation. (B) Trp292 
in intra-HEAT loop of face A is highly conserved between TOG domains and is a 
major determinant of a TOG domain interaction with tubulin. Trp292 is forced to 
the surface by the salt bridge between Asp331 and Arg295 located directly below 








structure of Stu2 TOG1 in complex with αβ-tubulin confirms that the intra-HEAT 
loops are major determinants in αβ-tubulin binding by Stu2 (Ayaz et al, 2012).  
1.3.2. Microtubule Binding  
Dis1/TOG family proteins contain a variable number of TOG domains, yeasts have 
two TOGs, nematode three and higher eukaryotes have five TOGs. Based on 
sequence similarity, TOG domains of Dis1/TOG family can be classified into three 
groups. TOG1 and TOG3 are group A, TOG2 and TOG4 are group B and TOG5 is 
group C (Figure 1.8 A) (Currie et al, 2011; Slep, 2009). Thus, it is possible that the 
higher eukaryote Dis1/TOG family members evolved by duplicating TOG domains 
to efficiently polymerise tubulin.   
Dis1/TOG proteins bind free tubulin dimers. While it was shown that 
XMAP215 and Msps bind αβ-tubulin with 1:1 stoichiometry, two molecules of the 
yeast homologue, Stu2, are required to bind an αβ-tubulin dimer. Stu2 
homodimerises via the C-terminal coiled coil regions to efficiently bind tubulin (Al-
Bassam & Chang, 2011). Although the role of the fifth TOG domain of eukaryote 
Dis1/TOG proteins, TOG5, remains unclear, there is an indication that it may be 
enhancing binding of the Dis1/TOG proteins to tubulin (Al-Bassam & Chang, 2011; 
Widlund et al, 2011).  
Slep et al. (2007) showed that Stu2 domains, TOG1 or TOG2 as well as 
TOG1 and TOG2 added in trans, can bind tubulin dimers. However, TOG1 
interaction with tubulin heterodimer is much stronger than interaction of TOG2 with  
tubulin heterodimer (Al-Bassam, 2006). Neither of Msps fragments, TOG1 or TOG2 
nor TOG1 and TOG2 acting in trans, bind tubulin. However, Msps fragment 
containing TOG1 and TOG2 in tandem binds tubulin dimer indicating that the region 
that links TOG1 with TOG2 has, possibly a structural, role in tubulin binding.  
1.3.3. Regulation of Microtubule Dynamics  
XMAP215 stays bound to a growing microtubule during multiple rounds of tubulin 
addition, which is different from EB1, a protein discussed earlier that also tracks 
growing microtubule plus ends autonomously but associates with microtubules 
dynamically. Also differently to EB1, XMAP215 tracks not only growing but also 
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the depolymerising microtubule ends. XMAP215 acts as an antipausing factor of 
microtubule dynamics. It catalyses microtubule growth at physiological tubulin 
concentrations by adding up to 25 tubulin dimers into each 13 protofilaments and it 
depolymerises microtubules at low tubulin concentrations. XMAP215 and Stu2 are 
elongated, rod-shaped proteins with multiple flexible joints, presumably the inter-
TOG regions, when they are not in a complex (Brouhard et al, 2008; Cassimeris et al, 
2001). However, XMAP215 becomes well ordered when in complex with tubulin; 
XMAP215 wraps around a tubulin dimer adopting a globular conformation. The 
architecture of XMAP215 bound to tubulin is similar to that of the Stu2 homodimer 
in complex with tubulin. The Stu2 homodimer also forms a compact complex with 
tubulin. Together with a quick dissociation of the Stu2 homodimer-αβ-tubulin 
complex, a model was proposed where Stu2 homodimer captures αβ-tubulin, 
positions it at the growing end of a microtubule and dissociates from the assembled 
αβ-tubulin (Al-Bassam, 2006).  
More recently a structural study involving crystallisation of Stu2 TOG1 
with αβ-tubulin shed more light on Stu2-mediated microtubule polymerisation 
mechanism. It is apparent from the crystal structure that the curvature of the tubulin 
heterodimer facilitates TOG1 binding. Although TOG1 can still bind to straight αβ-
tubulin, the binding is less tight (Ayaz et al, 2012). TOG1 and TOG2 binding to 
tubulin discriminates between curved and straight tubulin heterodimer 
conformations. Tubulin adopts straight conformation when in microtubule body and 
curved when free or at the very ends of a microtubule. Both TOG1 and TOG2 
preferentially bind curved αβ-tubulin which does not exist in the microtubule body 
(Ayaz et al, 2012). Stu2 homodimer might associate to microtubule plus ends 
through TOG2 domains, which preferentially recognise conformation of αβ-tubulin 
at the microtubule plus ends, and incorporate tubulin heterodimer using TOG1 (Ayaz 
et al, 2012). Deletion of both TOG1 and TOG2 domains results in Stu2 associating 
with the microtubule body and abolishes plus end binding (Al-Bassam, 2006). The 
ability of Stu2 to recognise different tubulin conformations is consistent with Stu2 
being a microtubule polymerisation catalyst.  
XMAP215 targets both microtubule body and plus ends. XMAP215 bound 
to microtubule body diffuses along the microtubules towards the plus end where it 
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accumulates and persists for several rounds of tubulin addition and accelerates 
tubulin addition (Brouhard et al, 2008). However, XMAP215 accelerates 
microtubule depolymerisation in absence of tubulin. 
1.3.4. Regulation of Mitotic Spindle Architecture 
Since Msps depleted cells exhibit a number of spindle defects, Msps has an essential 
role in maintaining correct spindle architecture in the dividing cells.  
Msps interaction with D-TACC was demonstrated to have a key role in 
stabilisation of microtubules within the spindle of Drosophila embryos. A pool of D-
TACC-Msps complexes at the centrosomes can be phosphorylated by Aurora A to 
bind and stabilise microtubule minus ends (Barros, 2005). The minus end 
stabilisation by D-TACC-Msps complex is exclusive to the centrosomes. A 
phosphorylation site on TACC3, a Xenopus homologue of D-TACC, targeted by 
Aurora A is conserved amongst species (Kinoshita et al, 2005). Microtubule 
stabilisation by TACC3-XMAP215 complex was proposed to protect spindle 
microtubules from microtubule depolymerising protein, MCAK. In the presence of 
TACC3, XMAP215 counteracts MCAK depolymerising activity which allowed for 
the microtubule nucleation from centrosomes. Thus TACC3 presumably enhances 
XMAP215 activity at the centrosomes (Kinoshita et al, 2005). The protection of 
microtubules at the centrosomes from depolymerising activity of MCAK is crucial to 
prevent formation of multipolar spindles (Holmfeldt et al, 2004).    
1.3.5. Interplay with EB1 
Msps and EB1 are both key players in regulation of microtubule dynamics. Although 
EB1 alone has mild effects on acceleration of microtubule growth rate in vitro, it is 
essential to maintain microtubule dynamics in vivo and in cell extracts (Niethammer 
et al, 2007; Vitre et al, 2008). Msps significantly increases microtubule 
polymerisation rate but the in vitro reconstitution assays proved that alone it is not 
sufficient to fully restore microtubule growth rates seen in cells. EB1-Msps interplay 
was investigated in context of regulation of microtubule polymerisation rate. 
Although microtubule growth is not dependent on direct EB1-Msps interaction, both 
of the proteins are essential and sufficient to restore robust microtubule growth in 
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vitro (Zanic et al, 2013).  It was shown in vitro that EB1 and Msps increased 
microtubule polymerisation by up to 20 µm min-1, the levels seen in vivo. Since fast 
polymerisation activity of Msps relies on its TOG domains which release a tubulin 
dimer once straightened upon incorporation into a microtubule, it was suggested that 
EB1 speeds up Msps polymerisation activity because it accelerates protofilament 
straightening through enhancement of lateral interactions between tubulin dimers 
(Ayaz et al, 2012; Vitre et al, 2008; Zanic et al, 2013). Van der Vaart et al (2009) 
showed that SLAIN2 (a human homologue of Sentin), a MAP which interacts with 
EB1 using the SxIP, interacts also with ch-TOG. Inhibition of ch-TOG interaction 
with SLAIN2 results in microtubule growth defects and disruption of microtubule 
array in interphase (van der Vaart et al, 2011). The microtubule plus end localisation 
of Sentin or SLAIN2 depends on interaction with EB1 (Li et al, 2011; van der Vaart 
et al, 2011). Therefore, this indirect EB1-Msps interaction, via a MAP, gives a new 
insight to the regulation of microtubule plus end dynamics. 
1.4. Peptide aptamers 
1.4.1. Peptide aptamers as a powerful tool in genetic studies 
A multitude of cellular processes are regulated by protein interaction networks. Two 
types of genetic approaches, forward and reverse genetics, are used to elucidate 
protein functions within a network. The forward genetics relies on generation of 
random genetic mutants and selecting those which display a desired phenotype.  
Identifying the genes responsible for the phenotype, along with biochemical data on 
their interaction partners, gives the researcher an idea about the roles these genes 
play and their positions within a network. In reverse genetic analysis, an approach 
which is opposite to the forward genetics, individual genes are manipulated and the 
phenotype is observed to address the question of what is the possible role of the 
gene.  
However, there are limitations with regards to studying a protein function 
when mutating it at a DNA level. Knocking out a gene essential for cell proliferation 
makes it difficult to study the gene function in a developed organism unless 
conditional mutants, such as temperature sensitive mutants, are available. Also, even 
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though RNAi can be used to deplete the messenger RNA and thus inhibit protein 
expression, the pool of the protein which had already been produced remains intact. 
Thus RNAi is not sufficient if it targets transcription of a stable protein whose half-
life is long because the original protein pool would likely sustain its functions inside 
the cell. However, the protein levels would be reduced if the cell undergoes a 
sufficient number of divisions which is not the case in the differentiated cells.  
An alternative approach is the use of peptide aptamers. The name “peptide 
aptamer”, coming from a combination of Latin word “aptus” which means “fitting” 
and Greek “meros” meaning “part”, resulted from similarity of these molecules to the 
nucleic acid aptamers which are nucleic acid fragments binding to various molecular 
targets (Seigneuric et al, 2011). Peptide aptamers were originally described as double 
constrained peptides displayed in the active site of thioredoxin (TrxA) that were 
designed to function inside a cell and bind to their protein targets (Colas et al, 1996). 
They usually contain a 10-20 amino acid peptide fragment, so-called “variable 
region”, which can be either constrained from both sides by the protein sequence 
from which it is displayed or, less often, the variable region can be singly constrained 
by fusing it to one of the protein termini. These small, novel molecules advanced 
protein-protein interaction research and drug target discovery as well as 
understanding of protein interaction domains. What distinguishes peptide aptamers 
from unconstrained peptides or antibodies is their small size, stability and solubility, 
which relies on their fusion to a “scaffold” protein from which they are displayed as 
well as specificity to a certain region on a target protein resulting in disruption of 
particular protein-protein interactions (Crawford et al, 2003; Hoppe-Seyler et al, 
2001; Wickramasinghe et al, 2010). Also, as peptide aptamers are expressed inside 
the cells, they do not pose delivery problems. 
1.4.2. Design of peptide aptamers 
1.4.2.1. Selection 
Peptide aptamers can be applied in both forward and reverse genetic studies. In 
forward genetics a peptide library is screened for production of a desired cellular 
phenotype and such peptide aptamers and their target proteins can be selected for 
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further studies (Crawford et al, 2003). In the reverse genetics, a researcher finds 
peptide aptamers binding to a protein of interest and selects them for subsequent in 
vivo studies (Crawford et al, 2003; Geyer, 2001). Both, in vitro and in vivo selection 
methods have been reported. Various display platforms have been used for the in 
vitro selection of peptide aptamers, ranging from the display on surfaces such as 
phage, yeast, flagella of Escherichia coli as well as ribosomes (Geyer & Brent, 2000; 
Li et al, 2012b; Yeh et al, 2013). The in vivo selection of peptide aptamers is very 
common and probably more suited than an in vitro selection if one wants to perform 
further studies involving expressing these peptide aptamers in an organism. The first 
reported yeast two-hybrid (Y2H) screen for peptide aptamers was performed to find 
interactors of human cyclin dependent kinase 2 (Cdk2) (Colas et al, 1996). The tested 
interactors inhibited Cdk2 activity and bound to it with a dissociation constant in a 
nanomolar range (Colas et al, 1996). Y2H takes an advantage of transcription factor 
being split into two parts, a transcription activation domain (AD) and a DNA-binding 
domain (BD), which fused to proteins interacting with each other bring the AD and 
the BD in a close proximity (Figure 1.10). Three common features of Y2H screens 
for peptide aptamers binding to a protein of interest are:  
• A vector which carries DNA fragments from a library encoding
different peptide aptamers fused to an AD of a transcription factor, the so-called 
“prey”. The most commonly used transcription factor is GAL4. 
• A vector which carries DNA encoding the protein of interest fused to
a DNA-BD of the transcription factor, the so-called “bait”. 
• Reporter genes downstream of the activating sequence. Interaction of
the bait- and prey-fused proteins is detected due to BD and AD being brought 
together. The proximity of the two domains results in the activation of a downstream 
reporter gene (Figure 1.10). The common choice of the reporter genes are 
auxotrophic markers such as ADE2, HIS3, LYS2, LEU2 or URA3 (Hoppe-Seyler et 
al, 2004). Thus, the selection of yeast carrying the interacting peptide aptamers is 
possible by plating them on media deficient in an appropriate nutrient. Often a 
second reporter gene is introduced, such as lacZ, which has an enzymatic activity 
which can be quantified thus giving an information about bait-prey interaction 





promoter reporter 1 reporter 2 
transcription 
Figure 1.10 Strategy for detecting peptide aptamers 
interacting with a protein of interest by yeast two-hybrid 
Plasmid encoding a protein of interest fused with DNA binding 
domain (BD) of Gal4 is introduced into yeast which has the 
reporter genes lacZ and HIS3 under the control of the GAL1 
promoter.  Yeast are cotransformed with a plasmid expressing a 
library of peptide aptamers fused with activation domain (AD) of 
Gal4. Tranformants containing peptides interacting with the 
protein fused with BD of Gal4 reconstitute GAL4 activity causing 
expression from reporter genes. 
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1.4.2.2. Scaffolds for peptide aptamer display 
The most common protein used as a scaffold for peptide aptamer display is TrxA of 
E. coli. It is a protein of 12 kDa found in many eukaryotic and prokaryotic species 
(Holmgren, 1989). TrxA is a cytoplasmic protein which can be expressed inside the 
cells at high levels without toxic effects (Colas et al, 1996; LaVallie et al, 1993). 
Importantly for its use as a peptide aptamer scaffold, TrxA is stable and soluble thus 
often it is fused to other proteins to improve their solubility (Geyer, 2001; LaVallie et 
al, 1993). To display a peptide aptamer from TrxA, a random sequence fragment 
from a library is inserted into a biologically active site of TrxA abolishing its 
enzymatic activity (Klevenz et al, 2002). Importantly, a peptide insertion into this 
site does not affect the protein which retains its native folding (LaVallie et al, 1993; 
Lu et al, 1995). The active site sequence of TrxA is a good spot for presenting the 
peptides because it forms a loop on the protein surface and makes the peptides 
accessible (Lu et al, 1995). While being most commonly used, TrxA-based peptide 
aptamers were reported not to express stably in human cultured cells  (Woodman et 
al, 2005). Also, peptide aptamers double constrained within the loop on TrxA are 
enclosed by cysteine residues which can cause disulfide bond formation when in an 
oxidative environment. Thus, it has to be taken into consideration that a peptide 
displayed on TrxA may adopt a different conformation and become inactive when 
shifting between oxidative and reducting environments. However, alternative 
scaffolds have been proposed which can be applied accordingly to a need. An 
example of another scaffold for display of double constrained peptides is stefin A 
triple mutant (STM). STM was designed by Woodman et al (2005) and shown to 
confer stability in systems such as bacteria, mammals and yeast. STM is based on 
human stefin A, a small protein whose folding is independent of disulfide bonds, thus 
it can be applied in intra- and extracellular systems (Davis et al, 2009; Woodman et 
al, 2005). Examples of other protein scaffolds used for a double constrained display 
of peptides include green fluorescent protein (GFP) or a derivative of staphylcoccal 
nuclease (SNase). 
While the double constraint of peptides can be advantageous because of 
their usually higher proteolytic stability, the conformations that can be adopted by 
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these double constrained peptides are highly limited (Colas et al, 1996; Geyer & 
Brent, 2000). Therefore, single constrained peptides were displayed as a direct fusion 
to the C-terminus of GAL4-AD by Yang et al. (1995) for selection in Y2H. They 
found several peptide interactors binding to the retinoblastoma (Rb) protein, one of 
which bound with ~10 µM affinity. Also, singly constrained peptides displayed on a 
phage as a fusion to the N-terminus of pIII, a phage coat protein, in search for 
concanavalin A interactors showed mid-micromolar range of binding (Oldenburg et 
al, 1992). However, the peptide aptamers with double constrained peptide fragments 
very often showed target binding affinity in nanomolar range (Colas et al, 1996; 
Fabbrizio, 1999). Thus, even though single constrained peptide interactors can be 
selected more easily from a library because of the higher conformational variability, 
their binding affinity to a target protein may not be as high as the binding of peptides 
whose folding is double constrained.  
Klevenz et al. (2002) addressed the question of whether exchange of a 
peptide aptamer scaffold to a different scaffold, from which a peptide was not 
originally displayed, would affect the peptide aptamer affinity to its target. This 
study is important because, if a scaffold exchange did not affect a peptide-protein 
interaction, one could screen a library of single constrained peptide interactors and 
then double constrain the interacting peptides within a different scaffold to improve 
their affinity to a target protein. Variable peptide regions of three TrxA-based peptide 
aptamers were shifted to alternative scaffolds, doubly-constraining catalytically 
inactive derivative of SNase or GFP, as well as to singly-constraining GAL4-AD, 
rendering the peptides partially flexible (Klevenz et al, 2002). Only one of the 
peptides continued binding to its target protein when displayed from SNase, GFP or 
GAL4-AD, the other two lost a detectable binding activity (Klevenz et al, 2002). The 
authors explained the loss of binding with peptides adopting different folding in 
different scaffolds while the one which retained the binding, in both doubly-
constrained and singly-constrained form, adopted a strong intrinsic stability, thus not 
requiring a support from a scaffold constraining it from both sides (Klevenz et al, 
2002). While it is not known whether the affinity of that peptide for its target 
improved when the scaffold was changed in the research described by Klevenz at al. 
(2002), Cohen et al. (1998) reported improving a peptide-protein binding affinity 
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1000-fold by displaying an originally single constrained peptide from the double-
constraining TrxA scaffold.  
Therefore, peptides whose folding relies on a double-constraint from a 
scaffold may not show a target-binding activity when screened in a context of 
another scaffold. Thus it is necessary to rethink the experimental design for peptide 
aptamer screening because changing the scaffold may not be an option for some 
peptides. 
1.4.3. Applications 
1.4.3.1. Biomedical research - identification of drug targets 
Perturbing a target proteins’ function is a general approach to validate a drug target 
and it is often done by methods which reduce the proteins’ expression levels or 
abolish its expression (Baines & Colas, 2006). However, inadequate validation of a 
drug target is a significant problem in drug discovery (Colas, 2008). Peptide 
aptamers are a very powerful alternative for target validation in the drug discovery 
process because, similarly to therapeutic ligands, they bind to a specific site on a 
protein thus disturbing a particular interaction rather than all the interactions in 
which a protein is involved (Baines & Colas, 2006). Therefore, peptide aptamers 
enable one to verify, at a cellular or an animal model level, whether a therapeutic 
ligand would revert a pathological phenotype associated with a disease. A selected 
peptide aptamer which produces a desired therapeutic effect can be potentially used 
as a therapeutic itself or the crystal structure information, coming from co-
crystallising a peptide aptamer with its target, can be used for screening potential 
small molecule inhibitors in silico or their rational synthesis (Crawford et al, 2003).  
Alternatively, a peptide aptamer can be applied in a competitive displacement assay 
where a pool of small molecule ligands are selected based on their ability to displace 
the peptide aptamer (Dibenedetto et al, 2013). Such selected interactors can become 
precursors for therapeutic drugs. 
The druggable sites on a protein can be mapped using peptide aptamers if 
the target protein structure is known or if it can be modelled by homology 
(Pamonsinlapatham et al, 2008). In AptaPrint technology a target protein structure is 
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visually investigated for presence of structural features, such as putative binding 
pockets or protein-protein interaction sites, and amino acid mutations are introduced 
into such molecular surfaces (Baines & Colas, 2006). Next a pool of peptide 
aptamers previously selected for binding to the wild-type version of the mutated 
protein are screened to examine whether they retain binding ability to each of the 
protein mutants. The peptide aptamers which no longer bind to a mutant version of 
the target are likely to bind to the mutated site (Baines & Colas, 2006). The pitfalls 
of AptaPrint include limitations of the software used to build a homology model of a 
protein which was not crystallised and structural modifications which may arise 
when mutating the protein target (Baines & Colas, 2006; Hoppe-Seyler & Butz, 
2000). 
1.4.3.2. Biomedical research - biosensing in diagnostics 
Another potential implementation peptide aptamers have is in disease diagnostics 
where they can be used on various protein detection platforms. Since peptide 
aptamers are highly selective towards their targets, they can be applied to detect a 
mutant form of a protein causing a disease as well as distinguish between different 
protein isoforms (Davis et al, 2009). Thibaut at al. (2012) reported a novel peptide 
aptamer-based enzyme-linked immunosorbent assay (ELISA) used for detection of 
antibodies against anti-human platelet antigen antibodies (HPA-1a). In neonatal 
alloimmune thrombocytopenia (NAIT), a pregnant woman generates HPA-1a 
antibodies against the foetus which may destroy foetal platelets (Thibaut et al, 2011). 
Therefore, early detection of HPA-1a in maternal blood is essential. The advance of 
this method comes from abandoning human platelets, used in current NAIT 
diagnostics to detect HPA-1a antibody, which pose storage problems and can differ 
between the batches coming from different donors (Thibaut et al, 2011). In their 
assay, Thibaut et al. (2011) used TrxA-displayed peptide aptamer, specifically 
binding to HPA-1a antibody, coated onto a microtitration plate, followed by 
sequential incubations with human serum and Fc fragment-specific antibody 
conjugated to HRP. Addition of an HRP substrate allows for detection of a reaction 
product by optical density.    
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Another successful biomedical application of peptide aptamers was reported 
by Murray et al. (2007) who obtained peptide aptamers with high specificity to 
anterior gradient-2 (AG-2). AG-2 is the most abundant, upregulated protein in 
Barrett’s epithelium, a proliferative condition causing abnormal change in cells of 
oesophagus (Murray et al, 2007).  Since Barrett’s epithelium is strongly associated 
with esophageal adenocarcinoma, development of a biomarker assay for detection of 
AG-2 in a patient’s biopsy serum could help to target the disease early (Murray et al, 
2007). They identified two peptide aptamers binding with high specificity to AG-2 
which were used to affinity-purify AG-2 from a crude clinical biopsy lysate to near 
homogeneity. Interestingly, three attempts to obtain monoclonal antibodies specific 
to AG-2 did not yield antibodies effective enough in similar purification or 
diagnostic experiments (Murray et al, 2007). 
Park et al. (2011) developed a peptide aptamer biosensor for detection of 
hepatotoxicity marker, alanine aminotransferase (ALT) enzyme, a biomarker of liver 
damage. The advance of their biosensor over the those currently in use is that the 
peptide aptamer-based biosensor detects ALT itself rather than its enzymatic activity 
(Wu et al, 2011). Thus, they provided an alternative for development of biosensors to 
detect almost any protein target regardless of its physico-chemical activities. The 
biosensor platform described by Park et al. (2011) and other peptide aptamer-based 
platforms which couple peptide aptamer-target protein binding to the electrochemical 
detection methods offer a powerful, label-free technique which could find a clinical 
application.  
 
1.4.3.3. Basic Research - identifying pathway components and binding motifs 
Peptide aptamers can be widely applied in identifying components of biological 
pathways and learning the binding motifs. The origin of the peptide aptamer work is 
attributed to Colas et al. (1996) who found fourteen TrxA-based peptide aptamers 
which could bind human Cdk2 in vitro (Hoppe-Seyler et al, 2004). While neither of 
them interacted with two unrelated control proteins, some of the peptide aptamers 
interacted with other Cdks. This was explained by these peptide aptamers binding to 
different regions on Cdk2, some of which can be conserved within the Cdk protein 
family (Colas et al, 1996). This pioneering work was followed by many researchers 
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investigating biological pathway components also using peptide aptamers to target 
different protein sites.  
Similarly to Colas et al. (1996), Butz et al. (2000) in their search of peptide 
aptamers binding to human papillomavirus (HPV) E6 also found peptide aptamers 
which could bind to E6 proteins of other HPV types indicating a structural homology 
between the proteins. Moreover, several of the identified peptide aptamers contained 
motifs similar to those found in natural binding partners of E6 and proposed to be E6 
protein binding motifs (Butz et al, 2000). Some of these peptide aptamers induced 
apoptosis of HPV-positive cancer cells by targeting the E6 protein which has an 
antiapoptotic potential (Butz et al, 2000). Also a screen where peptide aptamers were 
selected to outcompete DP for E2F binding isolated a peptide aptamer with a four 
amino acid motif which is present on DP and is conserved across the species 
(Fabbrizio, 1999). They showed that the motif on DP is essential for the progression 
through the cell cycle because it allows for DP/E2F heterodimerisation. Therefore, 
peptide aptamers could help to identify new protein interactors by giving an idea of 
the functional motifs used for interaction with the target protein and thus ease finding 
drug targets. 
Another example of successful peptide aptamer application to dissect a 
biological pathway and narrow down an interaction to a motif level was presented by 
Wickramasinghe et al. (2010) who isolated a peptide aptamer named “swiggle”. 
Swiggle interacts specifically with the LLY motif of Membrane-Type 1 Matrix 
Metalloproteinase (MT1-MMP) intracellular domain (ICD). Expression of MT1-
MMP, a major player implicated in extracellular matrix remodelling, is associated 
with processes promoting tumour progression such as tumour cell invasion and 
metastasis (Uekita et al, 2001). However, the only information on MT1-MMP 
interaction involving its ICD comes from the studies in which the domain was either 
partially or completely deleted (Wickramasinghe et al, 2010). Wickramasinghe et al. 
(2010) applied swiggle in their research and showed that it outcompetes a protein 
interactor required for MT1-MMP internalisation, and that the LLY motif of ICD is 
essential for the interaction between MT1-MMP and its internalisation partner 
(Wickramasinghe et al, 2010). They also showed that peptide aptamers can be found 
to interact with domains as small as 21 amino acids of MT1-MMP ICD.  
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Even though not yet extensively explored, peptide aptamers were used in 
living organisms. Kolonin et al. (1998) expressed two peptide aptamers against Cdk 
proteins in Drosophila, each resulting in rough eyes associated with cell division 
defects. They showed by overexpressing Cdks, in peptide aptamer-expressing 
Drosophila, that the effect of these peptide aptamers on cell cycle progression is 
dosage-dependent (Kolonin & Finley, 1998). Moreover, the peptide aptamers were 
selected in Y2H for binding to Cdk1 or Cdk2 and this specificity was demonstrated 
in in vitro assay and was preserved upon expression in Drosophila. By expressing in 
Drosophila, peptide aptamers were applied to target Wnt signalling pathway which is 
an essential and highly conserved pathway for an animal development (Yeh et al, 
2013). Expressing a peptide aptamer in Drosophila wing targeting β-catenin (β-cat), 
one of the Wnt pathway effector proteins, resulted in bubbles and blisters on the 
wing and growth defects. Yeh et al. (2013) further explored a crosstalk between the 
Wnt and Notch pathways showing that Ankyrin (ANK) repeats motif on Notch1 is a 
regulatory region for the Wnt pathway. Therefore, peptide aptamers can be expressed 
in living organisms as they retain their target binding and successfully applied to 
dissect interactions within a network.  
1.4.3.4. Basic Research - peptide aptamer biotechnology 
Peptide aptamers can be applied to assess peptide motif specificity required for a 
target protein binding. Dibenedetto et al. (2013), having found a peptide aptamer 
binding to two unrelated human proteins, wanted to dissect its target specificity. 
They randomly mutagenised the peptide aptamer to generate a library comprising of 
1200 variants and a subset of the variants was picked by chance and examined for 
binding to either one or other protein target. They observed that substitution of an 
amino acid at a particular position to isoleucine conferred the peptide aptamer 
specificity to one of the proteins, while tyrosine at that position resulted in binding 
the other protein target (Dibenedetto et al, 2013). Such peptide aptamer evolution 
approach can improve its specificity to a target thus having a potential application in 
obtaining peptide aptamers specific to a target protein and discriminating between 
related proteins. 
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It has been shown that peptide aptamers selected from a peptide library of 
random sequences often bind to a site on a protein target which is physiologically 
significant (Warbrick, 2006). An example is a screen for peptide aptamers binding to 
proliferating cell nuclear antigen (PCNA) which yielded peptide aptamers binding to 
a site used for PCNA binding by its known partner p21. Thus, peptide aptamers can 
guide a researcher to a protein domain which is significant for biological interactions 
and even narrow down the search to the protein site level.  
Peptide aptamers can be potentially used to map an interaction site used by a 
protein to bind its partner. Warbrick et al. (1995) to map the minimum PCNA 
binding site on p21WAF1 first, using Y2H, established the regions on each of the two 
proteins involved in their interaction. To narrow down the interaction region on 
p21WAF1 to the residues critical for the binding, they generated overlapping peptide 
fragments of the p21WAF1 region and binding efficiency of each p21WAF1-derived
peptide to PCNA was detected by ELISA (Warbrick et al, 1995). 
Also Hall et al. (2011) used a whole protein fragment as a peptide aptamer. 
To kill Trypanosoma brucei, the binding of tbBRCA2 and RAD51, which is essential 
to mediate recombination repair, was perturbed. Induction of peptide aptamer 
encompassing the BRC motif of tbBRCA2 (which is essential for RAD51 binding) 
significantly slowed down growth of T. brucei (Hall et al, 2011). Thus, it was shown 
that a protein motif-derived peptide aptamer can have an inhibitory effect on this 
protein function.  
Peptide aptamers atop of their basic function which is binding to the target 
proteins can be engineered to have additional functions. Hence, peptide aptamer 
harbouring a nuclear localisation signal (NLS) was used to direct its protein target 
from cell cytoplasm to the nucleus (Colas et al, 2000). Such protein depletion from a 
compartment where it plays a biological function by redirecting it to a compartment 
where it has no activity results in its functional knockout. Also Colas et al. (2000) 
demonstrated that a target protein can be modified using peptide aptamers. By fusing 
a peptide aptamer to a ubiquitin ligase, one can target the protein interactor of such 
peptide aptamer to induce its ubiquitination (Colas et al, 2000; Crawford et al, 2003). 
Therefore peptide aptamers can be further modified to act as a shuttle for enzymes to 
modify proteins of interest. 
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1.5. Project aims 
There are limitations to study post-mitotic roles of Msps and DmEB1, particularly in 
a developing organism, as these proteins are essential for cell division. To overcome 
these limitations, new tools are required. I aimed to develop new tools which would 
allow inactivating the proteins at specific time and space at a whole organism level. 
More specifically, I aimed to 
1) generate a msps temperature-sensitive Drosophila to inactivate Msps
2) select peptide aptamers interfering with Msps and DmEB1 functions. This also
reveals what residues promote binding to Msps and DmEB1. 
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CHAPTER 2 
Materials and methods 
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2.1. Standard materials 
2.1.1. Buffers  
Buffers were prepared as in Sambrook et al., 1989 (Sambrook et al, 1989; Sambrook 
& Russell, 2001). Most of the non-temperature-sensitive solutions were sterilised by 
autoclaving, the temperature-sensitive solutions were filtered using 0.2 µm Millex 
syringe filters (Millipore) or bottle top filters (TPP).  
2.1.2. Enzymes and chemicals  
Chemicals used in this study were supplied by Sigma, Invitrogen, Fisher Scientific 
and BDH and were of analytical grade. Restriction enzymes were provided by New 
England BioLabs (NEB) and Promega. Taq DNA polymerase (Roche) and 
primeSTAR HS DNA polymerase (TaKaRa) were used throughout.  
2.1.3. Antibodies 
Antibodies used for Drosophila S2 cell immunostaining were as follows 





Mouse anti-tubulin (dm1A) (1:250) Sigma 
Mouse anti-GFP (1:500) Molecular Probes 
Rabbit anti-GFP (1:500) Molecular Probes 
Rabbit anti-EB1 (1:200) (Elliott et al, 2005) 
Rat anti-Sentin (1:50) by the Ohkura lab (unpublished) 






Anti-mouse Cy3 (1:500) Jackson Labs 
Anti-mouse Alexa Fluor 488 (1:1000) Molecular Probes 
Anto-rabbit Cy3 (1:2000) Jackson Labs 
Anti-rabbit Cy5 (1:2000) Molecular Probes 
Anti-rabbit Alexa Fluor 488 (1:200) Molecular Probes 
Anti-rat Cy3 (1:500) Jackson Labs 
Anti-sheep Cy3 (1:1000) Jackson Labs 
2.2. DNA techniques 
Standard DNA techniques were used throughout (Sambrook et al, 1989). Kits were 
used according to the manufacturer’s instructions: QIAquick PCR Purification Kit 
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(Qiagen) to purify PCR products, HiSpeed Plasmid Midi Kit (Qiagen) for large scale 
purification of DNA from bacteria and Wizard Plus SV Minipreps DNA Purification 
System (Promega) for small scale purification of DNA from bacteria. 
2.2.1. DNA Sanger sequencing 
DNA sequencing reaction [25 x (96°C x 30 sec + 50°C x 15 sec + 60°C x 4 min) + 
4°C hold] was performed in thermocycler using BigDye polymerase (Life 
Technologies) and 0.8 pmol/μl sequencing primer and analysed by Sanger 
sequencing services at Genepool (Edinburgh).  
2.2.2. Gateway cloning for generation of peptide aptamer constructs 
To allow for efficient gene transfer between cloning vectors while maintaining the 
reading frame, genes encoding peptide aptamers were cloned into pDONR221 donor 
vector as follows. The genes were flanked by attB1 and attB2 sites, for 
recombination with pDONR221, using polymerase chain reaction (PCR) by 
including these sites in primers (oKMT43: 
GGGGACCACTTTGTACAAGAAAGCTGGGTCCACGATGCACAGTTGAAGT
GAA and oKMT44: 
GGGGACAAGTTTGTACAAAAAAGCAGGCTCCAAAATCTGTATGGCTTAC
CCATACG). These PCR products were run on an agarose gel to confirm their sizes. 
The PCR products were cloned into pDONR221 donor vector using Gateway BP 
Clonase II enzyme mix (Invitrogen) following the manufacturer’s instructions. The 
destination vectors pAGW or pARW were used for the expression of an aptamer 
fused to a GFP or mRFP under the actin5C promoter in S2 cells, and pPGW was 
used for expression of an aptamers fused to GFP under the UASp promoter in 
Drosophila. To introduce a gene of interest to a destination vector, Gateway LR 
Clonase II enzyme mix (Invitrogen) was used and the reaction was performed 
according to the manufacturer’s instructions. Escherichia coli (E. coli) One Shot 
TOP10 (Invitrogen) cells, [F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 
Δ lacX74 recA1 araD139 Δ(araleu)7697galU galK rpsL (StrR) endA1 nupG], were 
used throughout and bacterial transformations were carried following the 
manufacturer’s instructions. 
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2.3. Yeast techniques 
2.3.1. Construction of bait plasmids 
Vector pGBT9 was used to construct all bait plasmids. Msps, DmEB1, HsEB1 or 
HsEB3 coding sequences were flanked, using PCR, by ~50 nucleotide fragments 
complementary to pGBT9 upstream and downstream of the EcoRI site on pGBT9 by 
inclusion of these fragments in primers. The PCR products were run on agarose gel 
to confirm their sizes and purified using PCR purification kit (QIAGEN). A gene 
was inserted by gap repair into pGBT9 vector linearised by digestion with EcoRI in 
Y190 S. cerevisiae strain. To confirm insertion of a gene into the vector, PCR was 
performed from a yeast colony (as in 2.3.4) using primers to amplify the plasmid 
region including the putative insertion site and sequenced. 
2.3.2. Construction of prey plasmids 
pACT2 was used throughout as a prey vector. Prey plasmids containing D-TACC or 
α-tubulin coding sequence were constructed in the same manner as bait plasmids, 
except using the prey vector (pACT2). To express double constrained peptide 
aptamers, pACT2 plasmid was used with TrxA coding sequence cloned into it (gift 
from Emma Warbrick, Dundee).  
2.3.3. Making libraries for expression from prey plasmid 
Deoxyoligonucleotides were synthesised commercially (Eurofins), encoding 16 
random amino acids (for NNK library) or 13 random with fixed Ser-x-Ile-Pro (for 
SxIP library) followed by stop codon and flanked by 48 bp at 5’ and 21 bp at 
3’complementary to the sequence upstream and downstream of the EcoRI restriction 
site in pACT2. The complementary strands to the deoxyoligonucleotides were 
polymerised by a single polymerisation (98°C x 10 sec + 50°C x 10 sec + 72°C x 10 
min + 4°C hold) using PrimeSTAR HS DNA polymerase (TaKaRa). The primer 
contained the further 29 bp fragment of pACT2 adding it to the 3’ end of the 
deoxyoligonucleotide fragments. 
48
Deoxyoligonucleotide was synthesised commercially (Eurofins), encoding 
13 random amino acids with fixed Ser-x-Ile-Pro, flanked by 48 bp at 5’ and 24 bp at 
3’complementary to the sequence upstream and downstream RsrII restriction site in 
TrxA sequence. A further 24 bp complementary fragment was added to the 3’ end by 
inclusion in a primer by a single polymerisation reaction as previously.  
2.3.4. Amplification of a gene from a yeast colony 
To prepare template for PCR from yeast genomic DNA, a yeast colony was picked 
into an Eppendorf tube with 10 μl of 0.02M NaOH freshly made from 10M NaOH. 
The tube was vortexed briefly and incubated for 5 min at 100°C. Immediately after 
the incubation, the tube was put on ice and, once cold, condensation was spun down 
in a table top centrifuge. The cells were suspended and used as a template in a PCR 
reaction [94°C x 2 min + (94°C x 30 sec + 55°C x 30 sec + 68°C x 1min/kb) x30 + 
68°C x 10min + 4°C hold] using Taq polymerase. 
2.3.5. Yeast two-hybrid methods 
2.3.5.1. Screening for peptide aptamers 
Growth, maintenance and transformation of S. cerevisiae were carried out according 
to (Guthrie & Fink, 2004). Y190 S. cerevisiae strain (MATa leu2-3 112 ura3-52 trp1-
901 his3-D200 ade2-101 gal4D gal80 D cyhR URA3::GAL1-lacZ, LYS2::GAL1-
HIS3) was used for all Y2H analyses. Yeast carrying a bait plasmid were 
cotransformed with linearised prey vector and a library of the variable DNA 
fragments for insertion into the prey plasmid. In order to test for expression from 
HIS3, transformants were plated on yeast minimum media, YMM (6.7g Difco Yeast 
Nitrogen base without amino acids, 20g Glucose, 1L distilled water) supplemented 
with 20 mM 3-Amino-1,2,4-triazole (3-AT) and essential amino acids (adenine), 
incubated for 1 week and plates were examined for formation of colonies. Where 
growth occurred, a colony was picked and patched on YMM plate with 10 mM 3-AT 
and adenine and incubated for 3 days. Where growth occurred, a colony was patched 
on a YMM agar plate without 3-AT and allowed to grow for one day. A plate was 
replicated to two copies and positive and negative control yeast for expression from 
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lacZ were patched on one of the replicas. Yeast were allowed to grow for one day 
and β-galactosidase activity was assayed on plate by overlay with 0.72% X-Gal 
(Guthrie & Fink, 2004). Yeast from one of the replica plates, corresponding to yeast 
patches which produced β-galactosidase on the other replica, were used to isolate 
single colonies by streaking the yeast on YMM plate with  10 mM 3-AT and then 
YMM without 3-AT. Single colonies were, as previously, patched on YMM, allowed 
to grow, plates were replicated and and β-galactosidase activity was assayed on plate 
by X-Gal overlay. PCRs were performed from yeast colonies (as in 2.3.4) which 
produced β-galactosidase to amplify from prey plasmid a library insert sequence and 
the flanking region, 127 bp of the 5’ and 138 bp of the 3’. To exclude that activation 
of lacZ reporter gene was caused by random mutation in yeast or a plasmid, the DNA 
was used together with linearised prey vector to cotransform yeast carrying a bait 
plasmid. The DNA was also sequenced. Transformants were assayed on plates for β-
galactosidase activity as previously and these true positives which produced blue 
colouration were stocked in glycerol.  
2.3.5.2. Selecting strongest Y2H interactors 
Y2H was performed and transformants were assayed on plates for β-galactosidase 
activity, as previously. Transformants which expressed β-galactosidase were assayed 
in liquid as in Miller et al. (1972) with the following modifications (Miller, 1972). 1 
ml of yeast cultured overnight in liquid at 30°C with constant shaking were diluted 3 
ml media. After 3 hours A600 was measured. If A600 was 0.5-1.0, the incubation was 
stopped. 1 ml of yeast cell culture was centrifuged for 1 min in a table top centrifuge 
at 14000 rpm. Supernatant was discarded, not disturbing the pellet, followed by 
adding 400 μl Z buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM 
Mg2SO4, 1 mM dithioerythritol, 0.2% (v/v) sarcosyl, pH7) and 100 μl of 4 mg/ml 
ortho-Nitrophenyl-β-galactoside. Cells were resuspended by pipetting and incubated 
in a water bath at room temperature for 15 min and then at 30°C until the colour 
developed. 500 μl of 1 M Na2CO3 was added and the solution was spun down for 10 
min in a table top centrifuge at 14000 rpm.  The A420 of the supernatant was 
measured. The β-galactosidase activity was calculated as A420/A600 ratio. The assay 
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as performed in replicas (usually three) and average of A420/A600 was calculated for 
corresponding yeast clones. 
2.4. Techniques of Drosophila cell culture 
2.4.1. Culturing and transfecting Drosophila S2 cells 
Drosophila S2 cells were cultured in tissue culture flasks at 27°C in Schneider’s 
Drosophila medium (Gibco by Life Technologies) supplemented with 10% Foetal 
Bovine Serum (FBS) heat inactivated (Gibco by Life Technologies). The cells were 
split twice a week to 6 x 106 cells/ml in 5 ml culture. Cells were transfected with a 
recombinant expression vector for transient expression studies using Effectene 
Transfection Reagent kit (Qiagen) and following the manufacturer’s instructions. 
2.4.2. Coating coverslips with Concanavalin A (ConA) 
Glass coverslips (1 mm thick, VWR international) or 35 mm glass bottom Petri 
dishes (MatTek Corporation) were washed in distilled water, 3 x 5 min, then 
submerged for 30 min in 0.5M HCl and, next washed with distilled water, 3 x 5 min 
and then with 100% ethanol for 30 min. The coverslips were allowed to air-dry 
before dipping them individually in 0.5 mg/ml ConA (Calbiochem) and they were 
air-dried again. The coverslips were stored at 4°C. 
2.4.3. Fixing Drosophila S2 cells 
Cells were first adhered to ConA coverslips by incubating a coverslip submerged in 1 
ml of 6 x105 cells/ml culture at 27°C for 2 hours. After removing the media, and cold 
methanol fix (90% methanol, 3% formaldehyde, 5mM Na2CO3 at pH 9) was applied 
after chilling it on dry ice. The coverslips were incubated for 15 min at -80°C and 15 
min at room temperature. The coverslips were rinsed and stored in washing buffer, 
PBS-T (0.1% Triton X-100 in PBS: 137mM NaCl, 2.7mM KCl, 10mM 
Na2HPO4.2H2O, 2mM KH2PO4, pH7.4). 
2.4.4. Immunostaining of Drosophila S2 cells 
Cells fixed on coverslips coated with ConA were incubated at room temperature for 
1 hour in blocking buffer (10% FBS in washing buffer from 2.4.3), followed by 
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incubation for 1 hour with the primary antibodies in blocking buffer. The coverslips 
were rinsed and washed 3 x 5 min with PBS-T, followed by 1 hour incubation with 
secondary antibody solution in blocking buffer. Following rinsing and 3 x 5 min 
washing with PBS-T, coverlips were incubated for 10 min with 0.4 µg/µl DAPI 
diluted in PBS-T. The coverslips were then washed twice in PBS-T and once with 
PBS and mounted on glass slides using mounting medium (2.5% propyl gallate, 85% 
glycerol). 
2.4.5. Adhering Drosophila S2 cells for live imaging  
ConA coverslips were submerged in 1 ml of 0.5 x 105 cells/ml culture at 25°C and 
incubated for 2 hours. 
2.5. Microscopy techniques 
2.5.1. Analysis of fixed Drosophila S2 cells 
Following cell fixation and staining, as described, images were taken with an 
Axioplan 2 microscope (Zeiss) attached to a CCD camera (Hamamatsu) controlled 
by OpenLab 2.2.1 software (Improvision). To measure Sentin or CLIP-190 signal at 
the microtubule plus ends, the method was used as described by Dzhindzhev et al. 
(2005), with the following modifications. The plus end signal was calculated using 
the formula S–B, where S is the total pixel intensity for a particular plus end signal 
and B is the total pixel intensity of the local background. The local background 
signal intensity was measured, of the same size as plus end signal area, at one side of 
a plus end signal area. Three plus end signals were measured in at least ten separate 
interphase cells. Measurements were made using OpenLab 2.2.1 (Improvision). 
2.5.2. Analysis of live Drosophila S2 cells 
Cells were first adhered to Petri dishes (MatTek Corporation) coated with ConA by 
incubating the dish with 1 ml of 0.5 x 106 cells/ml culture at 27°C for 2 hours. Cells 
were imaged using an Axiovert (Zeiss) spinning disc microscope.  
2.6. Protein techniques 
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2.6.1. Expression of MBP and MBP-DmEB1 recombinant proteins 
E. coli bacterial culture (F–, ompT, hsdSB (rB–, mB–), dcm, gal, λ(DE3), pLysS, Cmr) 
carrying pSC23 or pSC22 plasmids (provided by Sara Clohisey) for expression of 
MBP or MBP-DmEB1 respectively were grown overnight at 37°C in LB medium 
with 50 µg/ml ampicillin with constant shaking. Following 1:100 dilution, a bacterial 
culture was grown until OD600 was 0.4 – 0.6. To induce protein expression, isopropyl 
β-D-1-thiogalactopyranoside (IPTG) was added to a final concentration of 1 mM and 
the culture was grown for additional 4 hours. Bacterial culture was next spun down at 
4000 rpm for 10 min and pellets were either processed immediately or stored at -
20°C. 
2.6.2. Purification of MBP and MBP-DmEB1 recombinant proteins 
To lyse the bacteria, a pellet was suspended in 1/10 of the original culture volume in 
ice cold PBS buffer  supplemented with Complete EDTA-free protease inhibitors, 1 
mM phenylmethylsulfonyl fluoride, a pinch (picked with the wider end of a 200 µl 
pipette tip) of lysozyme, 3mM dithiothreitol and 0.5 M EDTA, and mixed well and 
left on ice for 30 min. The suspension was sonicated in short bursts (5 sec ON, 10 
sec OFF) for a total ON-time of 2 min. The lysate was centrifuged at 4°C and 
14000rpm in a JA-25.50 rotor of Beckman Avanti-25 centrifuge for 30 min and the 
supernatant was passed through a 0.2 μm syringe filter. The proteins were affinity 
purified using 1 ml MBPTrap HP column (GE Healthcare) on ÄKTA system (GE 
Healthcare) at the flow rate 1 ml/min. The column was equilibrated with five column 
volumes of the wash buffer (1mM EDTA, 1mM DTT in PBS). One-step elution was 
applied by injection of ten column volumes of 100% elution buffer (1mM DTT, 
10mM maltose in PBS). The elute was collected in 0.5 ml fractions. The proteins 
were further purified by size exclusion chromatography using 24 ml Superdex 200 
10/300 GL column (GE Healthcare) on ÄKTA system (GE Healthcare) at the flow 
rate 0.5 ml/min.  The column was equilibrated with 1.5 column volumes of the buffer 
(1mM DTT in PBS). One 0.5 ml fraction from the affinity purification containing the 
protein was injected. 1.5 column volume of 0.5 ml fractions were collected, the 
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protein peak eluted at 11 ml. Protein purity was assessed by SDS-PAGE using 
standard methods (Sambrook et al, 1989). 
2.7. Affinity measurements by isothermal titration calorimetry (ITC) 
ITC experiments were conducted using MicroCal Auto-iTC200 (GE Healthcare). All 
peptides used were commercially synthesised (Eurogentec). They were weighed out 
as solids and dissolved in 100% DMSO. 1 μM MBP or MBP-DmEB1 was loaded 
into the cell with 20 μM peptide in the titrating syringe. MBP, MBP-DmEB1 and 
peptide were analysed in the same buffers (120 mM NaCl, 2.7 mM KCl, 30 mM 
NaH2PO4, 1 nM DTT, 2% DMSO, pH 7.4). The titration experiments were 
performed at 25°C. MBP or MBP-DmEB1 was titrated with increasing 
concentrations of a peptide. The resulting heats were integrated using Origin 
(OriginLab) software by fitting to a single-site binding model provided by the 
software package. Experiments were done in at least three replicas.  
2.8. Drosophila techniques 
Standard Drosophila handling techniques were used (Ashburner et al, 2005). 
Drosophila were grown on standard yeast agar medium (107g agar, 442 brewers 
yeast, 786g glucose, 714g maize, 57g yeast, 32g nipagin, 32ml propionic acid, 200ml 
ethanol) at 25°C or 18°C. Drosophila lines used in this work were as follows: 
genotype source 
w[1118] Bloomington Stock Centre 
y w; Act5C-GAL4/TM6B Lab stock 
w; mspsA/TM6C By A. Brittle and H. Ohkura, 
unpublished 
y w; mspsP/TM6C (Cullen et al, 1999) 
w; pKMT138 P[w+m, UAS-GFP-aptamer 37]/TM6C This work 
w; pKMT224 P[w+m, UAS-GFP-aptamer 37dimer]/TM6C This work 
w; pKMT139 P[w+m, UAS-GFP-aptamer Perfect]/TM6C This work 
w; pKMT210 P[w+m, UAS-GFP-aptamer Perfect dimer]/TM6C  This work 
w; pKMT217 P[w+m, UAS-GFP-aptamer T14]/TM6C This work 
w; pKMT98 P[w+m, UAS-GFP-aptamer C2]/TM6C This work 
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w; pKMT99 P[w+m, UAS-GFP-aptamer C28]/TM6C This work 
w; pKMT23(pAB106) P[w+m, mspsE190K]/TM6C This work 
w; pKMT23(pAB106) P[w+m, mspsE190K] mspsA/TM6C This work 
2.8.1. Generating genetic recombinants 
To obtain Drosophila mutants carrying both transgenic msps[E190K] and msps null 
mutation at the same third chromosome Drosophila were crossed as depicted on a 
crossing scheme in Figure 2.1. 
2.8.2. Expressing peptide aptamers 
Peptide aptamers were expressed in Drosophila by crossing them as described in 
chapter 4 and 5.  
2.8.3. Drosophila temperature shifts 
Temperature shift experiments of Drosophila pupae or Drosophila which emerged 
out of pupae case were performed as described in chapter 5. Young adult Drosophila, 
after shifting them to restrictive temperature, were monitored daily and their abilities 
to climb up a vial wall were assessed by tapping vials of mutant and control 
Drosophila side by side and then allowing the Drosophila to climb up. Drosophila 
coming from temperature shifts of pupae were dissected out of pupae case, if they 
had not not emerged themselves, and analysed under the microscope. Drosophila 
which emerged out of pupae case and could walk were knocked upside-down and 
their recovery was compared to the control Drosophila.  
2.9. Statistics 
Statistical analyses were performed as described in chapters 3 and 4 using following 































































































































































































































































































































































































































































































Identification of peptide aptamers to EB proteins 
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3.1. Single constrained peptide aptamers to DmEB1 
3.1.1. Making bait plasmid 
EB proteins recruit many MAPs to the microtubule plus ends by a consensus Ser-x-
Ile-Pro sequence on these MAPs. Since many proteins have SxIP but do not bind to 
EB1, amino acids in the region surrounding SxIP are likely also involved in the 
binding. In other words SxIP is required but not sufficient for the binding. I aimed to 
establish the amino acid determinants in the region flanking SxIP which promote 
strong binding to DmEB1, by large scale screening for peptide aptamers. I screened a 
library encoding single constrained peptides, displayed from the C-terminus of 
GAL4-AD. The single constraint promotes higher conformational variability of 
peptides making it easier to select singly constrained peptides than the double 
constrained peptides. The N- and C-terminus of a double constrained peptide is fused 
to a protein from which it is displayed making this peptide less flexible.  
I constructed a bait plasmid containing the DNA encoding full length 
DmEB1 by inserting the DNA into EcoRI site of Y2H bait vector (pGBT9) by gap 
repair in yeast on transformation (Figure 3.1). Gap repair relies on homologous 
recombination between the same sequences on two different DNA fragments. 
Therefore, to allow insertion into the bait vector by gap repair, sequences of 50 bases 
upstream and 50 bases downstream of the EcoRI site of the bait vector were added to 
either end of the DmEB1-coding sequence by PCR through inclusion of the 
sequences in the primers. A Y2H strain of yeast was transformed with a mixture of 
the bait vector linearised by EcoRI and the PCR product, and plated on selective 
media for the bait plasmid.  
Next, to confirm that the bait plasmid had a correct insert, yeast 
transformants were tested by amplifying the insert by PCR. After confirming the 
correct insert size (~1 kb) on agarose gel, I sequenced this PCR product and 
confirmed that no mutation was introduced during construction. This transformant 
was stored in glycerol for future experiments. 










Figure 3.1 Making bait plasmid 
To make bait plasmids, ~50 nucleotide fragments complementary to 
pGBT9 bait vector (red) upstream and downstream of the EcoRI site 
on pGBT9 were added to DmEB1 (purple) using PCR, by inclusion 
of these sequences in primers. Yeast (Y190) were cotransformed with 
the PCR product and pGBT9 vector linearised with EcoRI for 













I aimed to find peptide aptamers which bind tightly to the C-terminal EBH domain. 
To identify these peptide aptamers, after constructing bait plasmid, I next constructed 
Y2H prey plasmid library. Instead of a library encoding completely random peptides, 
I fixed codons for SxIP which were preceded by 5 and followed by 7 random amino 
acids and a stop codon (Figure 3.2). Random amino acids were encoded by NNK 
codons, where N represents any of the four bases and K represents guanine or 
thymine. Using NNK reduced bias among the amino acids (for example frequency of 
codons for arginines was reduced from six to thee) and included a complete set of 
standard amino acids (Mena & Daugherty, 2005). NNK also allowed to avoid UAA 
and UGA stop codons. To allow the insertion into a prey vector (pACT2) by gap 
repair in yeast on transformation, a pool of single-stranded (ss) DNAs was first 
commercially synthesised. These DNAs contained sequences encoding 16 amino 
acids and the stop codon flanked by sequence corresponding to the prey vector 
sequences upstream (48 nucleotides) and downstream (21 nucleotides) of the EcoRI 
site on the vector. Next, I synthesised complementary strands to the ssDNAs by 
using a primer partially complementary to 3’ end of the ssDNAs and adding further 
29 nucleotides complementary to the prey vector sequence by inclusion of the 
sequence in the primer (Figure 3.2). By performing a single polymerase reaction 
instead of a PCR, I added the complementary strand. This minimised the likelihood 
of screening the same sequences multiple times.  
To verify the quality of the Y2H prey plasmid library, yeast were 
cotransformed with the prey vector linearised at EcoRI site and the above DNA 
encoding the random peptides with fixed SxIP, and plated on media selective for the 
prey plasmid but not activation of reporters. To test the DNA fragments were 
inserted into Y2H prey vector by gap repair, the region embracing the insert site on 
the prey plasmid was amplified by PCR from 11 yeast transformants and sequenced. 
Six of the 11 prey plasmid library fragments encoded 13 random amino acids and the 
fixed SxIP motif followed by the stop codon as originally designed (Figure 3.3). 
Premature stop codons were present in 4 other DNA fragments, but they were 
located after the codons for SxIP (Figure 3.3). Only 1 out of the 11 DNA fragments 










Figure 3.2 Generating prey plasmid library by gap repair. 
To make prey plasmid library, oligonucleotide was synthesised whose 
core region encodes Ser-x-Ile-Pro preceded by 5 and followed by 7 
random residues (xxxxxSxIPxxxxxxx), followed by a stop codon 
(TGA) and flanked by 48 nt at the 5' end and 21 nt at the 3' end, each 
of which corresponds to the sequence upstream and downstream of 
the EcoRI restriction site on the prey vector pACT2.  A further 29 nt 
were added to the 3’ end through inclusion in a primer during 
synthesis of the complementary strand.  Y190 carrying a bait plasmid 
was cotransformed with a DNA fragment as above and a prey vector 














1  WQYLQSVILGVKI-ASC 
2  TRLSFSTIPGHAKPIV- 








Figure 3.3 The amino acid sequences encoded by unselected clones from the prey 
SxIP library  
Yeast were cotransformed with linearised prey vector and DNA encoding random 
peptides with fixed SxIP flanked by sequences corresponding to fragments of 5’ and 3’ 
on linearised prey vector for gap repair. Transformants were plated on media selective 
for the prey plasmid but not activation of reporters. The region embracing the insert site 
on the prey plasmid was amplified by PCR from 10 clones picked at random and 
sequenced. Fixed SxIP motif is denoted with asterisks, bold indicates translated 
sequence. 
*   * * 
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To determine whether amino acids encoded in the SxIP prey plasmid library 
occurred at random at each position a further 39 transformants were sequenced. The 
sequences were a heterogeneous mixture of nucleotides (Figure 3.4). The encoded 
peptides appeared to be composed of amino acid mixture without any amino acids 
dominating and each of the peptides was unique (Figure 3.5). To verify whether the 
occurrence of amino acids at subsequent positions encoded in the SxIP library was 
random, a chi-squared test was performed. The amino acid occurrence at each 
position was scored for ~40 peptides and compared to the expected number of each 
amino acid, which was calculated taking into account the number of codons by 
which each of the amino acids can be encoded using NNK. The amino acids 
occurrence at all 13 positions was random (p > 0.01) (Figure 3.6). 
Since 91% of the peptide fragments contained SxIP and amino acids were 
encoded at random at the subsequent positions within the SxIP library, I concluded 
that the library was of a good quality.  
3.1.3. Optimizing screening conditions and screening the prey plasmid library 
Before performing Y2H screen on a large scale, I optimised the conditions of yeast 
transformation with the SxIP library. A number of small scale yeast transformations 
were performed altering the amounts of the linearised prey vector and the SxIP 
library fragments. The optimal amounts of the linearised vector and the fragments to 
transform 5 ml of 1-2 x 107 cells/ml yeast were 0.5 µg of each.  
Then, I optimised the concentration of 3-AT, an inhibitor of histidine 
biosynthesis, for selection of interactors. Increased level of a reporter expression, 
HIS3, required for yeast to survive on 3-AT reduced the background growth allowing 
to select bait-prey plasmid interactors. I cotransformed yeast carrying DmEB1 bait 
plasmid with linearised prey vector and the SxIP library and plated on media 
containing 10, 20, 25, 30, 35, 40 and 50 mM 3-AT. Growth of these transformed 
yeast was severely inhibited when plated on media containing ≥20 mM 3-AT. I 
concluded that 3-AT concentration as low as 20 mM was enough to suppress growth 
of yeast expressing background levels of HIS3.  
To perform the large scale Y2H screen, 50 µg of each the linearised prey 
vector and the SxIP library fragments were used to transform 500 ml of 1-2 x 107 
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   nnKnnKnnKnnKnnKTCCnnKATTCCAnnKnnKnnKnnKnnKnnKnnKTGA 
1  GAGTTGTATACTTGGTCCTGGATTCCATCGGATGTTTGTGGGGTGGCTTGA 
2  TTTATGCAGAGTAGGTCCGGTATTCCAGAGATGGTGAGGGGGTTGGGGTGA 
3  GGTTCGTGGTGCGGGTCCATTATTCCAATGGTTCGGTTGGCTCAAGGGTGA 
4  GCTGGGCGTATTGGGTCCACTATTCCAAGGCAGTTGCATGTGGATCATTGA 
5  ACTGAGACGCAGAATTCCAGTATTCCAGCTTTGTGGCGTTGGCTTAGTTGA 
6  CAGTTGGCTTTGGTGTCCGCGATTCCAAGTGTTAGTCTTTATAAGCTTTGA 
7  GTTGTGCGTGCGGTTTCCGTTATTCCATTGTGGGGTCAGGGGGGGGGGTGA 
8  AGGCGGATGCATCCTTCCAGTATTCCACAGCGGGTTGATTGGGCGAGGTGA 































Figure 3.4 The composition of the unselected SxIP prey plasmid library  
The DNA sequences of random unselected clones from SxIP prey plasmid library 
were obtained by sequencing. The sequences were a heterogeneous mixture of 
nucleotides. K = G/T, n = A/T/C/G 
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1  ELYTWSWIPSDVCGVA- 
2  FMQSRSGIPEMVRGLG- 
3  GSWCGSIIPMVRLAQG- 
4  AGRIGSTIPRQLHVDH- 
5  TETQNSSIPALWRWLS- 
6  QLALVSAIPSVSLYKL- 
7  VVRAVSVIPLWGQGGG- 
8  RRMHPSSIPQRVDWAR- 































Figure 3.5 Amino acid sequences of peptides encoded in SxIP prey plasmid library 
Yeast were cotransformed with linearised prey vector and DNA encoding random 
peptides with fixed SxIP flanked by sequences corresponding to fragments of 5’ and 3’ 
on linearised prey vector for gap repair. Transformants were plated on media selective 
for the prey plasmid but not activation of reporters. The region embracing the insert site 
on the prey plasmid was amplified by PCR from clones picked at random and 
sequenced. Fixed SxIP motif is denoted with asterisks, bold indicates translated 
sequence. 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































cells/ml yeast. The transformants were plated on media with 20 mM 3-AT and clones 
which grew on the media were further patched on the minimal media and overlaid 
with X-galactose to test expression from the second reporter gene, lacZ. Blue 
colouration indicated expression from the lacZ reporter gene.  
To estimate how many peptides I screened during one round of the large 
scale transformation, I plated onto histidine containing media an aliquot of yeast 
transformed with linearised prey vector and the SxIP library, and an aliquot of yeast 
transformed with the linearised prey vector only. I estimated that I screened between 
0.5 and 1 million peptides encoded on the SxIP prey plasmid library in each 
transformation.  
In total I screened ~5 million peptides and I found ~500 transformants 
which grew on 3-AT media and turned blue when overlaid with X-galactose 
indicating both reporter genes were activated.  
3.1.4. Certain amino acid residues flanking SxIP promote peptide binding to 
DmEB1 
I aimed to find amino acids in region flanking SxIP which promote binding to 
DmEB1. DNA encoding the SxIP-containing peptides was amplified and sequenced 
from 45 yeast transformants found in Y2H screen which activated both reporters. It 
appeared that the encoded peptides were rich in arginine and the occurrence of some 
of the amino acids was not random at certain positions (Figure 3.7 and 3.8). 
To test whether the occurrence of particular amino acids at certain positions 
in the vicinity to SxIP was significantly different in selected peptides than unselected 
peptides, chi-squared test was performed. I scored an amino acid occurrence at each 
position encoded by the 45 sequenced DNA fragments and compared them with the 
amino acids scored for the 39 peptides from the unselected SxIP library (unselected 
peptides) (Figure 3.8). Since occurrence of amino acids Lys and Arg at -5, Thr at -4, 
Arg and Phe at -2, Arg and Val at -1, Arg and Lys at x, Arg and Val at +1, Trp at +2, 
Val at +3, Gly at +4, Arg at +5 and Gly at +7 was significantly different in selected 
than unselected peptides (p < 0.01), I concluded that these amino acids promote 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.8 Sequence bias within SxIP motif  and flanking region 
promoting binding to EB1 
(A) Amino acids of peptide aptamers selected from SxIP library for 
interaction with DmEB1. Peptide aptamers selected from SxIP 
library revealed that some amino acids flanking SxIP are 
overrepresented and promote interaction with DmEB1. (B) EB1-
recruited +TIPs that contain confirmed SxIP motifs. SxIP sequence 
logo was derived from an alignment of SxIP motifs of known SxIP 
proteins (accession numbers: Q7Z460, O75122, Q9UPN3-2, 
P25054, Q13586, Q99661, Q86Y91, Q9P270, Q9VUA5, Q96SN8, 
Q9VQ69, P38991) from D. melanogaster, S. cerevisiae and H. 
sapiens. 
The total height of each stack indicates the "information content" at 
that position (measured in bits). The height of symbols within the 
stack reflects the relative frequency of the corresponding amino acid 
at that position. The subsequent positions within the sequences are 
labeled -5 to +7. The figures were generated using 
www.meme.nbcr.net server by submitting 16 amino acid long 
sequences in fasta format. 
-5 -4 -3 -2 -1  S  x  I  P +1 +2 +3 +4 +5 +6 +7 
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3.1.5. Designing an artificial peptide aptamer to DmEB1 
By large scale screening of peptides for binding to DmEB1 combined with statistical 
analysis of occurrence of each of the amino acids at subsequent positions, I revealed 
that some of the amino acid residues promote binding to DmEB1. I aimed to find out 
whether a peptide made by combining these amino acids which promote binding to 
DmEB1 into one sequence of, what I called, an “aptamer Perfect” would bind to 
DmEB1 (Figure 3.9).  
I tested DmEB1 interaction with aptamer Perfect by Y2H. DNA encoding 
aptamer Perfect, flanked by sequence allowing for gap repair with prey vector, was 
commercially synthesised. I cotransformed yeast containing DmEB1 bait plasmid 
with linearised prey vector and DNA encoding the aptamer Perfect and plated on 
selective media. Overlay of the transformants with X-galactose turned them blue, 
indicating that the clones activated expression from the lacZ reporter gene. Correct 
DNA construct and sequence encoding the aptamer Perfect was confirmed by PCR 
and sequencing. 
To exclude the possibility that a spontaneous mutation in the prey plasmid 
or yeast caused reporter gene activation, I amplified the DNA encoding aptamer 
Perfect and the flanking sequences from a transformant. Yeast with DmEB1 bait 
plasmid were cotransformed with the amplified DNA and linearised prey vector and 
overlaid with X-galactose. Blue colouration was observed, so I concluded that 
presence of DNA encoding the aptamer Perfect, not a spontaneous mutation in 
plasmid or yeast, caused expression from the lacZ. 
3.1.6. Identifying strongest single constrained peptide aptamers to DmEB1  
In Y2H assay, the strength of protein interaction correlates with reporter gene 
expression levels. I aimed to categorise the strength of interaction by assessing 
expression levels from the lacZ on plate. As a positive control of strong bait-prey 
plasmid interaction, I used yeast transformed with bait and prey plasmid carrying S. 
cerevisiae SPO13 and S. pombe plo1+ genes which are known to have high affinity 
for each other (personal communication, Hiro Ohkura). This yeast patch gave a very 
dark blue colouration when overlaid with X-galactose. For negative control, I 
transformed yeast with a bait plasmid and an empty prey vector. Since the prey 
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plasmid had no insert, I expected no specific expression from the reporter gene. 
Indeed, yeast overlaid with X-galactose remained white.  
I aimed to roughly categorise the yeast clones into three groups producing 
light, medium or dark blue colouration. The clones selected in Y2H screen were 
patched along with the negative and the positive controls on the same plate. Yeast 
were allowed to grow and were next overlaid with X-galactose. Examining all the 
yeast patches simultaneously allowed for more accurate comparison of the colour 
intensity between the patches allowing for the clone categorisation. However, this 
classification was based on visual examination rather than quantification. A yeast 
patch could have given a darker colouration if it was represented by a bigger number 
of yeast in a patch. Also, I was not able to discriminate between many of the clones 
within each of the three groups. I concluded that this method was good enough to get 
a general idea of how strongly each of the clones interacted with DmEB1 but it was 
not good enough to get a better insight and that a quantitative method was required.  
A more quantitative assay has been developed to measure expression from 
the lacZ reporter gene. In this assay β-galactosidase cleaved o-nitrophenyl-β-D-
galactoside (ONPG) to yield galactose and o-nitrophenol (ONP). When ONPG is in 
excess over the enzyme in a reaction, the production of ONP per unit time is 
proportional to the concentration of β-galactosidase (Estojak et al, 1995). To 
quantitatively assay β-galactosidase activity, yeast found in Y2H screen were first 
cultured in liquid media. Absorbance of each of the yeast cultures at 600 nm (A600) 
was measured to determine yeast cell density. Then yeast cells were permeabilised to 
release the β-galactosidase and incubated with ONPG. The A420 was measured after 
the cell debris were removed. The ratio of A420, which is proportional to 
concentration of ONP, and A600, which reflects the yeast cell density used in the 
assay, gives an indication of the amount of the β-galactosidase per cell.  
The assay was performed for 281 out of 472 the yeast clones found in Y2H 
screen as well as the yeast transformant for the aptamer Perfect in batches of up to 50 
clones and in three independent replicas. For the negative control, yeast transformant 
containing DmEB1 bait plasmid and the empty prey vector was used. To compare 
between the batches, I included three aptamers, 155, 172 and 188, to all assays. 
These three clones were chosen because they appeared in the first experiment and 
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they were all giving similar absorbance readings.  Average of the A420/A600 from 
three experiments for each yeast clone was calculated. Between 5 and 10 clones from 
each batch which gave the highest A420/A600 (a total of 51 clones) were further 
assessed together (Figure 3.10). The transformant expressing aptamer Perfect gave  
one of the highest A420/A600 (Figure 3.10). Thus the amino acids at subsequent 
positions which were each shown to promote binding to DmEB1, also promote 
strong binding when they act in concert. Twelve transformants with the highest 
A420/A600 were further analysed. 
3.1.7. Confirming interaction with DmEB1 
I aimed to exclude a possibility that expression from the lacZ reporter gene in the 
transformants found in the Y2H was caused by a spontaneous mutation in plasmid or 
yeast. Twelve clones were analysed which showed highest β-galactosidase 
expression in liquid assay (Figure 3.10). 
Inserts encoding the variable peptide region of prey plasmids were 
amplified from yeast transformants. Yeast containing the DmEB1 bait plasmid were 
cotransformed with these amplified DNAs and linearised prey vector DNA. Yeast 
from all the transformations expressed from the lacZ reporter gene as confirmed 
quantitatively in liquid assay for β-galactosidase activity. Therefore, a possibility that 
a spontaneous mutation in yeast or plasmid caused expression from the reporter gene 
was excluded.  
To exclude the possibility of mutations introduced into the DNA inserts 
during their amplification in PCR, I sequenced them and compared with the sequence 
of the original plasmid. The corresponding DNA sequences were identical. To rule 
out the possibility that these peptides encoded on prey plasmids activate expression 
from the lacZ reporter gene by binding to the GAL4 binding domain, rather than 
binding to DmEB1 fused with the GAL4 binding domain, transformations were 
performed where yeast carrying empty bait vector were cotransformed with the 
linearised prey vector DNA and the DNA encoding each of the peptides and plated 
on selective media. All the transformants overlaid with X-galactose remained white 












































































































































































































































































peptides, hereafter named peptide aptamers, interact with DmEB1 at Y2H level 
(Figure 3.11). 
3.1.8. Aptamer Perfect binds to DmEB1 within nM range  
To determine affinity of aptamer 37 or Perfect to DmEB1, I performed ITC 
experiment. ITC measures heat absorbed or generated when molecules interact to 
calculate binding constant (Kd) (Turnbull & Daranas, 2003).  
Maltose binding protein (MBP) or MBP-DmEB1 were produced in bacteria 
and purified by affinity chromatography followed by size-exclusion chromatography. 
Protein purity was assessed by running protein samples on SDS-PAGE (Figure 3.12 
A, B). The only protein bands on the gel corresponded to the masses of MBP-EB1 
and MBP in the corresponding lanes. Peptides corresponding to aptamer Perfect or a 
shorter version of aptamer 37 (RCVSRSKIPKLCLSWYLIR) missing seven C-
terminal amino acids, were commercially synthesised. The shorter version of 
aptamer 37 was used because the deleted fragment is unlikely to contribute to 
interaction with DmEB1 (Buey et al, 2012). A study of an interaction between EB1 
and a peptide derived from a MAP and containing SxIP showed that seven amino 
acids following SxIP are the most critical for the peptide-EB1 binding (Buey et al, 
2012). Additionally, deleting a fragment of aptamer 37 which included hydrophobic 
amino acids may improve the solubility of the peptide improved.   
Each of the peptide aptamers dissolved in 100% DMSO was next diluted to 
obtain the same buffer conditions as those of MBP and MBP-DmEB1 (120 mM 
NaCl, 2.7 mM KCl, 30 mM NaH2PO4, 1 nM DTT, 2% DMSO, pH 7.4) and titrated 
into solutions of MBP-DmEB1 or MBP for control. Heat changes resulting from the 
binding reactions were recorded.  Also, the buffer alone was titrated into the MBP-
DmEB1 or MBP solutions to later subtract the background heat changes generated 
by titration of the buffer from the heat changes generated by titrating the peptide 
aptamers in this buffer (Figure 3.13).  
As no significant heat change was recorded when titrating aptamer Perfect 
to MBP solution, I concluded that the peptide aptamer did not interact with MBP 
(Figure 3.13). However, titrating aptamer Perfect into MBP-DmEB1 caused 
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Aptamer Variable region
37    RCVSRSKIPKLCLSWYLIRAREIYES- 
171   LQSRRSRIPRWVGCRQ- 
380   RSRTRSRIPRWVGFVQ- 
312   RRAGKSRIPVAVRQSSCFELERSMNRRY- 
188   RWVGVSRIPRWVGWES- 
314   GRCRVSRIPRWVGGIK- 
Perfect   RTRGRSRIPRWVGRRG- 
356   RKRAPSRIPVLKRWPA- 
457   PGKYVSKIPVWRGGRM- 
319   LKLKRSRIPVPTKVRGDSSSRDL- 
8      IKRGRSKIPRWIGDQH- 
439   EYRGVSRIPVWKGRGT- 
165   ITTRPSLIPRWVGRGG- 
Figure 3.11 Strongest single constrained peptide aptamers to DmEB1 
Interaction strength of peptide aptamers to DmEB1 was assessed by quantitative 
assay measuring expression of the reporter gene LacZ. Twelve peptide aptamers that 
proved strongest interaction in Y2H assay were sequenced. Asterisks denote codons 
for the fixed SxIP motif.
*   * * 
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A) B) 
Figure 3.12. SDS-PAGE analysis of MBP-DmEB1 and MBP 
purification 
Cleared bacterial lysate from E. coli containing MBP or MBP-DmEB1 
protein was loaded on a MBPTrap HP column (1 ml) for affinity 
purification and the protein were eluted with 10mM maltose and collected 
in 0.5 ml fractions. A fraction from the affinity purification containing 
MBP or MBP-DmEB1 were loaded onto 24 ml Superdex 200 10/300 GL 
columns for purification by size exclusion chromatography and 1.5 
column volume of 0.5 ml fractions were collected. Protein purity was 
assessed by SDS-PAGE using standard methods. The elution fractions 
containing the protein peak for (A) MBP-DmEB1 and (B) MBP were 
































Figure 3.13 Binding of aptamer Perfect to MBP-DmEB1 or MBP 
Isothermal titration calorimetry (ITC) shows a high affinity of aptamer Perfect to 
DmEB1.  (A) Raw ITC data showing that aptamer Perfect interacts with MBP-
fused DmEB1, but not MBP in vitro.  Heat released by titrations of 20 μM aptamer 
Perfect into 1 μM solution of MBP-DmEB1 (blue), MBP (black) and buffer alone 
(red).  Each peak corresponds to one injection.  An initial smaller injection was 
followed by ten injections.  For MBP-DmEB1, the heat became smaller for each 
injection, as the binding site became saturated.  For buffer and MBP, it stayed 
constant, as heat was released only from dilution of the peptide without specific 
binding.  (B) Integrated heat peaks were plotted against the molar ratio of the 

















significant heat changes (Figure 3.14). From these data, Kd of ~300 ± 80 nM was 
calculated.  
Titrating aptamer 37 into MBP-DmEB1 solution resulted in exothermic 
followed by endothermic spikes indicating that aptamer 37 solubilises only upon 
injecting it into the solution. To overcome the solubility problem, I reversed the 
experimental design by injecting concentrated MBP-DmEB1 into a diluted solution 
of aptamer 37. However, because I did not have enough concentrated MBP-DmEB1 
the experiment was not completed. 
The C-terminal fragment of human EB1 was shown to bind an APC-derived 
C-terminal peptide, containing SxIP, with 5 µM affinity (Honnappa et al, 2005). I 
concluded that affinity of aptamer Perfect to DmEB1 is significantly higher than that 
of APC to EB1. 
3.2. Peptide aptamers to reveal variability within SxIP motif for 
DmEB1 binding    
3.2.1. Some amino acid variations in SxIP are tolerable for DmEB1 binding 
Sequence variants of the consensus SxIP have been shown to exist amongst EB1 
interactors using this motif for binding to EB1. While proline in the SxIP looks to be 
invariant, serine is often replaced by threonine and isoleucine by leucine. Lysine and 
arginine often occupy the “x” position. I aimed to determine what amino acids within 
the motif promote binding to DmEB1 and whether other variants than Ser/Thr-x-
Ile/Leu-Pro are also possible. I performed Y2H as previously described using the 
prey plasmid library (“XXXX library”) encoding the aptamer Perfect where SRIP 
was substituted by NNK codons for random amino acids (Figure 3.15). 
The peptides encoded in the prey plasmid library appeared to have a mixture 
of amino acids at the four positions encoded by NNK without any of the amino acids 
dominating (Figure 3.16). All the prey plasmid library fragments encoded the 
aptamer Perfect where SRIP was substituted with random amino acids at positions 
X1, X2 and X3, as verified by the statistical analysis (Figure 3.17). P-value for 
position X4 was < 0.01 indicating that amino acids at X4 in the library were not 
random, Phe and Leu appeared much more frequently than expected (Figure 3.17). 
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Figure 3.14 Binding of aptamer Perfect to MBP-DmEB1 
A) Raw data for titrations of 20 µM aptamer Perfect into 1 µM solution of
MBP-DmEB1. Each peak corresponds to one injection. An initial smaller 
injection was followed by ten injections. Heat released by titrations of 20 
μM aptamer Perfect into 1 μM solution of MBP-EB1.  Each peak 
corresponds to one injection.  An initial smaller injection was followed by 
ten injections. The heat became smaller for each injection, as the binding 
site became saturated. (B) Integration of the data, corrected for the heat of 
dilution, and plotted against the molar ratio of the peptide to MBP-EB1. 
The line represents the fit to the single-site binding model generated by 

















































































































































































































































































































































































































































1  RTRGRRWRFRWVGRRG- 
2  RTRGRLFCSRWVGRRG- 
3  RTRGRSGNFRWVGRRG- 
4  RTRGRDLVFRWVGRRG- 
5  RTRGR-HAARWVGRRG- 
6  RTRGRRGRARWVGRRG- 
7  RTRGRLRGCRWVGRRG- 
8  RTRGRWPFLRWVGRRG- 









Figure 3.16 Amino acid sequences of peptides encoded in XXXX prey plasmid 
library 
Yeast were cotransformed with linearised prey vector and DNA encoding XXXX 
prey plasmid library flanked by sequences corresponding to fragments of 5’ and 3’ 
on linearised prey vector for gap repair. Transformants were plated on media 
selective for the prey plasmid but not activation of reporters. The region embracing 
the insert site on the prey plasmid was amplified by PCR from clones picked at 
random and sequenced. Fixed sequence is denoted with asterisks, bold indicates 
variable sequence. 
*****    ******** 
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Figure 3.17 The frequencies of amino acids for each position encoded by unselected prey 
clones from XXXX library.   
Yeast carrying DmEB1 bait were cotransformed with XXXX prey plasmid library 
and plated on non-selective media. Prey plasmid inserts of randomly picked clones 
were sequenced and occurrence of amino acids at subsequent positions in these 
sequences was scored. Each position was tested using chi-squared test for statistical 
differences from the frequency expected from random DNA sequences. No 
significant differences were observed for position X1, X2 and X3. Amino acid 
occurrence on position X4 was not random. “+”, p ≤ 0.01, “-”; p  ≥ 0.05. 
Position 
Average amino acid 
occurrence  
X1 X2 X3 X4 
observed expected 
Ala 0 0 1 2 0.75 1.13 
Arg 3 1 3 2 2.25 1.69 
Asn 0 0 1 0 0.25 0.56 
Asp 1 0 1 0 0.25 0.56 
Cys 0 0 1 1 0.50 0.56 
Glu 1 2 0 0 0.75 0.56 
Gln 0 0 0 0 0.00 0.56 
Gly 0 3 1 0 1.00 1.13 
His 0 1 0 0 0.25 0.56 
Ile 0 1 0 0 0.25 0.56 
Leu 6 1 4 4 3.75 1.69 
Lys 0 1 0 0 0.25 0.56 
Met 1 0 1 0 0.50 0.56 
Phe 0 1 1 6 2.00 0.56 
Pro 1 1 0 1 0.75 1.13 
Ser 1 0 1 1 0.75 1.69 
Thr 0 1 0 0 0.25 1.13 
Trp 1 2 0 1 1.00 0.56 
Val 1 0 1 0 0.50 1.13 
Tyr 0 0 2 0 0.50 0.56 
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Although some amino acid bias can be observed in the library, which could have 
been caused by some synthesis issues, all the amino acids are represented even 
though some are rare. A stop codon followed the all the 18 amino acid sequences as 
designed. 
The XXXX library was screened as previously described. I screened ~1 
million peptides and found 57 transformants which activated both reporter genes. To 
 analyse the amino acid composition within the fragment encoded by the NNK 
codons, I sequenced the region including the insertion site on prey plasmids in these 
57 transformants. The encoded peptides had the same amino acid sequence apart 
from the positions encoded by NNK codons, as designed. Amino acids at positions 
X1, X2, X3 and X4 occurred not at random, as verified by statistical analysis (Figure 
3.18).  
Notably, Ser/Thr-x-Ile/Leu-Pro are also common amino acids in SxIP of 
natural DmEB1 interactors. These amino acids were amongst the most frequently 
occurring at the corresponding positions of DmEB1 interactors selected from the 
XXXX library. Chi-squared test was performed to analyse whether the occurrence of 
most frequent amino acids at each of the four positions was significantly different in 
these peptides selected for DmEB1 binding than in the random peptides encoded in 
the XXXX library. Since occurrence of amino acids S and T at position X1, Arg and 
Leu at X2, Ile and Leu at X3 and Pro at X4 was significantly different in selected 
than unselected peptides (p < 0.01), I concluded that these amino acids promote 
binding of the SxIP proteins to DmEB1 (Figure 3.19). Finding these amino acids, 
Ser/Thr-x-Ile/Leu-Pro, promoting binding to DmEB1 is consistent with finding these 
amino acids within SxIP of natural DmEB1 interactors. Interestingly, I additionally 
found that the most conserved positions X1, X3 and X4 allowed for amino acid 
variants other than the so far observed Ser/Thr-x-Ile/Leu-Pro in natural protein 
interactors of EB1. Additionally to the known amino acid variants, Cys and Gly were 
observed at X1, Arg, Met, Phe, Val at X3 and Ala and Leu at X4 (Figure 3.20 A). 
Almost all amino acids were found at X2 (Figure 3.20 A). 
3.2.2. S-x-I/L-P in SxIP motif promote strong binding to DmEB1 
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Figure 3.18 The frequency of amino acids at each position encoded by prey 
plasmid clones selected from XXXX library interacting with DmEB1 bait.   
Yeast carrying DmEB1 bait were cotransformed with XXXX prey plasmid library 
and selected for bait-prey interaction. Prey plasmid inserts were sequenced and 
occurrence of amino acids at subsequent positions in these sequences was scored. 
Each position was tested using chi-squared test for statistical differences from the 
frequency expected from random DNA sequences. Occurrence of amino acids at 
positions X1-X4 was significantly different from expected (p ≤ 0.01). “+”, p ≤ 0.01, 
“±”; 0.01 < p < 0.05, “-”; p  ≥ 0.05. 
Position 
Average amino acid 
occurrence  
X1 X2 X3 X4 observed expected 
Ala 0 1 0 5 1.50 3.56 
Arg 0 13 1 0 3.50 5.34 
Asn 0 2 0 0 0.50 1.78 
Asp 0 2 0 0 0.50 1.78 
Cys 4 1 0 0 1.25 1.78 
Glu 0 0 0 0 0.00 1.78 
Gln 0 0 0 0 0.00 1.78 
Gly 3 5 0 0 2.00 3.56 
His 0 4 0 0 1.00 1.78 
Ile 0 0 32 0 8.00 1.78 
Leu 0 10 17 1 7.00 5.34 
Lys 0 3 0 0 0.75 1.78 
Met 0 4 1 0 1.25 1.78 
Phe 0 0 1 0 0.25 1.78 
Pro 0 0 0 51 12.75 3.56 
Ser 41 2 0 0 10.75 5.34 
Thr 9 0 0 0 2.25 3.56 
Trp 0 4 0 0 1.00 1.78 
Val 0 2 5 0 1.75 3.56 
Tyr 0 4 0 0 1.00 1.78 
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Figure 3.19 Amino acids in XXXX region promoting binding of peptide 
aptamers to DmEB1 
Peptides interacting with DmEB1 were selected from XXXX prey 
plasmid library in Y2H. Occurrence of amino acids at subsequent 
positions (X1-X4) in these peptide aptamers was scored. The 
frequencies of amino acids at each position were compared between 
these peptide aptamers and peptides from XXXX prey plasmid library 
not selected for DmEB1 binding. Some amino acids occurred more 
frequently in peptide aptamers than in unselected peptides (p < 0.01) 
and are marked with yellow background. Amino acids occurring most 
frequently in peptide aptamers to DmEB1 are presented. 




















Figure 3.20 Sequence bias within SxIP motif promoting binding 
to DmEB1  
Residues within the SxIP motif overrepresented among interactors 
showing any interaction with DmEB1 (A) and among the 15 
strongest DmEB1 interactors (B) selected from a library based on 
the aptamer Perfect sequence in which SRIP was replaced with 4 
random residues (XXXX library). The total height of each stack 
indicates the "information content" at that position (measured in 
bits). The height of symbols within the stack reflects the relative 
frequency of the corresponding amino acid at that position. The 
subsequent positions within the sequences are labeled -5 to +7. The 
figures were generated using www.meme.nbcr.net server by 
submitting 16 amino acid long sequences in fasta format. 
R  T  R  G  R  x  x  x  x  R  W  V  G  R  R  G




Although some amino acid variation within SxIP is allowed for peptide binding to 
DmEB1, I investigated which amino acid variants in SxIP promote strong binding by 
measuring expression from the lacZ reporter gene as previously.  
The quantitative liquid assay was performed for all 57 the yeast clones 
found in Y2H screen in three independent replicas. For the negative control, yeast 
transformant containing DmEB1 bait plasmid and the empty prey vector was used. 
To compare between the batches, I included aptamer 37 to all assays (Figure 3.21). 
All of the 15 strongest peptide aptamers invariably have Ser and Pro at positions X1 
and X4 respectively and either Ile or Leu at position X3 (Figure 3.20 B). I concluded 
that these amino acids promote strong binding to DmEB1.  
3.3. Improving binding of peptide aptamers to DmEB1 
3.3.1. Oligomerising peptide aptamers 
Proteins recruited to microtubule plus ends by EB1 often have more than one SxIP 
motifs. Also, it was shown that a dimerised SxIP motif enhanced MACF, one of EB1 
interactors, accumulation at polymerising microtubule plus ends in human cultured 
cells (Honnappa et al, 2009). Thus, I aimed to design oligomerised aptamer 37 and 
Perfect.  
Since the genes encoding for these oligomers need to express efficiently in 
both yeast and Drosophila cells, codon usage in these organisms was taken into 
account when designing genes for the peptide oligomers. Codons which constituted 
less than 10% of the total codon usage for a particular amino acid in the organisms 
were not used. To minimise recombination between DNA encoding for each peptide 
repeat within the genes encoding the oligomers, a combination of various codons was 
used to encode the same amino acid sequences (Figure 3.22). The gene for the 
aptamer Perfect oligomer encoded 7 aptamers Perfect separated by Ser-Gly-Ser-Gly 
(SGSG) linkers (Figure 3.22). Aptamer 37 oligomer was encoded by a gene for 4 
aptamers 37 separated by SGSG linkers (Figure 3.22). To allow gap repair, the 
sequences were further flanked by DNA complementary to the prey vector fragments 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































the vector. Genes were commercially synthesised and introduced onto ampicillin 
resistant cloning vectors. 
3.3.2. Effect of peptide aptamer oligomerisation on binding to DmEB1 
To establish whether the oligomerised aptamers, 37 and Perfect, bind DmEB1 
stronger than the monomers, I measured the strength of interaction by Y2H. 
The genes encoding the oligomerised peptides along with the flanking 
sequences upstream and downstream of the EcoRI site on the vector allowing for 
gap-repair were amplified from the commercially synthesised plasmids. 
Transformations were performed where yeast carrying DmEB1 bait plasmid were 
cotransformed with prey vector linearised at EcoRI site and either the amplified 37 
tetramer or Perfect septamer DNA, and plated onto selective media for yeast carrying 
bait and prey plasmids. Sequencing showed that tested transformants with DNA 
encoding 37 tetramer carried plasmid with the correct sequence, as designed. 
Although some of the transformants with DNA encoding Perfect septamer carried the 
correct plasmid, there were also transformants which carried a gene encoding two 
repeats of aptamer Perfect or a gene encoding four repeats. Thus, the prey plasmid 
inserts underwent recombination in some of the transformants in yeast. Having these 
additional oligomers of aptamer Perfect, Perfect dimer and Perfect tetramer, I 
decided to dimerise peptide 37, too. DNA for 37 dimer was obtained by amplifying a 
fragment of a gene encoding 37 tetramer and, to allow gap repair, the gene for 37 
dimer was flanked by DNA complementary to fragments of prey vector, as 
previously.  
To measure the expression from lacZ reporter gene in five transformants 
carrying prey plasmids with DNA for 37 dimer, 37 tetramer, Perfect dimer, Perfect 
tetramer and Perfect septamer, activity of β-galactosidase was assessed in liquid as 
previously described. Transformants carrying the genes encoding aptamer 37, Perfect 
and empty prey vector were included in the assay for better comparison and control.  
A420/A600 for Perfect dimer was almost three times higher than that for 
aptamer Perfect (Figure 3.23). 37 dimer peptide showed almost half A420/A600 value 
compared to aptamer 37 (Figure 3.23). However, Perfect tetramer, Perfect septamer 








Figure 3.23 Strength of two-hybrid interactions between DmEB1 and 
aptamers from XXXX library 
Y2H interactions between DmEB1 and multimerised aptamers 37 and 
Perfect. Strength of Y2H interactions was measured by a quantitative assay 
for β-galactosidase activity and normalised for the cell density (A420/A600). 






















Thus, the oligomerised aptamers 37 and Perfect interacted strongly with 
DmEB1 only as the dimers. Dimerised peptide Perfect interacted stronger with 
DmEB1 comparing to the monomer, while the dimerised peptide 37 interacted with 
DmEB1 weaker than the monomer.   
3.4. Double constrained peptide aptamers to DmEB1 
3.4.1. Screening the prey plasmid library  
Although single constrained peptide aptamers displayed from a scaffold protein as its 
terminal fusion are conformationally more flexible and thus easier to select, double 
constrained peptides whose N- and C-terminus are both constrained by inclusion 
within a scaffold protein often showed high affinity binding to its target (Colas et al, 
1996; Fabbrizio, 1999). To find double constrained peptide aptamers to DmEB1, a 
Y2H screen was performed in the same manner as the screen described for the single 
constrained peptide aptamers, except for the prey plasmid. The prey plasmid encoded 
a peptide where fixed SxIP flanked by random amino acid sequences was further 
flanked by TrxA sequence. The construct thus expressed an SxIP peptide library 
(called “Trx-SxIP”) as an internal fusion of TrxA. The whole Trx-SxIP was fused to 
the C-terminus of GAL4-AD.  
Prior to the screen, the quality of the Trx-SxIP prey plasmid library was 
verified as previously described. The encoded peptides appeared to be composed of 
amino acid mixture without any amino acids dominating and each of the peptides 
was unique. I examined 10 random sequences and majority of them (6) were as 
designed, another 3 sequences were shorter but they still encoded SxIP and only 1 
sequence had a stop codon, thus resulting in the peptide being singly constained 
(Figure 3.24). Hence the Trx-SxIP library was of a good quality.  
To test whether amino acids encoding the Trx-SxIP library were random at 
each position in the Trx-SxIP library, a chi-squared test was performed. Amino acid 
occurrence at each position was scored for the 9 peptides (the peptide with the stop 
codon was excluded) and compared to the expected number of each amino acid, 
which was calculated taking into account the number of codons by which each of the 
amino acids can be encoded using NNK (Figure 3.25). The amino acids on all 13 
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1  FKYLMSYIPYWCIWRW 
2  RSIVWSVIPINWLAGR 
3 NACYYSWIPLWQRLWI 
4  RTVSCSYIPLRDSWR 
5 ERMGFSFIPLSRWGLR 
6 TAMILSTIPMGGT-SW 
7  VGRQKSRIPLSCAATR 
8  RPRVSSRIPWNAVDWE 
9   GDYASLIPKDVTYVP 
10  EWGLSQIPVSVYYVS 
Figure 3.24 Amino acid sequences of peptides encoded in Trx-SxIP prey 
plasmid library 
Yeast were cotransformed with linearised prey vector and DNA encoding Trx-SxIP 
library (encoding random peptides with fixed SxIP displayed from Trx scaffold) 
flanked by sequences corresponding to fragments of 5’ and 3’ on linearised prey 
vector for gap repair. Transformants were plated on media selective for the prey 
plasmid but not activation of reporters. The region embracing the insert site on the 
prey plasmid was amplified by PCR from 10 clones picked at random and 
sequenced. Fixed sequence is denoted with asterisks, bold indicates variable 
sequence. 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































positions arose randomly (p > 0.05) (Figure 3.25). Since 100% of the library encoded 
SxIP motif, only 10% of the library fragments contained a stop codon and amino 
acids were encoded at random at the subsequent positions within the Trx-SxIP 
library, the library was of good quality. A Y2H screen for peptides encoded in the 
Trx-SxIP library binding to DmEB1 was performed as previously. In total, ~1 
million peptides were screened and 23 positive transformants were found.  
3.4.2. Impact of constraining peptides from both sides on binding to DmEB1  
To determine the amino acid sequence of double constrained Trx-SxIP peptides 
promoting binding to DmEB1, DNA inserts were amplified and sequenced from 23 
yeast transformants that activated both reporter genes in Y2H (Figure 3.26). Five of 
the transformants encoded stop codons either within or shortly after the insert 
sequence and these peptides were excluded from further analysis. It appeared that the 
encoded peptides were rich in arginine and glycine and occurrence of some of the 
amino acids did not appear random at certain positions (Figure 3.27). To test whether 
the occurrence of particular amino acids at certain positions in the vicinity to SxIP 
was significantly different in selected peptides than peptides from unselected Trx-
SxIP prey plasmid library, a chi-squared test was performed. I scored the amino acid 
occurrence at each position encoded by the 18 sequenced DNA fragments and 
compared them with the amino acids scored for the 10 random peptides from Trx-
SxIP library. Since the occurrence of amino acids Gly at -5, Phe at -2, Arg and Lys at 
x, Arg and Val at 1, Trp at 2, Cys at 3, Gly at 4, Lys at 5 and Ser at 6 was 
significantly different in selected than unselected peptides (p < 0.01), I concluded 
that these amino acids promote binding of the constrained Trx-SxIP peptides to 
DmEB1 (Figure 3.28). 
To verify whether occurrence of amino acids in the region flanking the SxIP 
and promoting binding to DmEB1 is different in the double constrained and the 
single constrained peptides (found in the SxIP library screen), I performed statistical 
analysis. Occurrence of amino acids Arg and Lys at position x, Arg and Val at +1, 
Trp at +2 and Gly at +4, which promote binding of both double constrained and the 
single constrained peptides to DmEB1 was not significantly different (p > 0.08). An 
exception was Phe at position -2 which appeared more frequently in double 
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Aptamer Variable region
T1    CGAFGSAIPRWN 
T6    VKTGRSKIPVWGGRKH 
T9    VSTFHSRIPVRADKRV 
T10   GRVRGSKIPILMTKYC 
T11   PSGVKSNIPRWVGWSK 
T12   GRVRGSRIPLWMGFHN 
T13   RQNNPSKIPVYTLRRD 
T14   HRPGVSRIPRWL 
T16   GSNGRSRIPRYTGKRK 
T17   WFKFKSRIPVRLGGR 
T20    RRSRIPRFQGGSGGG 
T21   AGRLRSLIPRYCGC 
T22   YTHMTSRIPIMRGSRV 
T23   GGKFVSRIPRYVRNLS 
T24   GRSSRSRIPRFCGFSS 
T27   LRHGYSRIPASAPGWL 
T28   SLVTGSLIPVATWRLG 
T29   RFASNSRIPRWCGLS 
Figure 3.26 Amino acid sequences of peptides encoded in Trx-SxIP prey plasmid 
library 
Yeast were cotransformed with linearised prey vector and DNA encoding Trx-SxIP 
library (encoding random peptides with fixed SxIP displayed from Trx scaffold) flanked 
by sequences corresponding to fragments of 5’ and 3’ on linearised prey vector for gap 
repair. Transformants were plated on media selective for the prey plasmid and 
activation of reporters. The region embracing the insert site on the prey plasmid was 
amplified by PCR from clones and sequenced. Fixed sequence is denoted with asterisks, 













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































constrained peptides than in the single constrained ones (p < 0.0001). I concluded 
that Phe at position -2 is more important for the binding of double constrained than 
the single constrained peptides to DmEB1. The rate of finding the double constrained 
DmEB1 interactors was 5 times lower than the single constrained interactors (18 in 1 
million vs. 500 in 5 million). This can be explained by the double constrained 
peptides being less conformationally diverse than the single constrained peptides 
(Colas et al, 1996). 
3.4.3. Identifying strongest double constrained peptide aptamers to DmEB1  
To identify yeast clones carrying Trx-SxIP peptides with strongest binding to 
DmEB1, I measured β-galactosidase activity in liquid as described in 3.1.6. Yeast 
carrying Trx-SxIP peptides T6, T11, T13, T14 and T16 (Figure 3.26 and 3.29) 
produced most β-galactosidase. Then, I excluded the possibility that a random 
mutation in yeast, plasmid or TrxA caused expression from the reporters in 
transformants carrying peptides T6, T11, T13, T14 and T16, as described in 3.1.7. To 
more precisely compare the strength of aptamers T6, T11, T13, T14 and T16 
interaction with DmEB1, I measured β-galactosidase activity in liquid in three 
independent replicas. I found that aptamers T6, T14 and T16 interact strongest with 
DmEB1 (Figure 3.30).  
3.5. Screening for single constrained peptide aptamers to HsEB1 or 
HsEB3  
3.5.1. Certain amino acid residues flanking SxIP promote peptide binding to 
HsEB1 or HsEB3 
Although highly homologous to human EB1, human EB3 was shown to be 
upregulated in brain as well as in muscle tissues in late stages of muscle 
differentiation (Nakagawa et al, 2000; Straube & Merdes, 2007). The regulation of 
the cytoskeleton by EB1 and EB3 may be tissue-specific and dictated by recruitment 
of different MAPs by EB1 or EB3.  
To find peptide aptamers interacting by SxIP with HsEB1 or HsEB3, I 








Figure 3.29 Strength of two-hybrid interactions between DmEB1 
and double constrained peptide aptamers 
The expression of the reporter gene LacZ was measured by a 
quantitative assay for β-galactosidase activity and normalised for the 
cell density (A420/A600).  The empty bait plasmid was used as a control 


















Figure 3.30 Strength of two-hybrid interactions of the strongest double 
constrained aptamers with DmEB1.   
The expression of the reporter gene LacZ was measured by a quantitative 
assay for β-galactosidase activity and normalised for the cell density 
(A420/A600).  The empty bait plasmid was used as a control (ctrl).  The bars 
represent standard error of the mean (SEM; n=3); numbers correspond to a 











T6 T11 T13 T14 T16 CTRL 
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as previously described containing either full length HsEB1 or HsEB3 coding DNA. 
In total, ~2 million peptides were screened for binding to HsEB1 and ~2 million 
peptides for binding to HsEB3. I found that 47 yeast HsEB1 interactors and 58 
 HsEB3 interactors that activate both reporter genes. Amino acids flanking SxIP 
which promote peptide interaction with HsEB1 or HsEB3 were determined as 
previously by sequencing the DNA encoding the variable peptide aptamer regions. 
These regions were arginine-rich and some of the amino acids appeared not random 
at certain positions (Figure 3.31 and 3.32).  
To test whether the occurrence of particular amino acids at certain positions 
in the vicinity to SxIP was significantly different in selected peptides for HsEB1 or 
HsEB3 than unselected peptides encoded in the SxIP library, the chi-squared test was 
performed. I scored the amino acid occurrence at each position encoded by the 47 or 
58 sequenced DNA fragments for HsEB1 or HsEB3, respectively (Figure 3.33 and 
3.34). I compared them with the amino acids scored for the 39 peptides from the 
unselected SxIP library. As previously, by chi-squared test, I analysed whether 
occurrence of the most abundant amino acids in the region flanking SxIP was 
significantly different in peptides selected for HsEB1 or HsEB3 than the unselected 
peptides encoded in the SxIP library. The occurrence of the amino acids Arg at -1, 
Arg and Lys at x, Arg and Val at +1, Leu at +2, Lys at +3, Lys and Arg at +4 and 
Arg at +5 was significantly different in peptides selected for HsEB1 binding than in 
the unselected peptides (p < 0.01) (Figure 3.35). In peptides selected for binding to 
HsEB3 the occurrence of amino acids Arg at positions -5, -4 and -2, Lys and Arg at 
positions -1 and x, Arg and Val at +1, Trp and Arg at +2, Ile and Val at +3, Gly at 
+4, Arg at +5, Lys at +6 and Arg and Lys at +7 was significantly different than 
occurrence of these amino acids in random peptides encoded in the library (p < 0.01) 
(Figure 3.36).  
I concluded that these amino acids promote binding of the SxIP-containing 
peptides to HsEB1 or HsEB3.  
3.5.2. Peptide aptamers suggest sequence preferences for binding to HsEB1, 
HsEB3 or DmEB1 
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Figure 3.31 Sequence bias within SxIP motif  and flanking 
region promoting binding to HsEB1 
Amino acids of peptide aptamers selected from SxIP library for 
interaction with HsEB1. Peptide aptamers selected from SxIP 
library revealed that some amino acids flanking SxIP are 
overrepresented and promote interaction with HsEB1. The total 
height of each stack indicates the "information content" at that 
position (measured in bits). The height of symbols within the stack 
reflects the relative frequency of the corresponding amino acid at 
that position. The subsequent positions within the sequences are 
labeled -5 to +7. The figures were generated using 
www.meme.nbcr.net server by submitting 16 amino acid long 
sequences in fasta format. 
-5 -4 -3 -2 -1  S  x  I  P +1 +2 +3 +4 +5 +6 +7 
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Figure 3.32 Sequence bias within SxIP motif  and flanking 
region promoting binding to HsEB3 
Amino acids of peptide aptamers selected from SxIP library for 
interaction with HsEB3. Peptide aptamers selected from SxIP 
library revealed that some amino acids flanking SxIP are 
overrepresented and promote interaction with HsEB3. The total 
height of each stack indicates the "information content" at that 
position (measured in bits). The height of symbols within the stack 
reflects the relative frequency of the corresponding amino acid at 
that position. The subsequent positions within the sequences are 
labeled -5 to +7. The figures were generated using 
www.meme.nbcr.net server by submitting 16 amino acid long 
sequences in fasta format. 
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The sequence analyses of the peptide aptamers to HsEB1, HsEB3 or DmEB1 
revealed that amino acids at certain positions flanking SxIP promote binding to these 
EB proteins. I further compared the sequences to find amino acids that are enriched 
in peptide aptamers to one EB protein, not to the other.  
I found that different amino acids are preferred for binding to different EB 
proteins at certain positions downstream of SxIP (Figure 3.37). For example, Leu at 
position +2 is preferred for binding HsEB1 but Trp at this position is preferred for 
binding HsEB3 (Figure 3.37 A). More differences between HsEB1 peptide aptamers 
and HsEB3 peptide aptamers were detected at positions +3, +4 and +6 and they were 
all statistically different (p < 0.01). Also different amino acids are enriched at certain 
positions among DmEB1 peptide aptamers compared to HsEB1 or HsEB3 peptide 
aptamers (Figure 3.37 B and C).  
These results suggest for the first time that even though similar sequences 
promote binding to HsEB1 and HsEB3, there are some differences between binding 
preferences of these two proteins. These differences between HsEB1 and HsEB3 
may suggest different binding partners and indicate their biological roles distinct 
from each other.  
3.6. Discussion 
In this work I showed that peptide aptamers can be used to establish sequence 
determinants required for strong DmEB1 binding. This work also showed how the 
screen for peptide aptamers can be accelerated.  
Although screening peptide libraries of random amino acid composition has 
been extensively used in search for peptide aptamers, a fixed motif flanked by 
random amino acid sequences was used for the first time in this work. This novel 
method not only saves the time required to perform a large-scale screen but it also  
allows selecting peptide aptamers which disrupt a very specific interaction. Indeed, I 
found ~500 single constrained interactors after screening ~5 million peptides. It can 
be estimated that ~203 times more peptides would have to be screened if the amino 
acids for SxIP motif were not fixed to find the same number of interactors. This new 
method could significantly change the peptide aptamer field as screening for peptide 
aptamers becomes considerably more effective.   
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Figure 3.37 Certain amino acids that follow on from SxIP promote specific 
binding to HsEB1, HsEB3 or DmEB1 
Presented amino acids are overrepresented in peptide aptamers binding to HsEB1, 
HsEB3 or DmEB1, as determined by comparison to non-selected (random) peptides 
from SxIP library. Occurrence of amino acids overrepresented in peptide aptamers to 
(A) HsEB1 or HsEB3, (B) HsEB1 or DmEB1 and (C) HsEB3 or DmEB3 was 
analysed using chi-squared test. Yellow background highlights residues whose 
frequencies are significantly different between a pair of EB1 homologues (p < 0.01). 
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I also compared the frequency of peptide interactors found in a screen for 
single- and double constrained peptides displayed from TrxA protein scaffold. I 
found that the likelihood of finding a single constrained peptide aptamer is ~6-fold 
higher than finding a double constrained peptide aptamer binding to the same protein 
(18 peptide aptamers found after screening ~1 million of Trx-SxIP peptides). 
Although the frequency may vary greatly between the different protein targets and 
when screening peptide libraries of completely random sequences, this study gave 
experimental evidence that the chance of finding double constrained peptide 
aptamers is lower than finding the single constrained ones. 
While the double constrained peptide aptamers reported by other research 
groups very often showed target binding affinity in nanomolar range and the single 
constrained fell in a mid-millimolar range (Colas et al, 1996; Fabbrizio, 1999; 
Oldenburg et al, 1992). Also, it was shown that a peptide-protein binding affinity 
was improved 1000-fold by displaying an originally singly-constrained peptide from 
the double-constraining TrxA scaffold (Cohen et al, 1998). However, I demonstrated 
that single constrained peptide aptamers can bind its target strongly since aptamer 
Perfect interaction with DmEB1 fell in a high nM range (Kd of ~300 nM). 
Nevertheless, it would be interesting to doubly-constrain this peptide to investigate 
how it affects its binding strength. 
In this study I also showed that amino acids promoting binding of a peptide 
to DmEB1 can be revealed using peptide aptamers combined with statistical analysis. 
Peptides binding to DmEB1 were selected from a pool of peptides with fixed SxIP 
and flanked with random amino acids. Then, by statistical methods, I compared 
amino acid sequences of these DmEB1 interactors with random peptides encoded in 
the SxIP library. This comparison uncovered amino acids at certain positions which 
occurred more frequently in peptides interacting with DmEB1 than in peptides 
encoded in the library, thus promoting binding.  
By finding amino acids which promote DmEB1 binding, I was able to 
generate a synthetic peptide aptamer, aptamer Perfect, resulting from combining 
these amino acids in one sequence. By performing a quantitative assay, indirectly 
evaluating a peptide-DmEB1 interaction, I showed that this synthetic peptide 
aptamer bound strongly to DmEB1. Thus the amino acids at specific positions which 
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were each shown to promote binding to DmEB1, also promote strong binding when 
they act in concert. This study showed that peptide aptamers can be designed to 
generate a very strongly interacting peptide aptamer if required. Also, considering 
that SxIP sequence occurs frequently in proteins but only some of them bind EB1, 
my study may be used to predict whether a MAP binds to EB1 (Jiang et al, 2012). 
Additionally, using the aptamer Perfect as the basis for the design of a 
peptide library, I investigated whether other amino acids than the observed in the 
natural interactors (Ser/Thr-x-Ile/Leu-Pro) would allow for binding to DmEB1. I 
showed that additionally to the known amino acid variants, Cys and Gly can occupy 
X1, Arg, Met, Phe, Val position X3, Ala and Leu position X4 and almost all amino 
acids were found at X2. This finding shows that composition of SxIP motif is variant 
and interaction with DmEB1 is not purely dictated by Ser/Thr-x-Ile/Leu-Pro.  
Since it was shown that dimerisation of an SxIP motif-containing fragment 
of MACF enhanced its accumulation at the plus end, I investigated what effect has 
oligomerisation of peptide aptamers on binding to DmEB1 (Buey et al, 2012). This 
study showed that binding of some peptides to DmEB1 can be improved by 
oligomerisation but not always. Importantly, more than two consecutive repeats 
significantly reduced peptide aptamer binding to DmEB1.  
To investigate sequence determinants for binding to human EBs, HsEB1 or 
HsEB3, I performed the same screen and analysis as for DmEB1. I showed that some 
amino acids in the region flanking SxIP promote specific binding to HsEB1 or 
HsEB3. These binding preferences to HsEB1 or HsEB3 may characterise their 
biological roles distinct from each other. This suggestion is in agreement with 
previous studies demonstrating different expression patterns of HsEB1 or HsEB3 in 
some of the tissues (Geraldo et al, 2008; Zhang et al, 2009). The regulation of the 
cytoskeleton by HsEB1 or HsEB3 may be tissue-specific and dictated by recruitment 
of different MAPs by HsEB1 or HsEB3. Knowing this amino acid specificity it may 
be possible to classify in silico different EB-interacting MAPs to those preferentially 
interacting with HsEB1 or HsEB3.  
I next decided to investigate whether some of the peptide aptamers can bind 
DmEB1 in cells, where other endogenous proteins are present, and outcompete 
natural SxIP-containing interactors from DmEB1 binding. I also tested what effect 
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inhibition of DmEB1 has on a multicellular organism by expressing in Drosophila 
some of the peptide aptamers I found. This work is presented in the next chapter.  
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CHAPTER 4 
 Disrupting DmEB1 functions in Drosophila using 
peptide aptamers
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4.1. Peptide aptamers in Drosophila S2 cells 
4.1.1. Expressing peptide aptamers in Drosophila S2 cells 
Since I planned to express peptide aptamers in Drosophila, I tested whether single 
and double constrained peptide aptamers which bound most strongly to DmEB1 in 
yeast colocalise with DmEB1 in Drosophila S2 cells, hence in the presence of other 
proteins. 
DNA encoding each of these peptide aptamers was cloned into a GFP C-
terminus fusion vector (Materials and methods) under control of actin 5C promoter 
and Drosophila S2 cells were transfected with these plasmids. Drosophila S2 cells 
were transfected with a plasmid expressing GFP for a negative control (Figure 4.1). 
Localisation of peptide aptamers with respect to DmEB1 and microtubules was 
assessed by immunostaining using GFP, DmEB1 and tubulin antibodies.  
All the peptide aptamers I tested, 37, 188, 312, 356, 380, Perfect, T13, T14 
and T16, colocalised with DmEB1 at the microtubule plus ends in interphase cells 
and did not affect microtubule array (Figure 4.2 and 4.3). Visual examination 
indicated that aptamers 37, Perfect, T14 and T16 colocalised more strongly than 
aptamers 188, 312, 356, 380 and T13. Also in the mitotic cells, all the peptide 
aptamers displayed colocalisation with DmEB1 at the centrosomes, microtubule tips 
and on the interpolar microtubule bundles (Figure 4.4).  
Colocalisation of aptamers 37, 188, 312, 356, 380, Perfect, T13, T14 and 
T16 to DmEB1 confirms specific binding of these peptide aptamers to DmEB1 in 
cells.  
4.1.2. Expressing oligomerised peptide aptamers in Drosophila S2 cells 
It was shown that dimerisation of human MACF fragment containing SxIP motif 
enhances its accumulation at the polymerising microtubule plus ends in mammalian 
cultured cells (Honnappa et al, 2009). I aimed to test if oligomerised aptamer 37 or 
Perfect colocalise to DmEB1 and whether their accumulation at the microtubule plus 
ends is enhanced relative to the monomeric aptamer forms.  
DNA encoding each of the peptide aptamers was cloned into a GFP C-
terminus fusion vector under control of actin 5C promoter and localisation of these 
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Figure 4.1 Expression of GFP aptamer scaffold in Drosophila S2 cells 
Drosophila S2 cells were transfected with  plasmid encoding GFP protein 
scaffold. GFP, DmEB1 and Sentin signals were visualised by immunostaining 
with anti-GFP, anti-DmEB1 and anti-Sentin antibodies. GFP did not colocalise 
with DmEB1 (second column, top panel) at the microtubule plus ends but was 
diffused inside the cells (first column, top panel) . Sentin immunostaining was 
not affected in cells expressing GFP (third column).  A typical transfected (top 
panel) and untransfected (bottom panel) cell on the same slide are shown for 
comparison. The fourth column shows merged images from the three preceding 
columns. Bars, 10 µm. The yellow boxes indicate the areas that are magnified in 
the images below. 
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Figure 4.2 Peptide aptamers can colocalise to DmEB1 in interphase of 
Drosophila S2 cells 
Aptamer T14 (green arrowheads) colocalises with DmEB1 (red arrowheads) at 
microtubule plus ends. Drosophila S2 cells were transfected with plasmid 
encoding double constrained peptide aptamer T14 displayed from GFP protein 
scaffold. GFP and DmEB1 signals were visualised by immunostaining with 
anti-GFP and anti-DmEB1 antibodies. The third column shows merged images 
from the two preceding columns. A typical transfected (top panel) and 
untransfected (bottom panel) cell on the same slide are shown for comparison.  
Bar=10 μm.  The yellow boxes indicate the areas that are magnified in the 
images below. 
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Figure 4.3 Peptide aptamers can colocalise to microtubule plus ends in 
Drosophila S2 cells and do not affect microtubule array 
Aptamer T14 (green arrowheads) colocalises with microtubule plus ends (red 
arrowheads). Drosophila S2 cells were transfected with plasmid encoding 
double constrained peptide aptamer T14 displayed from GFP protein scaffold. 
GFP and DmEB1 signals were visualised by immunostaining with anti-GFP 
and anti-DmEB1 antibodies. The third column shows merged images from 
the two preceding columns. A typical transfected (top panel) and 
untransfected (bottom panel) cell on the same slide are shown for 
comparison.  Bar=10 μm.  
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Aptamer Perfect Tubulin Merge 
Figure 4.4 Localisation of peptide aptamers in mitotic cells 
Drosophila S2 cells were transfected with plasmid encoding single 
constrained peptide aptamer Perfect displayed from GFP protein 
scaffold. GFP, tubulin and DmEB1 signals were visualised by 
immunostaining with anti-GFP, anti-γ-tubulin and anti-DmEB1 
antibodies. The third column shows merged images from the two 
preceding columns. Peptide aptamer Perfect colocalised with DmEB1 
at the centrosomes (purple arrowheads) and microtubule tips (green 
arrowheads) in metaphase (top panel). Additionally, the aptamer 
colocalised with the the interpolar microtubule bundles (yellow 
arrowheads) that separated each chromosomal mass in anaphase 
(bottom panel). The aptamer expression did not affect the spindle 
architecture. Bars, 10 µm. 
Aptamer Perfect DmEB1 Merge 
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peptide aptamers with respect to DmEB1 and microtubules was assessed by 
immunostaining, as previously.  
Aptamer 37 dimer colocalised with DmEB1 in interphase cells (Figure 4.5) 
and did not affect microtubule organisation (Figure 4.6). However, although 
aptamers, 37 tetramer, Perfect dimer, Perfect tetramer or Perfect septamer, 
colocalised with DmEB1, localisation of DmEB1 was different in cells transfected 
than in the cells untransfected with the aptamers. In addition to the microtubule plus 
end localisation, DmEB1 localised along the microtubules and the microtubules 
sometimes bundled (Figure 4.7 and 4.8).  
Colocalisation of the oligomerised peptide aptamers to DmEB1 confirmed 
their specific binding to DmEB1 in presence of endogenous proteins. However, some 
peptide aptamers, Perfect dimer, tetramer, septamer or aptamer 37 tetramer, affected 
DmEB1 localisation in the cells possibly by binding many DmEB1 molecules 
simultaneously and forming a higher-order structure.  
4.1.3. Sentin localisation in Drosophila S2 cells expressing peptide aptamers 
Sentin is one of the proteins which are recruited to microtubule plus ends by DmEB1 
via SxIP (Li et al, 2011). To test whether peptide aptamers can compete with 
endogenous proteins for binding to DmEB1, I investigated localisation of Sentin in 
cultured cells expressing peptide aptamers.   
Drosophila S2 cells were transfected with plasmids encoding GFP C-
terminus-fused peptide aptamers under the control of actin 5C promoter and 
immunostained for GFP, DmEB1 and Sentin. For a control, cells were transfected 
with a plasmid expressing the GFP only. 
By visual examination, Sentin immunostaining level at the microtubule plus 
ends was reduced in cells expressing peptide aptamers, Perfect, 37, T14 or T16 
(Figure 4.9). To assess the extent to which peptide aptamers reduced Sentin levels at 
the microtubule plus ends, ~50 transfected and ~50 untransfected cells on the same 
slides were visually examined. The cells transfected and untransfected were scored 
for the comet-like staining typical for Sentin. The number of cells with typical Sentin 
staining was ~5% upon expression of aptamers Perfect, 37, T14 or T16 while in the 
untransfected cells ~90% of cells have the typical Sentin staining (Figure 4.10). To 
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Figure 4.5 Peptide aptamer 37 dimer can colocalise to DmEB1 in 
interphase of Drosophila S2 cells. 
Drosophila S2 cells were transfected with plasmid encoding single 
constrained aptamer 37 dimer displayed from GFP protein scaffold. GFP and 
DmEB1 signals were visualised by immunostaining with anti-GFP and anti-
DmEB1 antibodies. The third column shows merged images from the two 
preceding columns. Peptide aptamer 37 dimer (green arrowheads) 
colocalised with DmEB1 (blue arrowheads) at the microtubule plus ends The 
aptamer expression did not affect the spindle architecture. A typical 
transfected (top panel) and untransfected (bottom panel) cell on the same 
slide are shown for comparison. Bar=10 μm.  The yellow boxes indicate the 
areas that are magnified in the images below. 
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A) Aptamer 37 dimer Tubulin Merge 



























Figure 4.6 Microtubule array in Drosophila S2 cells expressing aptamer 
37 dimer  
Drosophila S2 cells were transfected with plasmid encoding single 
constrained peptide aptamer 37 dimer. (A) The aptamer was displayed from 
GFP protein scaffold. GFP and tubulin signals were visualised by 
immunostaining with anti-GFP, anti-γ-tubulin antibodies. Aptamer 37 dimer 
(green arrowheads) colocalises with microtubule plus ends (red arrowheads) 
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in interphase cells and does not affect the microtubule array. (B) The 
aptamer was displayed from mRFP protein scaffold in Drosophila S2 cells 
stably expressing GFP-tubulin. GFP and mRFP signals were visualised by 
laser excitation upon life imaging. Peptide aptamer 37 dimer colocalised 
with microtubule plus ends (yellow arrowheads) and to the centrosomes 
(blue arrowheads) in metaphase cells. The microtubule array was not 
affected in cells transfected with the peptide aptamer.  
A typical transfected (top panel) and untransfected (bottom panel) cell on the 
same slide are shown for comparison. The third column shows merged 
images from the two preceding columns. Bars, 10 µm. 
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Aptamer Perfect 














Figure 4.7 Localisation of aptamer Perfect septamer in Drosophila S2 
cells 
Drosophila S2 cells were transfected with  plasmid encoding aptamer 
Perfect septamer displayed from GFP protein scaffold. GFP and DmEB1 
signals were visualised by immunostaining with anti-GFP and anti-DmEB1 
antibodies. The third column shows merged images from the two preceding 
columns. The peptide aptamer colocalised with DmEB1. Staining for the 
aptamer and DmEB1 revealed long bundles (red arrowheads) and comets 
(yellow arrowheads).  The images show interphase cells. A typical 
transfected (top panel) and untransfected (bottom panel) cell on the same 
slide are shown for comparison.  Bar=10 μm.  
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B) Aptamer Perfect
septamer Tubulin Merge 
A) Aptamer Perfect
septamer Tubulin Merge 
The image part with relationship ID rId9 was not found in the file.The image part with relationship ID rId9 was not found in the file.



























Figure 4.8 Microtubule array in Drosophila S2 cells expressing aptamer 
Perfect septamer 
Drosophila S2 cells were transfected with plasmid encoding single constrained 
aptamer Perfect septamer. (A) The aptamer was displayed from GFP protein 
scaffold. GFP and tubulin signals were visualised by immunostaining with anti-
GFP, anti-γ-tubulin antibodies. In interphase cells, in addition to the microtubule 
plus end localisation, aptamer Perfect septamer localised along the microtubules 
(green arrowheads) and microtubules sometimes bundled (red arrowheads). (B) The 
aptamer was displayed from mRFP protein scaffold in Drosophila S2 cells stably 
expressing GFP-tubulin. GFP and mRFP signals were visualised by laser excitation 
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upon life imaging. In mitotic metaphase cells transfected with the peptide aptamer, 
astral microtubules collapsed forming a blob (blue arrowheads, second panel). 
Peptide aptamer colocalised with the microtubules (yellow arrowheads) and with 
the blob at the centrosome (blue arrowheads, first panel). A typical transfected (top 
panel) and untransfected (bottom panel) cell on the same slide are shown for 
comparison. The third column shows merged images from the two preceding 
columns. Bars, 10 µm. 
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Aptamer 37 














Figure 4.9 Sentin accumulation in Drosophila S2 cells expressing aptamer 37 
dimer 
Drosophila S2 cells were transfected with  plasmid encoding aptamer 37 dimer 
displayed from GFP protein scaffold. GFP, DmEB1 and Sentin signals were 
visualised by immunostaining with anti-GFP, anti-DmEB1 and anti-Sentin 
antibodies. By visual examination, Sentin immunostaining level (third column) 
was reduced in cells expressing peptide aptamer (top panel) comparing to the 
cells not expressing the aptamer (bottom panel). The peptide aptamer (green 
arrowheads) colocalised to DmEB1 (blue arrowheads) at the microtubule plus 
ends. DmEB1 localisation was not affected in the cell expressing the aptamer 
compared to the cell not expressing the aptamer. A typical transfected (top panel) 
and untransfected (bottom panel) cell on the same slide are shown for 
comparison. The fourth column shows merged images from the three preceding 
columns. Bars, 10 µm. The yellow boxes indicate the areas that are magnified in 
the images below. 
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Figure 4.10 Sentin immunostaining (comets) at the 
microtubule plus ends in Drosophila S2 cells expressing 
peptide aptamers 
Drosophila S2 cells were transfected with  plasmids encoding 
aptamer Perfect, 37, T14 or T16 displayed from GFP protein 
scaffold. GFP , Sentin and tubulin signals were visualised by 
immunostaining with anti-GFP, anti-Sentin and anti-γ-tubulin 
antibodies. By visual examination, Sentin immunostaining level at 
the microtubule plus ends was reduced in cells expressing 
aptamers Perfect, 37, T14 or T16. To assess Sentin 
immunostaining signal at the microtubule plus ends, > 50 
transfected and  > 50 untransfected cells on the same slides were 
visually examined. The cells transfected and untransfected were 
scored for the comet-like staining typical for Sentin. ”+”; 
transfected cells,”-”; untransfected cells. 

















more quantitatively assess Sentin delocalisation, Sentin signal at the microtubules 
plus ends was measured in cells transfected with plasmids encoding GFP-fused 
aptamers or GFP only for a control. The transfected and the untransfected Drosophila 
S2 cells on the same slide were imaged for each of the peptide aptamers using the 
same exposure time. The microtubule plus end signals for DmEB1 or Sentin were 
calculated using S-B formula, where S is a total pixel intensity for a particular plus-
end signal and B is a total pixel intensity of the equivalent area for the local 
background (Dzhindzhev, 2005). A hand-drawn DmEB1 area surrounding the comet 
was used to measure both DmEB1 and Sentin immunostaining intensities, and the 
local background area of the same size as the area of the comet was selected next to 
each comet. Three comets were measured in ten separate cells.  
While Sentin signal intensity was significantly reduced in cells transfected 
with a plasmid expressing GFP fused aptamers Perfect, 37, 37 dimer, T14 or T16 
compared with untransfected cells, the Sentin signal was not significantly reduced in 
cells expressing GFP alone (Figure 4.11 A). I concluded that aptamers caused Sentin 
displacement from the microtubule plus ends. To compare between the experiments 
carried out in different days, I calculated Sentin signal intensity in the transfected 
cells relative to the untransfected cells (Figure 4.11 B).  Sentin signal was strongly 
reduced in cells expressing all the peptide aptamers (by at least 50%) (Figure 4.11 
B). In conclusion, peptide aptamers compete with endogenous proteins for binding to 
DmEB1.  
4.1.4. Spindle length in Drosophila S2 cells expressing peptide aptamers  
Since some peptide aptamers displace Sentin from the microtubule plus ends, I 
investigated if expression of peptide aptamers in Drosophila S2 cells can cause 
shorter spindles, a phenotype specific to Sentin loss (Li et al, 2011). 
Drosophila S2 cell line stably expressing GFP-fused tubulin was transfected 
with plasmids expressing aptamers 37, 37 dimer, T14 or T16 fused to the C-terminus 
of monomeric red fluorescent protein (mRFP). Cells transfected with a plasmid 
expressing mRFP only were included for control. A minimum of 10 metaphase 
spindles in transfected and untransfected cells each were imaged from the same cell 
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Figure 4.11 Sentin signal at the microtubule plus ends in Drosophila 
S2 cells expressing peptide aptamers 
Drosophila S2 cells were transfected with  plasmids encoding aptamer 
T14, T16, Perfect, 37 or 37 dimer displayed from GFP protein scaffold. 
GFP , Sentin and tubulin signals were visualised by immunostaining with 
anti-GFP, anti-Sentin and anti-γ-tubulin antibodies. (A) To assess Sentin 
immunostaining signal at the microtubule plus ends, Sentin signal was 
measured using Volocity by hand-drawing DmEB1 area surrounding the 
comet and the local background area of the same size as the area of the 
comet was selected next to each comet. Three comets each were measured 
in ten separate cells. (B) Sentin signal at the microtubule plus ends in cells 
transfected relative to untransfected. Error bars are SEM ; for control 





















































cultures. Spindle length was measured as a distance between the points where the 
microtubules focused.  
Spindle lengths in cells transfected with peptide aptamers were not 
significantly different from spindles in untransfected cells (p > 0.01) (Figure 4.12). 
Even though the metaphase spindles were shorter in the Drosophila S2 cells 
expressing aptamer 37 dimer in the initial experiment, increasing the sample number 
did not reproduce significant differences. I concluded that peptide aptamers, 37, 37 
dimer, T14 and T16, did not significantly affect spindle lengths. 
4.1.5. CLIP-190 localisation in Drosophila S2 cells expressing peptide aptamers 
CAP-Gly or SxIP motifs are commonly used to recruit proteins to microtubule plus 
ends in an EB1 dependent manner. However, he CAP-Gly and SxIP binding sites on 
EB1 partially overlap (Slep, 2010). I investigated whether CLIP-190, which is 
recruited to microtubules by CAP-Gly but it also has SxIP, can be outcompeted from 
the microtubule plus ends by peptide aptamers. 
Drosophila S2 cells were transfected with plasmids encoding peptide 
aptamers fused to the C-terminus of GFP and the localisation of CLIP-190, DmEB1 
and aptamers was assessed by immunostaining as previously. Cells transfected with 
each of the peptide aptamers and untransfected cells on the same slides were visually 
examined. Consistently with the previous results, all the peptide aptamers 
colocalised with DmEB1. CLIP-190 colocalised to DmEB1 in cells transfected with 
aptamers 37, Perfect, T14 or T16 and in the untransfected cells (Figure 4.13).  For a 
quantitative assessment of CLIP-190 accumulation at the microtubule plus ends, 
CLIP-190 fluorescence signal was measured in cells transfected or untransfected 
with DNA encoding peptide aptamers following the same method as for Sentin 
(4.1.3). 
CLIP-190 signal intensity was not significantly different in cells expressing 
aptamers 37, T14 or T16 compared to the cells not expressing these peptide aptamers 
(Figure 4.14 A). However, a significant decrease of CLIP-190 signal was observed in 
cells expressing aptamer Perfect (Figure 4.14 A). The ratio of Sentin signal from 
132
Figure 4.12 Spindle length in Drosophila S2 cells expressing 
peptide aptamers 
Drosophila S2 cells stably expressing GFP-tubulin were transfected 
with  plasmids encoding aptamer T14, T16, 37 or 37 dimer displayed 
from mRFP protein scaffold. GFP and mRFP signals were visualised 
by laser excitation upon life imaging. The spindle length was 
measured as a distance between the points where microtubules 
focused. Three separate experiments for aptamer 37 dimer, A, B and C, 
were performed, increasing the sample number in experiment B and C 
(at least 25 spindles in each transfected and untransfected cells were 
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Figure 4.13 CLIP-190 accumulation in Drosophila S2 cells expressing 
aptamer Perfect or T14 
Drosophila S2 cells were transfected with  plasmid encoding aptamer Perfect or 
134
T14 displayed from GFP protein scaffold. GFP, DmEB1 and CLIP-190 signals 
were visualised by immunostaining with anti-GFP, anti-DmEB1 and anti-CLIP-
190 antibodies. By visual examination, CLIP-190 immunostaining level (third 
column) was reduced in cells expressing peptide aptamers (top panels) 
compating to the cells not expressing the aptamer (bottom panels). The peptide 
aptamer (green arrowheads) colocalised to DmEB1 (blue arrowheads) and CLIP-
190 (red arrowheads) at the microtubule plus ends. DmEB1 localisation was not 
affected in the cell expressing the aptamer compared to the cell not expressing 
the aptamer. A typical transfected (top panels) and untransfected (bottom panels) 
cells on the same slide are shown for comparison. The fourth column shows 
merged images from the three preceding columns. Bars, 10 µm. The yellow 
boxes indicate the areas that are magnified in the images below. 
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Figure 4.14 CLIP-190 signal at the microtubule plus ends in 
Drosophila S2 cells expressing peptide aptamers 
Drosophila S2 cells were transfected with  plasmids encoding aptamer 
T14, T16, Perfect, 37 or 37 dimer displayed from GFP protein 
scaffold. GFP, DmEB1 and CLIP-190 signals were visualised by 
immunostaining with anti-GFP, anti-DmEB1 and anti-CLIP-190 
antibodies. (A) To assess CLIP-190 immunostaining signal at the 
microtubule plus ends, CLIP-190 signal was measured using Volocity 
by hand-drawing DmEB1 area surrounding the comet. The local 
background area of the same size as the area of the comet was also 
selected next to each comet. Three comets each were measured in ten 
separate cells. (B) CLIP-190 signal at the microtubule plus ends in 
cells transfected relative to untransfected. Error bars are SEM ; for 
control Drosophila S2 cells were transfected with plasmid encoding 













































cells transfected to untransfected with aptamer Perfect was reduced by half 
comparing to other aptamers (Figure 4.14 B). 
I concluded that aptamer Perfect, but not peptide aptamers 37, T14 or T16, 
can compete with CLIP-190 for the binding site on DmEB1.   
4.2. Sequence requirements of aptamer Perfect to bind DmEB1 
4.2.1. Interaction of Jumbled and SRAA peptide with DmEB1 in Y2H 
To investigate the sequence requirements of aptamer Perfect to bind DmEB1, I 
addressed two questions. Is binding of aptamer Perfect to DmEB1 sequence specific 
or is it the overall amino acid composition that causes binding of aptamer Perfect to 
DmEB1? Is the amino acid sequence flanking the SxIP in aptamer Perfect sufficient 
for DmEB1 binding? 
I tested binding of two peptides derived from the aptamer Perfect whose 
sequences were modified. In the first one, a “Jumbled” peptide, the amino acids 
order of the aptamer Perfect was changed in the region following SRIP (Figure 4.15). 
The second prey plasmid encoded “SRAA” peptide which resembled aptamer 
Perfect, except for the hydrophobic Ile-Pro which were replaced with polar Ala-Ala 
(Figure 4.16).  
To test whether Jumbled or SRAA peptide bound to DmEB1 in Y2H, two 
prey plasmids encoding these peptides were constructed by gap repair as previously 
(chapter 3). I cotransformed yeast carrying DmEB1 bait plasmid with prey plasmid 
encoding peptide Jumbled or SRAA. For negative control, yeast carrying DmEB1 
bait plasmid were cotransformed with empty prey plasmid and for the positive 
control yeast were cotransformed with prey plasmid encoding aptamer Perfect. 
Interactions between DmEB1 and SRAA or Jumbled peptide were assessed 
quantitatively. It showed that neither of the two peptides interacts with DmEB1 in 
Y2H assay (Figure 4.16).  
Interaction of aptamer Perfect with DmEB1 depends on specific amino 
acids at specific positions in the region following SxIP and the SxIP motif, which are 










Figure 4.15 SRAA and Jumbled peptide sequences 
Sequence of aptamer Perfect, that consists of the most frequently 
presented amino acid at each position in aptamers for DmEB1, 
was either shuffled following SRIP (Jumbled peptide) or the Ile-



















Perfect ctrl SRAA Jumbled 
Figure 4.16 Strength of two-hybrid interactions of peptide SRAA 
or Jumbled with DmEB1.   
Interaction strength was measured between DmEB1 and peptides 
whose sequence was derived from aptamer Perfect sequence: SRAA, 
where SxIP was replaced with SRAA; and Jumbled, where some 
amino acids in region flanking SxIP were shuffled. The expression of 
the reporter gene LacZ was measured by a quantitative assay for β-
galactosidase activity and normalised for the cell density (A420/A600).  
The empty bait plasmid and aptamer Perfect were used as controls.  
The bars represent standard error of the mean (SEM; n=3). 
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4.2.2. Expression of Jumbled and SRAA peptide in Drosophila S2 cells 
Although peptide Jumbled or SRAA did not bind to DmEB1 in yeast, I tested 
whether they colocalised with DmEB1 or outcompeted Sentin from the microtubule 
plus ends in Drosophila S2 cells.  
I cloned DNA encoding Jumbled or SRAA peptide into a GFP C-terminus 
fusion vector under control of actin 5C promoter. Drosophila S2 cells were 
transfected with these plasmids or a plasmid encoding GFP only for control and 
localisation of peptide Jumbled or SRAA with respect to Sentin, DmEB1 and 
microtubule was assessed by immunostaining as previously.  
Visual examination of cells transfected with plasmid for Jumbled or SRAA 
peptide showed that these peptides were diffused inside the cells and did not 
colocalise with DmEB1 at the microtubule plus ends, the same as in the 
untransfected cells (Figure 4.17 and 4.18). The level of Sentin accumulation at the 
microtubule plus ends in cells transfected with plasmid encoding SRAA or Jumbled 
peptide was indistinguishable from the untransfected cells (Figure 4.17 and 4.18). To 
assess quantitatively whether Sentin accumulation at the microtubule plus ends 
changed upon expression of peptide Jumbled or SRAA, I measured Sentin signal at 
the microtubule plus ends as previously. The Sentin signal was not significantly 
reduced in cells transfected with plasmid encoding for peptide SRAA comparing to 
the untransfected cells (Figure 4.19). However, a slight reduction of Sentin signal 
was observed in cells transfected with plasmid encoding for peptide Jumbled (Figure 
4.19). 
SxIP is critical for binding of aptamer Perfect to DmEB1. Partially jumbling 
amino acids flanking SxIP of aptamer Perfect abolished its interaction with DmEB1 
in Y2H and, when judged by eye, peptide Jumbled did not colocalise to DmEB1 at 
the microtubule plus ends in Drosophila S2 cells. However, measurements of Sentin 
signal at the microtubule plus ends show a small difference between cells expressing 
and not expressing peptide Jumbled, suggesting that this peptide weakly displaces 
Sentin. Since the statistical difference for Sentin signal between cells expressing and 
not expressing peptide Jumbled was marginal (p = ~0.02), increasing the sample 
number would show whether they are different.  
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Figure 4.17 Sentin accumulation in Drosophila S2 cells expressing peptide 
SRAA 
Drosophila S2 cells were transfected with  plasmid encoding peptide SRAA 
displayed from GFP protein scaffold. GFP, DmEB1 and Sentin signals were 
visualised by immunostaining with anti-GFP, anti-DmEB1 and anti-Sentin 
antibodies. By visual examination, Sentin immunostaining level (third column) was 
not affected in cells expressing SRAA peptide (top panel). SRAA peptide (first 
column, top panel) was diffused inside the cell. DmEB1 (blue arrowheads) 
colocalised to Sentin (red arrowheads) at the microtubule plus ends. DmEB1 or 
Sentin localisation was not affected in the cell expressing the peptide compared to 
the cell not expressing the aptamer. A typical transfected (top panel) and 
untransfected (bottom panel) cell on the same slide are shown for comparison. The 
fourth column shows merged images from the three preceding columns. Bars, 10 
µm. The yellow boxes indicate the areas that are magnified in the images below. 
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Figure 4.18 Sentin accumulation in Drosophila S2 cells expressing peptide 
Jumbled 
Drosophila S2 cells were transfected with  plasmid encoding peptide Jumbled 
displayed from GFP protein scaffold. GFP, DmEB1 and Sentin signals were 
visualised by immunostaining with anti-GFP, anti-DmEB1 and anti-Sentin 
antibodies. By visual examination, Sentin immunostaining level (third column) was 
not affected in cells expressing Jumbled peptide (top panel). Jumbled peptide (first 
column, top panel) was diffused inside the cell. DmEB1 (blue arrowheads) 
colocalised to Sentin (red arrowheads) at the microtubule plus ends. DmEB1 or 
Sentin localisation was not affected in the cell expressing the peptide compared to 
the cell not expressing the aptamer. A typical transfected (top panel) and 
untransfected (bottom panel) cell on the same slide are shown for comparison. The 
fourth column shows merged images from the three preceding columns. Bars, 10 


































Figure 4.19 Sentin signal at the microtubule plus ends in 
Drosophila S2 cells expressing peptide SRAA or Jumbled 
Drosophila S2 cells were transfected with  plasmids encoding peptide 
SRAA or Jumbled displayed from GFP protein scafold. For control, 
cells were transfected with plasmid expressing GFP only or aptamer 
Perfect. GFP, DmEB1 and Sentin signals were visualised by 
immunostaining with anti-GFP, anti-DmEB1 and anti-Sentin 
antibodies. (A) To assess Sentin immunostaining signal at the 
microtubule plus ends, Sentin signal was measured using Volocity by 
hand-drawing DmEB1 area surrounding the comet. The local 
background area of the same size as the area of the comet was also 
selected next to each comet. Three comets each were measured in ten 
separate cells. (B) Sentin signal at the microtubule plus ends in cells 
transfected relative to untransfected. Error bars are SEM ; for control 











These results show that SxIP is critical for binding of aptamer Perfect to 
DmEB1 and particular amino acids at specific positions are important for the 
binding.   
4.3. Expression of peptide aptamers in Drosophila 
4.3.1. Ubiquitous aptamer expression reduces Drosophila viability 
I aimed to test what effects has expression of peptide aptamers has on Drosophila. To 
express peptide aptamers in Drosophila, genes encoding these peptide aptamers were 
introduced into the Drosophila germline by P-element mediated transformation (done 
commercially). P-element mediated transformation is a powerful technique using 
transposable DNA that inserts itself randomly into genomic DNA of a Drosophila. 
The transformants were possible to select from the untransformed Drosophila 
because of an eye marker linked to the genes encoding the peptide aptamers. 
To express peptide aptamers in Drosophila, I took an advantage of 
GAL4/UAS system which allows for a targeted gene expression. The system has two 
components which can be carried by different Drosophila lines, the GAL4 gene 
specific to S. cerevisiae encoding GAL4, a transcription factor, and the UAS 
(upstream activating sequence) to which GAL4 binds and activates expression of a 
downstream gene (Duffy, 2002; Fischer et al, 1988). These can be brought together 
by genetic crossing to induce expression from a peptide aptamer gene downstream of 
the UAS. To ubiquitously express a peptide aptamer in a Drosophila, I introduced by 
genetic cross GAL4 driven by actin 5C promoter into a Drosophila line carrying a 
peptide aptamer gene under UAS. For control, I introduced the GAL4 driven by actin 
5C promoter into wild-type Drosophila.  
Drosophila expressing aptamer T14, 37, 37 dimer, Perfect or Perfect dimer 
were viable and formed a complete adult body. These Drosophila could recover into 
an upright position as quickly as the controls after they were turned upside down and 
walked normally. All the peptide aptamer Drosophila mutants were tested for 
viability. To quantify the Drosophila viability, a Drosophila line homozygous for a 
peptide aptamer gene under UAS was crossed with a Drosophila line heterozygous 
between chromosome carrying GAL4 (under actin 5C promoter) and one without it. 
144
This cross gave two types of progeny, first with GAL4 and UAS-aptamer, allowing 
for expression of a peptide aptamer, and the second population which contained only 
the UAS-aptamer, so not expressing a peptide aptamer. A ratio was calculated of the 
Drosophila number representing two genotypes resulting from the cross. For all cases 
a relative number of adult Drosophila expressing aptamers was reduced with respect 
to the Drosophila not expressing the aptamers (Figure 4.20). The highest reduction 
(by ~80%) in viability had Drosophila expressing aptamer 37 or Perfect (Figure 
4.20). Although less affected, the viability of Drosophila expressing aptamer T14, 37 
dimer or Perfect dimer was also reduced (by ~60%) (Figure 4.20). The Drosophila 
were next tested for fertility by crossing single Drosophila expressing a peptide 
aptamer with wild-type Drosophila. Frequency of sterile Drosophila was not 
statistically significantly different comparing to the control (p > 0.05).  
Expression of aptamers T14, 37, 37 dimer, Perfect or Perfect dimer did not 
affect adult Drosophila morphogenesis, fertility and locomotion. However, 
expressing these peptide aptamers significantly reduced Drosophila viability.  
4.4. Discussion 
In Drosophila S2 cells, DmEB1 is essential to maintain microtubules dynamic in 
interphase and it is required for accurate segregation of chromosomes by maintaining 
correct spindle architecture and dynamics in mitosis (Rogers, 2002). At the whole 
organism level, where residual amount of DmEB1 is produced, DmEB1 was shown 
to be essential during Drosophila development for neuromuscular functions and 
viability (Elliott et al, 2005). Not only being essential in Drosophila development, 
human EB1 is expressed in adult tissues, including tissues whose cells generally do 
not divide (Nakagawa et al, 2000). Consistently, DmEB1 is ubiquitously expressed 
in Drosophila adults, including head, abdomen and thorax (Elliott et al, 2005).  
Since DmEB1 is essential for cell division, it is challenging to study its 
post-mitotic roles, particularly in a context of a multicellular organism. I aimed to 
develop a new tool to inhibit DmEB1 in adult Drosophila, also after the Drosophila 
came out of the pupae case. By inducing expression of peptide aptamers strongly 
bound to DmEB1 in specific tissues, I would be able to investigate what impact has 
microtubule regulation by DmEB1 in tissues of a multicellular organism.  
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Figure 4.20 Viability of Drosophila expressing peptide aptamers 
To quantify viability, Drosophila heterozygotes of GAL4 (driven by 
actin 5C) and a wild-type chromosome (TM6C) were crossed with 
Drosophila homozygous for a peptide aptamer gene under UAS or 
wild-type flies for control. A relative number was calculated of the 
flies representing two genotypes resulting from the cross (first 
genotype with GAL4 and UAS components and the second genotype 
which contained only the UAS component). p = 0.02 for aptamer 













In the previous chapter, I described the use of peptide aptamers to dissect 
sequence determinants required for binding to DmEB1. I also found strong peptide 
aptamers to DmEB1. In this chapter, I showed that expressing these strong peptide 
aptamers in Drosophila S2 cells and in a multicellular organism of a Drosophila can 
be used to address biological questions. 
Since I aimed to express some of peptide aptamers in a multicellular 
organism, it was essential for these peptide aptamers to target DmEB1 in presence of 
other endogenous Drosophila proteins. Drosophila S2 cells were used to investigate 
localisation of peptide aptamers. I showed that peptide aptamers colocalised with 
DmEB1 at the microtubule plus ends which was an important confirmation of their 
specific binding to DmEB1. Importantly, the single constrained peptide aptamers, 
which are considered to have lower proteolytic stability than the double constrained 
ones, were observed to colocalise with DmEB1, too, which confirms their presence 
and activity inside the cells.  
This study showed that colocalisation of dimerised aptamer 37 with DmEB1 
at the microtubule plus ends was more pronounced than localisation of the monomer. 
The finding is in agreement with a study which showed improved microtubule plus 
end localisation of a dimerised peptide derived from MACF (Buey et al, 2012). The 
other oligomerised peptide aptamers also colocalised with DmEB1 in cells, however, 
they sometimes changed the DmEB1 localisation. Apart from DmEB1 localising to 
the microtubule plus ends, it also bound along the microtubules and bundled them. It 
is possible that a single peptide aptamer molecule bound multiple DmEB1 and 
formed a higher-order structure. 
Importantly, apart from binding to DmEB1, this work demonstrated that 
peptide aptamers also competed with endogenous proteins for binding to DmEB1. I 
showed that a level of a natural interactor protein at microtubule plus ends was 
significantly reduced in presence of all of the tested peptide aptamers. All the peptide 
aptamers interfered with binding to DmEB1 but none of these peptide aptamers 
could completely outcompete a natural interactor protein since residual amounts of 
Sentin were observed on some of the microtubule plus ends. This partial 
effectiveness of peptide aptamers may be a reason why expressing them did not 
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cause phenotype seen in cells depleted of that natural DmEB1 interactor (shorter 
spindles) (Li et al, 2011).  
Since DmEB1 is one of several EB1 homologues in Drosophila (Hiro 
Ohkura, personal communication), it is possible that the other homologues can 
complement for DmEB1 when it is inactivated by peptide aptamers. I showed in 
chapter 3 that amino acids promoting binding of peptides containing SxIP to human 
EB1 or EB3, although similar, are different at some positions. The peptide aptamers 
which I expressed in Drosophila S2 cells may bind specifically, or stronger, to 
DmEB1 but not to other DmEBs, allowing these other DmEBs to recruit MAPs to 
microtubules. To ensure that other DmEBs do not compensate for DmEB1 inhibited 
by peptide aptamers, one could find and simultaneously express peptide aptamers to 
other DmEBs or a single peptide aptamer which binds different DmEB proteins. 
However, it would be necessary to first investigate what are similarities and 
differences of SxIP binding motifs targeted by such DmEB proteins to find a 
universal aptamer.  
In this study, I also demonstrated that aptamer Perfect, a peptide aptamer 
designed by combining into one sequence amino acids which promoted binding at 
subsequent positions to DmEB1, colocalised with DmEB1 in Drosophila S2 cells. I 
also showed that this designed peptide aptamer displaced a natural DmEB1 
interactor. Therefore, a synthetic peptide aptamer was generated which binds a target 
protein in the presence of endogenous proteins. For the first time, this work showed 
novel approach to finding a strong peptide aptamer which was achieved by a specific 
designing of the peptide which has high binding activity in presence of endogenous 
competitors.  
I further showed that the amino acids flanking SxIP in this synthetic 
aptamer Perfect are not sufficient to trigger binding to DmEB1. The SxIP is crucial 
for binding of aptamer Perfect to DmEB1, as shown in Y2H and in Drosophila S2 
cells. This finding is in agreement with another study where these Ile-Pro residues of 
a peptide derived from a human MAP when mutated to polar amino acids also 
eliminated binding of this peptide to EB1 (Honnappa et al, 2009). I also showed that 
the amino acid order in SxIP vicinity of aptamer Perfect is essential for interaction 
with DmEB1 in Y2H. Although in Drosophila S2 cells the variant of aptamer Perfect 
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with the changed amino acid order did not colocalise with DmEB1, this variant still 
weakly interfered with binding of a MAP to DmEB1. However, the interference was 
much less pronounced as when expressing the non-jumbled aptamer Perfect. Since 
the effect was subtle and statistical difference between cells expressing and not 
expressing jumbled aptamer Perfect was marginal (p = ~0.02), I would repeat this 
analysis. A similar study was performed to verify a peptide aptamer sequence 
specificity to its target where the amino acid sequence of a peptide aptamer was 
randomised (Warbrick, 2006). However, my approach used a less dramatic change of 
amino acids. Not only the amino acid order was changed within a much shorter 
region (7 vs. 16 amino acids) but also each amino acid was shifted by one position 
(Figure 4.15). In comparison, in Warbrick et al., 2006, amino acids were shifted from 
the original positions by as far as 7 amino acids. Therefore, I demonstrated that 
interaction of aptamer Perfect with DmEB1 is highly specific to the order of the 
amino acids in the peptide aptamer, further confirming that certain amino acids at 
very specific positions are important for the binding. 
Expressing peptide aptamers in a multicellular organism has been done but 
it is not yet a common practice. Recently, peptide aptamers were expressed in 
Drosophila to demonstrate that disruption of a signalling pathway results in an 
abnormal wing development (Yeh et al, 2013). In this chapter, I demonstrated that 
the peptide aptamers I found, and the synthetic aptamer Perfect, can be also used for 
a protein function studies. Expressing peptide aptamers in Drosophila significantly 
reduced their viability (by up to 80%). Although it is most likely that this reduction 
in viability was caused by aptamers which disrupted recruitment of MAPs to 
microtubules by binding to DmEB1, one cannot exclude the possibility that these 
peptide aptamers targeted different proteins than DmEB1 when expressed in 
Drosophila. Also, assuming that these peptide aptamers inhibit DmEB1 function 
when expressed in Drosophila, they did not inhibit DmEB1 completely. It was 
previously shown that neuromuscular functions and viability were affected in mutant 
Drosophila expressing residual amounts of DmEB1 (Elliott et al, 2005). It would be 
interesting to investigate whether expressing peptide aptamers to DmEB1 in these 
mutant Drosophila would enhance the phenotype. Another interesting approach 
would be to introduce genes encoding a peptide aptamer to DmEB1 and a DmEB1 
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RNAi into the same Drosophila line. RNAi itself can only deplete messenger RNA 
and hence inhibit a protein expression, leaving the already produced protein intact. 
Expressing peptide aptamers in concert with RNAi could abolish the protein 
function. This method would be particularly valuable in differentiated cells. Since the 
already produced protein pool, carried from previous cells from which a tissue 
originates, in differentiated cells cannot be diluted by rounds of cell division, as in 
the mitotic cells, because differentiated cells no longer divide. Although peptide 
aptamers were not as effective in Drosophila as expected, they can be used to 
inactivate the residual DmEB1 in cells no longer expressing this protein because of 
RNAi. Peptide aptamers have never been used in Drosophila together with RNAi, 
thus it would be a novel and possibly a powerful tool to study protein functions in 
differentiated cells in Drosophila.   
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CHAPTER 5 
Msps is important for neuromuscular functions 
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5.1. Single constrained peptide aptamers to Msps 
5.1.1. Screening prey plasmid library for peptide aptamers to Msps 
Msps is one of two unique MAPs which bind and track growing microtubule plus 
ends autonomously. In interphase cells, Msps has an antipausing activity on 
microtubules and in mitosis it is also responsible for keeping spindle integrity (Brittle 
& Ohkura, 2005; Cullen et al, 1999). Except for being abundant in the dividing cells, 
since it is essential for cell division, Msps is also highly expressed in brain 
(Charrasse et al, 1998; Gard & Kirschner, 1987). To identify post-mitotic roles of 
Msps in a context of a multicellular organism, I aimed to find peptide aptamers 
which bind to Msps. To perform Y2H screen, two bait plasmids were constructed by 
gap repair as previously. One bait plasmid contains N-terminal fragment of Msps 
including tubulin interaction region (amino acids 1-550) and the other contains C-
terminal fragment of Msps including D-TACC interaction region (amino acids 1543-
2042). For positive controls of Y2H, two prey plasmids were made including either 
full length D-TACC or α-tubulin.  
Y2H prey plasmid library encoding completely random, single constrained 
peptides with 16 residues was constructed next and its quality was verified as 
previously described. The sequences were heterogeneous mixture of nucleotides 
encoding peptides composed of amino acid mixture without any amino acids 
dominating and each of the peptides was unique (Figure 5.1 and 5.2). Five out of the 
ten transformants contained a prey plasmid encoding 16 amino acids followed by the 
stop codon, as designed (Figure 5.2). A premature stop codon was present in four 
transformants, but three of them were still reasonably long (Figure 5.2). There was 
no stop codon after the 16th amino acid in one transformant making the insert longer 
than it was designed (Figure 5.2).  A chi-squared test was performed to test whether 
amino acids encoding the library occurred at random at each position in the library, 
as previously described (Figure 5.3). Amino acids occurrence on all 16 positions was 
random (p > 0.05). Since 90% of the random peptide fragments were of good 
composition and acceptable lengths and amino acids were encoded at random at the  
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   nnKnnKnnKnnKnnKnnKnnKnnKnnKnnKnnKnnKnnKnnKnnKnnKTGA 
1  CTTCCGTTTTTGTCTCTGTTTAGGAGTCGGGTTGAGCTTTTGATGCATTGA 
2  GTTAGGTTTAGATTTTTATTGAGCCTATTTATGAGAATAGGCGGGGTTTGA 
3  TGGTCGTGTCATTTTTGTCTGCTGCCTGGTGTTATGCAGTTTTTTGTGTGA 
4  TGATAAGGCTTGTTTGGTGAATTCACAGTTGTTGATTCGAGCTCGAGAGAT 
5  AGGGTTAGTGGTCATTAGTATATTTAAAATGTGGATTTTGCTTATACGTGA 
6  ACTTTTAGTGTTTTGAAGGCGTGATTCGAGCTCGAGAGATCTATGAATCGT 
7  CCTTTTGGTTCTGTTACGTGTTATGTTGATTGTGCTGTTCAGGTTAATTGA 
8  GAGTATGGGACTGGGATGCCGTGCCATTTGTTTTAGAGGGAGTGTGGTTGA 
9  GCGGGGTTGTCGATGCATGTGCTTTGGAGTCGTTGGACGTCTCGTAATTGA 
10 ATTCATGATCCTGCTTTTGAGAAGGCGAAGTCGCGTTTGTATGTGTTTTTG 
Figure 5.1 The composition of the unselected NNK prey plasmid library  
Yeast were cotransformed with linearised prey vector and DNA encoding random 
peptides flanked by sequences corresponding to fragments of 5’ and 3’ on linearised 
prey vector for gap repair. Transformants were plated on media selective for the prey 
plasmid but not activation of reporters. The region embracing the insert site on the prey 
plasmid was amplified by PCR from clones picked at random and sequenced. The 
sequences were a heterogeneous mixture of nucleotides. K = G/T, n = A/T/C/G  
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1  LPFLSLFRSRVELLMH- 
2  VRFRFLLSLFMRIGGV- 
3  WSCHFCLLPGVMQFFV- 
4  --GLFGEFTVVDSSSRD 
5  RVSGH-YI-NVDFAYT- 
6  TFSVLKA-FELERSMNR 
7  PFGSVTCYVDCAVQVN- 
8  EYGTGMPCHLF-RECG- 
9  AGLSMHVLWSRWTSRN- 
10 IHDPAFEKAKSRLYVFL 
Figure 5.2 The composition of the unselected NNK prey plasmid library  
Yeast were cotransformed with linearised prey vector and DNA encoding random 
peptides flanked by sequences corresponding to fragments of 5’ and 3’ on linearised 
prey vector for gap repair. Transformants were plated on media selective for the prey 
plasmid but not activation of reporters. The region embracing the insert site on the 
prey plasmid was amplified by PCR from clones picked at random and sequenced.  


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































subsequent positions within the library, I concluded that the library was of good 
quality. 
Y2H was performed as previously described. In total, ~40 million peptides 
were screened for binding to Msps N-terminus. Only one transformant which 
activated both reporter genes was found, but later it was shown to be a false positive 
as expression of reporter was not dependent on aptamer. Two transformants, C2 and 
C28, which showed activation of both reporter genes, were found after screening ~6 
million peptides for Msps C-terminus.  
5.1.2. Peptide aptamers to Msps C-terminus  
To determine the amino acid sequences encoded in the variable region on prey 
plasmids in transformants C2 and C28, these DNA fragments were amplified from 
yeast colonies and sequenced. While C2 was a 16 amino acid peptide as designed, 
C28 was 24 amino acids long due to a frameshift resulting in a delayed stop codon 
(Figure 5.4 A). 
To exclude that expression from the lacZ reporter gene in transformants C2 
and C28 was caused by a spontaneous mutation in plasmid or yeast, the DNA 
encoding the peptides was amplified and inserted back into a prey plasmid in yeast 
transformation as described. Both yeast carrying Msps C-terminus and 
cotransformed with C2 or C28 showed expression of the reporter gene. However, 
one of C28 transformants tested failed to express from the reporter gene. The DNA 
encoding the variable peptide region of this white transformant was sequenced. A 
missense mutation of the first base was found in the DNA encoding the variable 
peptide region of the prey plasmid, changing Phe to Ile (Figure 5.4 B). To exclude 
the possibility that C2 and C28 peptides fused to the GAL4 activation domain induce 
expression of lacZ on their own, rather than by interaction with the bait, it would be 
necessary to cotransform yeast carrying empty bait vector with each of the prey 
plasmids. 
I found two true interactors of Msps C-terminus, which are hereafter called 
aptamer C2 and C28. I also showed that the first amino acid of aptamer C28, 
phenylalanine, is important for the C28 interaction with the C-terminus of Msps. 
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Figure 5.4 The amino acid sequences of the peptides found in Y2H for Msps 
interactors  
(A) Two peptides were found in Y2H screen for interactors of Msps C-terminus, C2 
and C28. (B) A point mutation in peptide C28, changing phenylalanine to isoleucine, 
showed that this phenylalanine is essential for interaction of C28 with Msps. 
Asterisks indicate stop codons. The sequence mutation resulting in amino acid 
substitution is highlighted in yellow.  
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5.2. Expression of peptide aptamers in Drosophila S2 cells 
5.2.1. Peptide aptamers to Msps are diffused in Drosophila S2 cells 
Since I aimed to express aptamers C2 and C28 in Drosophila, I tested whether they 
colocalise with Msps in presence of endogenous proteins by expressing them in 
Drosophila S2 cells. I expected that if peptide aptamers interact with Msps inside the 
cells, these peptide aptamers will colocalise with Msps. Drosophila S2 cells were 
transfected with a plasmid expressing GFP-fused aptamer C2 or C28 under control of 
actin 5C promoter. For negative control, Drosophila S2 cells were transfected with a 
plasmid expressing GFP only. Localisation of the aptamers was assessed by 
immunostaining using a GFP and a tubulin antibody. Both of the aptamers were 
diffused inside the cells (Figure 5.5). Microtubule array was unchanged in cells 
expressing the aptamers (Figure 5.5).  
While Msps binds to microtubules, aptamers C2 or C28 did not colocalise 
with microtubules. Instead, the aptamers were uniformly diffused inside the cells. 
However, it cannot be excluded that these peptide aptamers interacted with the 
cytoplasmic pool of Msps.  
5.3. Expression of peptide aptamers in Drosophila 
5.3.1. Peptide aptamers have no effect on Drosophila 
Although aptamers C2 and C28 did not colocalise with microtubule plus ends in 
cultured cells, I investigated whether their expression has an effect on a developing 
Drosophila. Genes encoding the peptide aptamers were introduced commercially into 
the Drosophila genome by P-element-mediated transformation as previously. 
Taking advantage of the GAL4/UAS system, expression was induced by 
bringing the two components together, an aptamer gene under UAS and GAL4 under 
actin 5C promoter, in a genetic cross. For negative control, I introduced the GAL4 
driven by actin 5C promoter into wild-type Drosophila.  
Drosophila expressing aptamers C2 or C28 were viable and formed a 
complete adult body. The frequency of the Drosophila expressing the aptamers was 
not significantly different from the control Drosophila. To test whether expressing an 
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Figure 5.5 Peptide aptamers C2 and C28 are diffused in Drosophila S2 
cells and do not affect microtubule array 
Drosophila S2 cells were transfected with plasmid encoding peptide aptamer 
C2 or C28 displayed from GFP protein scaffold. GFP and tubulin signals were 
visualised by immunostaining with anti-GFP and anti-γ-tubulin antibodies. The 
third column shows merged images from the two preceding columns. The 
peptide aptamers were diffused inside the cells and they did not affect 
microtubule array. A typical transfected (top panel) and untransfected (bottom 
panel) cell on the same slide are shown for comparison.  Bar=10 μm. 















aptamer has an effect on Drosophila locomotion, the Drosophila were knocked 
upside-down. These Drosophila could recover into an upright position as quickly as 
the controls and they also walked normally. To test for fertility, single Drosophila 
expressing aptamer C2 or C28 were crossed with wild-type Drosophila. The 
frequency of fertile Drosophila expressing either of the peptide aptamers was not 
significantly different from the control Drosophila (p > 0.05).  
Summarising, expression of aptamers C2 or C28 has no detectable effect on 
Drosophila viability, morphogenesis, locomotion or fertility.  
5.4. Msps has neuromuscular functions in Drosophila 
5.4.1. A temperature-sensitive msps mutant was generated 
Since expression of peptide aptamers in Drosophila did not inactivate Msps, I 
investigated whether amino acid change equivalent to temperature-sensitive mutation 
in msps plant homologue, mor1, would result in msps temperature-sensitive 
Drosophila (Figure 5.6). 
Transgenic msps [E190K] Drosophila were generated commercially by P-
element-mediated transformation as previously. The plasmid used for the 
transformation was made by Brittle et al, 2005, and encoded a mutant gene under the 
control of the native msps promoter. The [E190K] mutation was generated by site-
directed mutagenesis (Brittle & Ohkura, 2005).  
To test if transgenic msps [E190K] Drosophila in the msps null background 
(as described in Figure 2.1) are temperature-sensitive, these Drosophila were grown 
at the permissive (18°C) or restrictive (25°C) temperature. The mutant larvae were 
able to pupate at both temperatures. The mutant Drosophila grown at the restrictive 
temperature died at early pupae. The msps [E190K] mutants in the msps null 
background grown at the permissive temperature came out of pupae case and looked 
normal. The msps [E190K] Drosophila in the msps null background were tested for 
fertility by crossing single Drosophila with the wild-type Drosophila. Crosses were 
set up at the permissive or at the restrictive temperature. The msps [E190K] female 
Drosophila were sterile at both temperatures. ~50% of male mutant Drosophila kept 
at permissive or restrictive temperature were fertile.  
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Figure 5.6 Point mutation in MOR1 and Msps causes their 
temperature-sensitivity. 
Amino acid sequence comparison of TOG1 fragments from 
MOR1 and Msps. Mutation at position 195 in MOR1 and 190 in 
Msps (indicated by red arrowhead) leading to substitution of  
glutamic acid to lysine renders the proteins temperature-sensitive. 
Residues in bold indicate sequence identity.  
MOR1  VRASAKGVTLELCRWIG 201 
Msps  VRDEGKQLAVEIYRWIG 196 
E195K 
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I concluded that Drosophila carrying msps [E190K] in the msps null 
background are temperature-sensitive and hereafter called mspsts Drosophila. 
5.4.2. Msps is essential for maintenance of neuromuscular functions but not 
survival of adult Drosophila  
To test if msps has a role in maintenance of adult functions, adult Drosophila 
carrying mspsts were grown at the permissive temperature and then, within 24 hours 
after coming out of pupae, they were shifted to the restrictive temperature. Wild-type 
Drosophila in the msps null background were used for control. Drosophila were 
tested daily for 13 days after temperature shift for their ability to climb up the wall of 
the vial. The vials, one with the mutant and the other with the wild-type Drosophila, 
were recorded daily side by side. The mspsts Drosophila climbed up the vial visibly 
slower than the control Drosophila or not at all after four days following the shift to 
the restrictive temperature (Figure 5.7). After nine days most of the mutant 
Drosophila kept at restrictive temperature did not climb up the vial (Figure 5.7). 
Therefore msps has a role in maintenance of neuromuscular functions of adult 
Drosophila. 
From day one after coming out of the pupae case, some of the mutant 
Drosophila had abnormally spread wings or held their wing(s) out and up and moved 
them in an uncoordinated way. To assess their flying abilities, flight tests were 
performed similar to that described by Benzer et al. (1973) with modification of the 
cylinder, which was lined with a moist tissue paper to reduce static electricity 
(Benzer, 1973). mspsts mutants, or wild-type Drosophila for the control, were grown 
at the permissive temperature and shifted to the restrictive temperature within 24 
hours after they came out of pupae case or were kept at the permissive temperature. 
Drosophila were assessed for flying abilities daily by releasing them individually into 
a cylinder through a funnel (Figure 5.8 A). The approximate height where a 
Drosophila landed in the cylinder was recorded. Next, statistical analyses showed 
that mspsts Drosophila, regardless the temperature, were significantly different from 
the wild-type Drosophila (p < 0.01). The median values for the flight of the mutant 
Drosophila were lower than for the wild-type Drosophila (Figure 5.8 B). No 














































































































































































































































































































































































Figure 5.8 Flying of mspsts Drosophila is compromised 
Adult mspsts Drosophila grown at the permissive temperature were shifted to 
the restrictive temperature within 24 hours after coming out of pupae case. 
Wild-type Drosophila in the msps null background were used for control. 
(A) Drosophila were assessed for flying abilities daily by releasing them 
individually into a cylinder through a funnel, gently tapping avial. An 
approximate height where a Drosophila landed in the cylinder was recorded. 





Day mspsts wild-type 
1 0 27 
2 0 25 
3 4 24 
4 0 28 
5 0 26 
6 18 27 
7 0 26 
8 18 26 
9 4 28 
11 0 26 






permissive temperature from the mutant Drosophila grown at restrictive temperature 
(p > 0.01).  
Hence the msps [E190K] mutation has a negative effect on neuromuscular 
abilities of Drosophila in both permissive and restrictive temperature. These results 
showed that msps is important for maintenance of neuromuscular functions in adult 
Drosophila. 
5.4.3. Msps is essential for neuromuscular functions in developing Drosophila 
pupae 
To test if Msps affects development of Drosophila pupae, Drosophila were crossed at 
permissive temperature to obtain mspsts progeny. Pupae were picked up each day (1-
24, 24-48, 48-72, 72-96, 96-120 and 120-144 hour) after pupation and transferred to 
the restrictive temperature. For the control, a vial of the mutant pupae was kept at the 
permissive temperature.  
Almost all, 97%, of 100 tested mspsts pupae shifted to 25°C earlier than 72 
hours after pupation failed to emerge from the pupae (Figure 5.9). Dissection of 
pupae indicated that a complete adult body was formed inside the pupae case and 
limited leg movement was observed in some. Half of mspsts Drosophila shifted to 
25°C four days after pupation came out from pupae (22 out of 44) but almost all of 
them, 18 Drosophila, were unable to walk (Figure 5.9). Two mutant adults (~10%) 
which emerged moved in an uncoordinated way and it took them significantly longer 
than the wild-type Drosophila to correct their body positions once pushed upside 
down. A large majority, 10 out of 13 (~80%), of mspsts Drosophila shifted to the 
restrictive temperature from five days after pupation emerged from pupae (Figure 
5.9). While half of them could walk normally, the other half was uncoordinated and 
they failed to recover their correct body position promptly once upside down. All 
nine control Drosophila kept at 18°C throughout the development emerged from 
pupae and seven (~80%) of them were fully coordinated (Figure 5.9). 
Therefore Msps is important for neuromuscular functions in developing 
Drosophila. The time period of 0 – 4 days (at 18°C) after pupation is critical for the 
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To narrow down the time period when msps is particularly important in 
developing pupae, mspsts larvae grown at 18°C were shifted to 25°C at pupation 
(Figure 5.10). Following incubations of half, one, one and a half or two days (0-12, 
12-24, 24-36 and 36-48 hours) at restrictive temperature, the pupae were shifted back 
to the permissive temperature. The vast majority (23 out of 28) of the mspsts 
Drosophila developing at the restrictive temperature for 12 hours from pupation 
emerged from pupae and 17 of them were fully coordinated (Figure 5.10). The 
remaining 6 of mutants had significant coordination problems. Less than 50% (41 out 
of 86) of the mutants developing at the restrictive temperature for 24 hours from 
pupation emerged from pupae but 37 of them did not walk at all (Figure 5.10). A 
complete adult body was formed inside the pupae case and limited leg movement 
was observed. 
Therefore, msps is critical for neuromuscular functions in developing 
Drosophila pupae in the time period from 12 to 48 hours at 25°C from pupation. 
5.5. Discussion 
In this chapter, I described work aiming to inactivate Msps, another crucial regulator 
of microtubule dynamics. Similarly to DmEB1, I tried to identify peptide aptamers to 
disrupt protein interactions with Msps. Moreover, I generated a new tool, a msps 
temperature-sensitive Drosophila, allowing to study role of microtubule regulation 
by Msps in multicellular organism. 
To find peptide aptamers to Msps, I used Msps fragments rather than the 
full length protein in Y2H. Firstly, Msps is a large protein (2050 amino acids) which 
could cause handling difficulties. Secondly, since the major interaction sites of Msps 
have been mapped (tubulin binding occurs via N-terminal TOG domains and D-
TACC binding via the C-terminus), I targeted peptide aptamers to disrupt specific 
interactions (Lee et al, 2001; Slep & Vale, 2007). Two peptide aptamers to Msps C-
terminus were found but I did not find any peptide aptamers binding to the N-
terminus. A possible explanation for the difficulty in finding interactors of the N-
terminus of Msps is the structure of TOG domains. The crystal structure of TOG 

































































































































































































































































































































did not emerge 
of pupae case 
168
peptide aptamer, could dock. Also, Msps binds to tubulin via multiple interfaces 
generated by TOGs arrayed in tandem.  
Next, the two peptide aptamers were expressed in cultured cells to 
investigate their localisation. I expected that if a peptide aptamer interacts with Msps, 
I would see an aptamer localising along the microtubules, the same as localisation of 
Msps. Although these peptide aptamers were evenly diffused inside the cells and I 
did not see their colocalisation with microtubules, it is possible that they still 
interacted with the cytoplasmic pool of Msps. However, another possibility is that C2 
and C28 peptides fused to the GAL4 activation domain in two-hybrid screen induced 
expression of lacZ on their own. To exclude this possibility, it would be necessary to 
cotransform yeast carrying empty bait vector with each of the prey plasmids to see if 
they express from the reporter gene. 
These peptide aptamers were further expressed in Drosophila. However, 
expression of aptamers did not have any strong effect on Drosophila viability, 
morphogenesis, locomotion or fertility. 
Peptide aptamers did not inactivate Msps but a different tool was presented 
in this study. I showed that an amino acid change in msps, equivalent to a 
temperature-sensitive mutation in plant homologue, mor1, results in msps 
temperature-sensitive Drosophila.  
Msps is required for cell division and it is not only highly expressed in 
proliferating tissues but also in brain, which is mostly composed of differentiated 
cells (Charrasse et al, 1998; Cullen et al, 1999; Gard & Kirschner, 1987). Similarly 
to DmEB1, studying the function of a protein which is necessary for cell division at a 
whole organism level is challenging. msps null mutant Drosophila are available but 
these mutants die around larvae-pupae transition (Cullen et al, 1999). The 
temperature-sensitive msps mutant Drosophila are an improvement in studies of 
Msps because these mutants will allow investigation of the roles of the protein in 
adult Drosophila.  
Initially, I investigated whether msps affects adult Drosophila in different 
stages of adulthood. I showed that Msps has neuromuscular functions in developing 
Drosophila. Shifting msps temperature-sensitive Drosophila at the pupae stage to the 
restrictive temperature for different amounts of time caused neuromuscular defects 
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ranging from uncoordinated movement, through walking difficulties to various 
degrees as well as partial or complete failure of emergence from the pupae. I also 
investigated whether Msps has a role in Drosophila after their emergence from the 
pupae by shifting msps temperature-sensitive Drosophila to the restrictive 
temperature. These Drosophila, five days after the shift, climbed up the wall of a vial 
visibly more slowly than the control and some of them did not climb up the vial at 
all. I showed that Msps is important for maintenance of neuromuscular functions in 
these adult Drosophila. I further confirmed that msps has neuromuscular functions in 
adult Drosophila by flight tests, where msps temperature-sensitive Drosophila did not 
fly as well as the control Drosophila. Therefore, msps is important for neuromuscular 
functions in Drosophila pupae as well as in Drosophila that came out of pupae case.  
However, I showed that the mspsts mutation is not fully functional at the 
permissive temperature since the Drosophila did not fly as well as the control 
Drosophila and they are also female sterile. It is important to be careful when mspsts 
Drosophila are used as a control. It would be interesting to find out whether the 
protein expression level is changed in the mutant Drosophila at both permissive and 
restrictive temperatures compared with the wild-type Drosophila.  
Previously, msps deficient embryos were shown to be defective in axonal 
fascicle morphology (incorrect bundling, axons and fascicles were wavy) (Lowery et 
al, 2010). I would like to investigate whether the neuromuscular defects that I 
observed in the adult Drosophila were also caused by abnormal neuron morphology, 
possibly leading to defective pathfinding by neurons and consequently, wrong 
neurone-muscle connections. Also, it is interesting to test whether neuromuscular 
junctions formed correctly in msps mutant adult Drosophila. Further, I would like to 
examine the organisation of microtubules in neurons of adult mutant Drosophila. 
Generating a msps temperature-sensitive mutant Drosophila will allow investigation 





Microtubules are highly regulated by MAPs to perform variety of functions in 
different types of cells. The same MAPs can regulate microtubule dynamics and 
organisation both in mitosis and in post-mitotic cells. However, it is a challenge to 
study non-mitotic functions of proteins essential for cell division at a whole organism 
level. To overcome the problem, I developed new tools: a msps temperature-sensitive 
Drosophila to study roles of Msps and peptide aptamers to interfere with DmEB1 
interactions.  
In this thesis I described the isolation of aptamers to DmEB1 which is 
central in regulating microtubule dynamics by recruiting many proteins to growing 
microtubule plus ends. I biased aptamer libraries by introducing invariant SxIP into a 
randomised amino acid sequence which improved efficiency of screening. This 
resulted in finding many aptamers which provided vital information on sequence 
determinants for DmEB1 binding. Although the SxIP motif was identified essential 
for binding of many MAPs to EB1, based on being overrepresented in known EB1-
binding fragments, it is not sufficient (Honnappa et al, 2009). Many proteins which 
have SxIP do not bind to EB1; the sequence flanking the motif has important 
stabilising effect on EB1-SxIP interaction (Buey et al, 2012). To find out what amino 
acids in the region flanking SxIP promote binding to HsEB1, a study was performed 
where each residue was systematically replaced in a MACF-derived fragment and 
tested for HsEB1 binding in vivo (Buey et al, 2012). The approach presented in this 
thesis was opposite; aptamers for EB proteins: DmEB1, HsEB1 and HsEB3 were 
selected in vivo from a pool of peptides with completely random amino acid 
composition in the region flanking SxIP. The results for HsEB1 sequence 
determinants are generally consistent between the two different studies but there are 
some differences in the pattern of sequence requirement. The differences may be due 
to different sequences used for testing: in my system a large pool of random 
sequences was used; the other study used a fragment of known HsEB1 interacting 
protein and changed amino acids systematically one by one. Also, the two studies 
were performed in different assay contexts, one was performed in vivo in yeast cells 
and the other study was carried out in vitro on a cellulose membrane. However, the 
sequence determinants found in either of the two screens do not strongly match any 
of the known EB1 interactor protein sequences; usually these are limited to only 
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some of amino acids determined in the screen laying in a basic amino acid 
environment. It is possible that too high SxIP-EB1 affinity is not advantageous inside 
the cells because it outcompetes other proteins from interacting with EB1. Also, 
considering that the SxIP protein family is large and still growing, these proteins 
have to have moderate affinities to EB1 for each of them being able to interact with 
EB1.  
By comparing peptide interactors found in screen for HsEB1 or HsEB3, I 
showed that sequence requirements in region flanking SxIP is similar for the two 
proteins but there are also significant sequence differences at particular positions. 
This finding is consistent with studies reporting that mammalian EB1 and EB3 share 
functions and SxIP interactors but they also have diverse functions and interactors in 
myogenesis and neurogenesis (Geraldo et al, 2008; Zhang et al, 2009). The finding 
presented in this thesis provides an insight into a molecular level of these differences. 
Findings presented in my study can be further applied if one wanted to 
improve an SxIP protein binding to EBs, for example to amplify the effects resulting 
from such interactions. Improving affinity of specific SxIP proteins to EBs could 
help addressing the question as to the role of this specific protein when in interaction 
with an EB. Such experiment could give a similar effect to overexpressing the 
protein but it would allow for a finer dissection of the protein role; providing an 
information of this protein’s role in the context of interaction with an EB protein. 
Such an experimental setup would also have an advantage over protein 
overexpression as it would not increase the global protein level. Peptide aptamers for 
the EB proteins also give an idea whether a set of natural protein interactors would 
significantly differ between the EBs and what amino acid positions are the most 
likely source of such differences.  
The aim of generating peptide aptamers binding to EBs was to learn about 
sequences that promote interaction with EB1 and its homologues. The other aim of 
using peptide aptamers in this study was to obtain new tools to interfere with 
DmEB1 or Msps functions at specific time and in specific tissues.  
Although aptamers for DmEB1 colocalised with the microtubule plus ends, 
the same as DmEB1, and they displaced Sentin from the microtubule plus ends, they 
did not cause shorter mitotic spindles, a phenotype specific to Sentin depletion. It is 
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possible that the aptamer expression level was not sufficiently high to saturate the 
DmEB1 pool. Also, it cannot be excluded that these aptamers targeted other proteins 
inside the cells reverting the Sentin RNAi phenotype. One could investigate this 
possibility by using a peptide aptamer to pull down proteins from the cell lysates. 
Also, Drosophila DmEB1 deletion mutants reach pupae stage but fail to eclose or 
they eclose (escapers) but have serious neuromuscular defects (Elliott et al, 2005). 
However, expressing peptide aptamers in Drosophila causes less severe effects. 
Although I observed strong reduction in viability, neuromuscular functions were not 
obviously affected. Previous studies by Elliott et al (2005) showed that the source of 
neuromuscular defects in Drosophila DmEB1 deletion mutants are disrupted 
chordotonal mechanosensory organs which are mechanosensory stretch receptors. 
Sensory units of chordotonal organs comprise of one or more ciliated neurons and 
several supporting cells where DmEB1 is concentrated. In Drosophila DmEB1 
deletion mutants neuronal cells in these organs are misaligned and stretched (Elliott 
et al, 2005). It would be interesting to look at the same organs in Drosophila 
expressing aptamers to investigate neuron morphology; whether aptamers cause a 
similar but possibly much less pronounced effect on chordotonal organs. Also, one 
could investigate at what stage of the development Drosophila die. However, to 
achieve the aim of utilising peptide aptamers for inhibiting DmEB1 function at 
specific time and tissue of Drosophila, it is necessary to improve its affinity for 
DmEB1 first. To improve binding of aptamer Perfect to DmEB1, I would perform 
another two-hybrid screen using prey plasmid library with fixed amino acids at these 
positions which were shown to promote the binding and leaving the rest of the 
positions random. It is also necessary to confirm the aptamer binding specificity 
inside the cells to ensure that it does not target different proteins. Additionally, I 
would introduce several genes for an aptamer in tandem to ensure saturation of 
aptamer-DmEB1 interaction.  
To study post-mitotic roles of Msps, I generated msps temperature-sensitive 
Drosophila. Although msps null mutant Drosophila are available, these mutants die 
around larvae-pupae transition (Cullen et al, 1999). Thus mspsts Drosophila is a 
powerful tool to investigate the protein roles at the whole organism level. To 
investigate the effect of this temperature-sensitive mutation, it would be interesting 
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to look at its molecular nature first, for example, does the mutant Msps still bind to 
tubulin? If so, is affinity of this interaction affected? Also, is the mutant protein 
produced at the wild-type protein level? One could check these by performing a pull 
down and western blotting experiments.  
In this thesis, I showed that Msps is crucial for development of 
neuromuscular functions in Drosophila pupae. However, further investigation is 
required to address the basis of these impairments. In this study, many of the 
Drosophila did not even eclose following pupae incubations at restrictive 
temperature. Since Msps is abundant in brain, I would first check if enough neurons 
were generated at pupae; neuroblasts continue dividing in brain and thorax until 
pupal stages, ceasing the division at ~120 hours from pupation (Maurange et al, 
2008). To investigate this, one could count the mitotic index of neuroblasts in the 
mutant and the wild-type pupae at subsequent stages.  
Msps is involved in axon guidance (Lowery et al, 2010). A study showed 
defects in axonal fascicle morphology in Drosophila embryos deficient of msps; 
axons and fascicles had incorrect pathfinding and axon bundling was abnormal 
(Lowery et al, 2010). Axonal guidance is an a very important process in Drosophila 
development because its body undergoes significant changes during metamorphosis 
and the neuronal network becomes significantly reorganized during the pupal period 
(Sánchez-Soriano et al, 2007). Many of the neurons which developed at larvae have 
to control their shape and size when at pupae. Microtubule dynamics is inherent to 
axon guidance as efficient microtubule rearrangements in the neuronal growth cones 
influence axon dynamics. Considering implication of Msps in embryonal axon 
morphology, one could predict its involvement in neuron rearrangements at pupae 
resulting in incorrect targeting of, for example, muscles and leading to walking 
impairments of mspsts Drosophila. One could investigate such possibility by pupae 
dissections and confocal imaging. 
In summary, new tools were developed which allow study of the roles of 
Msps and DmEB1 in Drosophila. Also, this work revealed amino acid residues 
which promote binding and specificity to EB proteins. Finally, my new approach to 
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